Sentence,class,file
Available from: http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.ema.europa.eu/em a/index.jsp?curl=pages/ medicines/human/medicines/002755/human_med_001711.jsp&mid=WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.ameli.fr/professionnels- de-sante/medecins/votre-convention/tarifs/index.php .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.ameli.fr/l-assurance-maladie/statistiques-et- publications/donnees-statistiques/affection-de-longue-duree-ald/ cout/cout-des-ald-en-2009.php .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
2011; Available from: http://www.sante.gouv.fr/ IMG/pdf/L_organisation_des_soins_psychiatriques_les_effets_du_plan_Psychiatrie_et_sante_mentale_2005-2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.ameli.fr/professionnels-de-sante/ medecins/votre-convention/tarifs/index.php .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: https://clinicaltrials.gov/ct2/ bye/uQoPWw4lZXc6edhHld-gWQ7xUXU3lB1ymB7gmXNgZdD9jdiudh9k6GgzwU6eBc8uB1glT490dhzzdUV9VLPD1WeKD zqcR48ayUgWi7PxQ7V9gCBWyN6edhHuB7Lzs8gDR4tWRC5 O1WgC8pxE6hB/SVD3FioH5TD3Z6p3WQh8J676NQ7gkB-5JdcBJwhGvQ13zwNz5dcxzno3kdhLeihGW6D3edp3WQh8J woyziNHuihzZdp3Z6p3S67gLwUyzdNgznh9NnoPl6D3FT7 LEih9mwS3Z6p3FBckeTN9EQoyzdNzk .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.codage.ext.cnamts.fr/ codif/bdm_it//ﬁche/index_ﬁc_ medisoc.php?p_code_cip=3400941766930&p_site= .,OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.codage.ext.cnamts.fr/ codif/bdm_it//ﬁche/index_ﬁc_ medisoc.php?p_code_cip=3400941766879&p_site= .,OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.codage.ext.cnamts.fr/ codif/bdm_it//ﬁche/index_ﬁc_ medisoc.php?p_code_cip=3400936249363&p_site= .,OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.codage.ext.cnamts.fr/codif/bdm_it//ﬁche/ index_ﬁc_medisoc.php?p_code_cip=3400938178883&p_site= .,OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.codage.ext.cnamts.fr/codif/bdm_it//ﬁche/index_ ﬁc_medisoc.php?p_code_cip=3400936407862&p_site=AMELI .,OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.codage.ext.cnamts.fr/ codif/bdm_it//ﬁche/index_ﬁc_ medisoc.php?p_code_cip=3400932635108&p_site= .,OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://www.codage.,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Availablefrom: http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?specid=666318 17&typedoc=R&ref=R0144737.htm .,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
Available from: http://agence-prd.ansm.sante.fr/php/ecodex/frames.php?,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
2012:8. http://www.invs.sante.fr/Publications-et-outils/Guides/Echantillon-national-temoin-representatif-des-personnes-diabetiques-Entred-2007-2010 90.,Non-OADS,/arxiv_data1/oa_pdf/1f/a9/40273_2015_Article_348.PMC4796324.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/8d/90/40271_2015_Article_136.PMC4796329.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.AdViSHE: Assessment of the Validation Status of Health-Economic Decision Models 359",Non-OADS,/arxiv_data1/oa_pdf/2c/d6/40273_2015_Article_327.PMC4796331.pdf
Availablefrom http://www.rand.org/pubs/papers/P3558.html 14.,Non-OADS,/arxiv_data1/oa_pdf/2c/d6/40273_2015_Article_327.PMC4796331.pdf
Availablefrom: http://www.nice.org.uk/Media/Default/About/what-we-do/ NICE-guidance/NICE-technology-appraisals/Guide-to-the-single- technology-appraisal-process.pdf 24. van der Meijden C. Procedure beoordeling extramurale geneesmiddelen [Procedure for the judgement of extramural drugs].,Non-OADS,/arxiv_data1/oa_pdf/2c/d6/40273_2015_Article_327.PMC4796331.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b5/71/40264_2015_Article_384.PMC4796333.pdf
2014. https://www.gov.uk/government/ uploads/system/uploads/attachment_data/ﬁle/306638/FluPlan2014_ accessible.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b5/71/40264_2015_Article_384.PMC4796333.pdf
2014. http://www.ema.europa.eu/ docs/en_GB/document_library/Scientiﬁc_guideline/2014/04/WC 500165492.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b5/71/40264_2015_Article_384.PMC4796333.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.FOODBORNE PATHOGENS AND DISEASE Volume 13, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/fpd.2015.1957 57",Non-OADS,/arxiv_data1/oa_pdf/a7/ac/fpd.2015.1957.PMC4796518.pdf
"Available at: http://www.inspection.gc.ca/ animals/terrestrial-animals/diseases/reportable/trichinellosis/ fact-sheet/eng/1330023015817/1330023110684, accessed October 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a7/ac/fpd.2015.1957.PMC4796518.pdf
"Available at: http://laws-lois.justice.gc.ca/eng/regulations/ C.R.C.%2C_c._870/, acces sed September 25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a7/ac/fpd.2015.1957.PMC4796518.pdf
"Available at: http://www.rff.or g/ﬁles/sharepoint/WorkImages/Download/ RFF-DP-06-17-REV.pdf, accessed on December 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/ac/fpd.2015.1957.PMC4796518.pdf
"Available at: http://www.who.int/water_ sanitation_health/publications/2011/dwq_guidelines/en/, ac-cessed on December 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/a7/ac/fpd.2015.1957.PMC4796518.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by- nc-sa/4.0/Role of CnB as a cytokine WW u et al 292 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/00/29/icb201591a.PMC4796594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.03.001 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: http://www.theguardian.com/society/2015/oct/09/ nhs-trusts-in-england-run-up-almost-1bn-de ﬁcit-in-three-months (accessed 25.10.15).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: http://www.pulsetoday.co.uk/news/commissioning-news/ government-announces-200m-cuts-to-public-health-budget/20010183.,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/443232/50325_ Summer_Budget_15_Web_Accessible.pdf (accessed 25.10.15).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: http://www.kingsfund.org.uk/health-social-care-three-priorities-new- government/new-funding-higher-productivity (accessed 18.11.15).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: http://www.institute.nhs.uk/index.,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: http://www.ldfa.co.uk/articles/2013/12/2/7-ways-to-improve- theatre-ef ﬁciency (accessed 25.10.15).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: https://www.gov.uk/government/ news/hospital-productivity-report-shows-how-nhs-can-make-large-savings (accessed 25.10.15).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: http://www.beckershospitalreview.com/or- efﬁciencies/6-cornerstones-of-operating-room-ef ﬁciency-best-practices-for- each.html (accessed 25.10.15).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available at: https://www.gov.uk/ government/uploads/system/uploads/attachment_data/ ﬁle/417554/ Procurement_Transp_2015-16_acc.pdf (accessed 25.10.15).,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
Available from: http://www.nhsiq.nhs.uk/resource-search/publications.aspx (accessed 23.01.16).W.W.,Non-OADS,/arxiv_data1/oa_pdf/62/fd/main.PMC4796663.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/16/main.PMC4796701.pdf
http://dx.doi.org/10.1016/j.atg.2016.01.0042212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/64/16/main.PMC4796701.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/16/main.PMC4796701.pdf
"Available at http://www.cdc.gov/art/reports/2012/national-summary.html (Accessed August 28, 2015).",OADS,/arxiv_data1/oa_pdf/64/16/main.PMC4796701.pdf
"Available at: (https://www.healthit.gov/sites/default/ ﬁles/oncdatabrief16.pdf ) (Accessed August 28, 2015).",OADS,/arxiv_data1/oa_pdf/64/16/main.PMC4796701.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"Table —tested listed by disease category bhttp://www.dnapolicy.org/news.release.php?action=detail&pressrelease_id= 145Naccessed 11 April 2012; Human Genetics Commission, 2003.",OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"2nd edn, Cavendish Publishing Limited, p. 249. http://dx.doi.org/10.1016/j.atg.2016.01.001 2212-0661/© 2016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"26(5), 972. http://dx.doi.org/10.1093/humrep/ der042 .",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"EASAC policy report 18 bhttp://www.easac.eu/home/reports-and- statements/detail-view/article/direct-to-co.html Naccessed 10 December 201,210; Hu- man Genetics Commission, 2010.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"14National Geographic's Genographic Project, bhttps://genographic.nationalgeographic.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"comNaccessed 15 October 2015; 23andMe, b23andme.com/ancestry /Naccessed 15 Octo- ber 2015; Family Tree DNA, bhttp://www.familytreedna.com Naccessed 17 October 2015; Nimble Diagnostics, bhttp://www.nimblediagnostics.com/home/anc.html Naccessed 13 October 2015; easyDNA, bhttp://www.easydna.co.uk/dna-ancestry-test.html Naccessed 13 October 2015; AfricanDNA, bhttp://www.africandna.com Naccessed 13 October 2015; African Ancestry, bhttp://www.africanancestry.com/home/ Naccessed 13 October 2015; DNA Ancestry Project, bhttp://www.dnaancestryproject.com Naccessed 13 October 2015.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"bhttp://www.huf ﬁngtonpost.com/2015/04/06/ ancestrycom-medical-research-juggernaut_n_7008446.html Naccessed 6 April 2015; Petrone, J., 17 July 2015.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"363(3), 204. http://dx.doi.org/10.1056/ NEJMp1005203 .",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"39 29Who'z the daddy?, bwhozthedaddy.com Naccessed 13 October 2015; Test Country, btestcountry.com Naccessed 13 October 2015; Gensys, bpaternity-answers.com Naccessed 13 October 2015; International Biosciences, bhttp://www.ibdna.com Naccessed 13 Octo- ber 2015; Genetic Pro ﬁles,bhttp://www.geneticpro ﬁles.com Naccessed 13 October 2015.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"36(10), 1122. http://dx.doi.org/ 10.1093/jpepsy/jsr068 ; Howard, H., Avard, D., Borry, P., 2011.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"9(6 –7), 32. http://dx.doi.org/10.1080/15265160902893916 ; Fletcher, A. L., 2004.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"bhttp://www.sciencedaily.com/releases/ 2011/05/110530190344.htm Naccessed 3 November 2011; European Academies Science Advisory Council (EASAC) and the Federation of European Academies of Medicine (FEAM), October 2012.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"9(6 –7) 3 –10.http://dx.doi.org/10.1080/ 15265160902928209 ; Howard, H. C., Borry, P., 2009.",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"9(6 –7), 11. http://dx.doi.org/10.1080/ 15265160902894005 .",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"339(6117), 321. http://dx.doi.org/10.1126/science.1229566 .",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
"15(6), 409 –21.http://dx.doi.org/10.1038/nrg3723 .",Non-OADS,/arxiv_data1/oa_pdf/a8/8a/main.PMC4796702.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Direct-to-consumer genetics/genomicsPersonal genetics/genomics Users' attitude and motivations Clinical utilityValueSocial genomes 1.,Non-OADS,/arxiv_data1/oa_pdf/96/30/main.PMC4796703.pdf
"E-mail addresses: mauro.turrini@univ-paris1.fr (M. Turrini), barbara.prainsack@kcl.ac.uk (B. Prainsack).1E-mail received by one of the authors (BP), customer #54,472. http://dx.doi.org/10.1016/j.atg.2016.01.008 2212-0661/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/96/30/main.PMC4796703.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/96/30/main.PMC4796703.pdf
"If a person deposits genomic in- formation in a repository or database used for scienti ﬁc bene ﬁt, then this social utility or value can extend to the entire society, and it can, at the same time, unfold personal value as well: In all of the qualitative studies on actual users mentioned here, making somebody's personal genetic or genomic data available to others was cited as a way to be6https://www.23andme.com/en-eu/research/ .6 M. Turrini, B. Prainsack / Applied & Translational Genomics 8 (2016) 4 –8",Non-OADS,/arxiv_data1/oa_pdf/96/30/main.PMC4796703.pdf
Ethics http://dx.doi.org/10.1136/medethics-2015- 102781 (online ﬁrst).,Non-OADS,/arxiv_data1/oa_pdf/96/30/main.PMC4796703.pdf
"(9 September, Available at: http://www.vox.com/2014/9/9/5975653/with-genetic- testing-i-gave-my-parents-the-gift-of-divorce-23andme ).",Non-OADS,/arxiv_data1/oa_pdf/96/30/main.PMC4796703.pdf
Available at: http://www.huf ﬁngtonpost.com/tim-spector/ 23andme_b_4417322.html .,Non-OADS,/arxiv_data1/oa_pdf/96/30/main.PMC4796703.pdf
"These experiences, and dozens of others, fueled a passion in me to lead an organization that was focused on the very people who needApplied & Translational Genomics 8 (2016) 40 –41 http://dx.doi.org/10.1016/j.atg.2016.01.007 2212-0661/© 2016 The Author.",Non-OADS,/arxiv_data1/oa_pdf/03/d9/main.PMC4796705.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/d9/main.PMC4796705.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Whole-genome sequencingWhole-exome sequencingDirect-to-consumer genetic testingConsumer genomics Human genome research Consent 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1016/j.atg.2016.01.005 2212-0661/© 2016 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Given that WES/WGS is likely to become increasingly more available and there is the potential for these services to be coupled with research activities using consumers' data ( http://www.technologyreview.com/ news/540711/inside-illuminas-plans-to-lure-consumers-with-an-app- store-for-genomes/ ), the ELSI of DTC genomics are particularly impor- tant to address now.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"” [https://www.geneyouin.ca/informed-consent ] Gene By Gene indicated in its terms and conditions that it would store consumer data for 30 days or longer; after this time the dataTable 1 Information on the companies, their WES/WGS services, model o f provision of testing, and the website documents studied.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"”(https://www.geneyouin.ca /)A health care professional is not required for test ordering (although 30 minute phone consultation is required before ordering) (https://www.geneyouin.ca/how-it-works/how-to-order/ )Informed Consent, Terms and Conditions Gene By Gene,USAWES/WGS —raw data or with “alignment and variant calling ”(https://www.genebygene.com/pages/research# ) or (only for WES) with “professional RUO [research use only] interpretation ” (https://www.genebygene.com/pages/research?goto=whole-exome-with-interpretation# )For Clinical Testing service a clinician orders the test (https://www.genebygene.com/pages/genetics#how-to-order ); information not available for “Research and Consumer ”services Terms and Conditions Inneova, CanadaWGS —“screening risk factors and sensitivity to particular molecules which can help a client's physician recommend speci ﬁc check-ups as well as optimize the administration of medications and diets ” (http://www.inneova.com/tout.php )“we accept test requests from licensed medical professionals only ” (http://www.inneova.com/tout.php )Statement of consent, Disclaimerand privacy policy 1The companies GeneYouIn and Gene By Gene use a word “customer ”in the analysed texts.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"”And: “The customer speci ﬁcally understands that they will not receive compensation for any research or commercial products that include or results from your sample, results, or personal re- cord”(https://www.genebygene.com/pages/terms ).",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Consent for services Based on the websites studied, consumers give their consent for the services purchased, including agreeing to the information in the afore- mentioned documents by ordering the test ( https://www.geneyouin.ca/Table 2 Information about the purpose and period of samples and data storage.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
terms-conditions/; https://www.genebygene.com/pages/terms; http:// www.inneova.info/contenu.php?page=disclaimer.php ) or by signing the form which is sent to the company together with the sample for analysis ( http://www.illumina.com/content/dam/illumina-marketing/ documents/clinical/forms/form-test-req-predisposition.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
” [https://www.geneyouin.ca/informed-consent/ ] The provision of information and the manner of consenting in the DTC GT context may raise the question of whether consumers have read and fully understood the information to which they agree and thus whether their decision is truly an informed decision.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"” [http://www.inneova.com/contenu.php?page=terms.php ] Although the ﬁrst clause stated no disclosure, the list of exceptions in brackets was long and vague.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"”(https://www.genebygene.com/ pages/terms ) suggests that consumers' data, in some way, may be in- deed, used by “collaborating partners ”and hence shared in some way.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Meanwhile, GeneYouIn described generally that it employs “commercially validated and reasonable computational and organizational safeguards ”(https://www.geneyouin.ca/terms- conditions/ ).",OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Similarly, Gene By Gene stated that it “implements admin- istrative, physical and technical safeguards to secure our client's protected health information as de ﬁned by HIPAA ”(https://www.genebygene.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
” (https://www.geneyouin.ca/informed-consent ) Terms and conditionsa:“Access to you biological sample and health data by a court-appointed order will be granted according to the Privacy laws of Canada and Ontario.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
”(https://www.geneyouin.ca/terms-conditions/ ) Gene By Gene Terms and Conditionsa:“Test results will be released only to the ordering clinician or genetic counselor.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"”(https://www.genebygene.com/pages/terms ) Inneova Statement of consenta:“I understand that ICL will not disclose my identity, contact details, or test results to third parties (except to its medical, scienti ﬁc, and other service partners, subsidiaries and related business entities, legal advisors, agents, or appointees for the purpose of performing genetic testing or interpretation services, as well as any associated administrative transactions, as deemed necessary by ICL in the normal course of business under the terms of this Agreement as well as under its Disclaimer and Privacy Policy).",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"”(http://www.inneova.com/contenu.php?page=terms.php ) aThese denote the speci ﬁc documents/sections of websites where the quotes can be found.27 E. Niemiec, H.C. Howard / Applied & Translational Genomics 8 (2016) 23 –30",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"GeneYouIn and Gene By Gene also cited the US Genetic Information Nondiscrimination Act (GINA), which “prohibits health insurers and employers from discrim- inating based on genetic information ”(https://www.genebygene.",OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Gene By Gene outlined pos- sible consequences of disclosure, including: “misuse, mishandling, or misrepresentation ”(https://www.genebygene.com/pages/terms ).",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
”(https://www.genebygene.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
” (https://www.geneyouin.ca/informed-consent ) Terms and Conditionsa:“We are not responsible for maintaining security and con ﬁdentiality of copies of Your Reports stored outside of GeneYouIn's databases.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"”(https://www.geneyouin.ca/terms-conditions/ ) Gene By Gene Terms and conditionsa:“After 3 months, the sample will be discarded or de-identi ﬁed and retained (...).",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
”(https://www.genebygene.com/pages/terms ) Inneova Disclaimer and privacy policya:“ICL uses a speci ﬁc tracking system to identify your sample as soon as it enters our facilities.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Meanwhile, one of the DTC GT companies, 23andMe, has been remarkably successful in recruiting research participants(http://www.forbes.com/sites/matthewherper/2015/10/14/23andme- prepares-a-comeback-raising-115-million-at-a-1-1-billion-valuation/ ), thus gaining a signi ﬁcant share of the general community of biobank re- search and in doing so, potentially in ﬂuencing the public perception of research.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
10 –11.http://dx.doi.org/10.1038/gim.2015.82 .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"31, 68 –69.http://dx.doi.org/10.1016/ j.tibtech.2012.11.007 .",OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1111/bioe.12004 .,OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1007/ s10676-015-9373-x .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1038/ejhg.2010.129 .,OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
14–20.http://dx.doi.org/10.1038/ejhg.2012.104 .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"6, 1 –3.http://dx.doi.org/10.1371/journal.pgen.1000965 .",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1126/ science.1229566 .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1038/embor.2010.105 .,OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
” (https://www.geneyouin.ca/informed-consent ) Terms and conditions:a“(…) you appoint GeneYouIn as a custodian of your genetic and health data.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"” (https://www.geneyouin.ca/terms-conditions/ ) Gene By Gene Terms and conditionsa:“The customer understands that by providing any sample, having your sample processed, accessing results, or providing personal information, that the customer acquires no rights in any research or commercial products or services that may be developed by Gene by Gene, LTD. or its collaborating partners.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"”(https://www.genebygene.com/pages/terms ) Inneova Not available aThese denote the speci ﬁc documents/sections of websites where the quotes can be found.29 E. Niemiec, H.C. Howard / Applied & Translational Genomics 8 (2016) 23 –30",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://www.sashg.org/documents/HGCUK- Policy-on-DTC-testing.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"John Wiley & Sons, Ltd., Chichester http://dx.doi.org/10.1002/9780470015902.",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"8, 3. http://dx.doi.org/10.1186/s11568-014-0003-1 .",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1177/0968533215571956 .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Washington, D.C. http://bioethics.gov/sites/default/ ﬁles/PrivacyProgress508_1.pdf .",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"59, 5 –15.http://dx.doi.org/10.1038/jhg.2013.114 .",OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://www.legislation.gov.uk/ ukpga/2004/30/pdfs/ukpga_20040030_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/ 10.1007/s00439-011-1019-4 .,Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
"Web references http://www.forbes.com/sites/matthewherper/2015/10/14/23andme-prepares-a- comeback-raising-115-million-at-a-1-1-billion-valuation/ (accessed 28 October 2015) http://www.illumina.com/clinical/illumina_clinical_laboratory/how-to-order.html (accessed 18 September 2015) http://www.illumina.com/clinical/illumina_clinical_laboratory/trugenome-clinical- sequencing-services.html (accessed 16 September 2015) http://www.illumina.com/content/dam/illumina-marketing/documents/clinical/forms/ form-test-req-predisposition.pdf (accessed 10 August 2015) http://www.inneova.com/contenu.php?page=terms.php (accessed 10 August 2015) http://www.inneova.info/contenu.php?page=disclaimer.php (accessed 10 August 2015) http://www.inneova.com/tout.php (accessed 16 September 2015) http://www.technologyreview.com/news/540711/inside-illuminas-plans-to-lure- consumers-with-an-app-store-for-genomes/ (accessed 19 August 2015) https://www.genebygene.com/pages/genetics#how-to-order (accessed 18 September 2015) https://www.genebygene.com/pages/research?goto=whole-exome-with- interpretation# (accessed 16 September 2015) https://www.genebygene.com/pages/research# (accessed 18 September 2015) https://www.genebygene.com/pages/terms (accessed 10 August 2015) https://www.geneyouin.ca /(accessed 16 September 2015) https://www.geneyouin.ca/how-it-works/how-to-order/ (accessed 18 September 2015) https://www.geneyouin.ca/informed-consent (accessed 10 August 2015) https://www.geneyouin.ca/terms-conditions/ (accessed 10 August 2015)30 E. Niemiec, H.C. Howard / Applied & Translational Genomics 8 (2016) 23 –30",Non-OADS,/arxiv_data1/oa_pdf/b2/47/main.PMC4796706.pdf
http://dx.doi.org/10.1016/j.atg.2016.01.0032212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/77/main.PMC4796707.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3d/77/main.PMC4796707.pdf
"2015; 15(9): 34 – 42.6National Commission for the Protection of Human Subjects of Biomedical and Behav- ioral Research, “The Belmont Report: Ethical Principles for the Protection of Human Sub- jects of Research, ”April 18, 1979, bhttp://www.hhs.gov/ohrp/humansubjects/guidance/ belmont.html N(2 November 2015).",Non-OADS,/arxiv_data1/oa_pdf/3d/77/main.PMC4796707.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/2b/main.PMC4796717.pdf
"The catalytic site of pepsin is formed by two aspartate residues, Asp32 and Asp215 (pKa values about1.4 and 4.5, respectively), one of which has to be protonated, andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinphsResults in Pharma Sciences http://dx.doi.org/10.1016/j.rinphs.2016.02.002 2211-2863/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/00/2b/main.PMC4796717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/2b/main.PMC4796717.pdf
"2014, doi: http://dx.doi.org/10.14227/DT210414P6 .",Non-OADS,/arxiv_data1/oa_pdf/00/2b/main.PMC4796717.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/e4/main.PMC4796718.pdf
"Two days later, he de- veloped pain, swelling and redness of the right side of face.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2016.03.003 2211-7539/ &2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/87/e4/main.PMC4796718.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/87/e4/main.PMC4796718.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 30112 - http://dx.doi.org/10.3402/jom.v8.30112 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30112 - http://dx.doi.org/10.3402/jom.v8.30112",Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
"(b) Relative abundance of the 10 most predominant genus-level probe targets in each group.Salivary bacterial profiles Citation: Journal of Oral Microbiology 2016, 8: 30112 - http://dx.doi.org/10.3402/jom.v8.30112 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30112 - http://dx.doi.org/10.3402/jom.v8.30112",Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
"Unstimulated saliva samples (blue) and stimulated saliva samples (red).Salivary bacterial profiles Citation: Journal of Oral Microbiology 2016, 8: 30112 - http://dx.doi.org/10.3402/jom.v8.30112 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30112 - http://dx.doi.org/10.3402/jom.v8.30112",Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
J OralMicrobiol 2014; 6: 23609. doi: http://dx.doi.org/10.3402/jom.,OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
J Oral Microbiol2015; 6: 27429. doi: http://dx.doi.org/10.3402/jom.v7.2742915.,Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
J Oral Microbiol 2016; 8: 30170. doi: http://dx.doi.org/10.3402/jom.,OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
"Periodontol 2000 2009; 50: 52/C164.Salivary bacterial profiles Citation: Journal of Oral Microbiology 2016, 8: 30112 - http://dx.doi.org/10.3402/jom.v8.30112 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/c3/JOM-8-30112.PMC4796727.pdf
http://dx.doi.org/10.1016/j.atg.2016.01.006 2212-0661/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/41/f7/main.PMC4796731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/f7/main.PMC4796731.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/28/2d/nihms748132.PMC4796757.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 1476-5586 http://dx.doi.org/10.1016/j.neo.2016.02.002,Non-OADS,/arxiv_data1/oa_pdf/7b/02/main.PMC4796801.pdf
"After H&E staining of a single section of each set and photomicrography of the whole area (10 to20 pictures per section), the total area of the section was determined by using the image J software (NIH, http://imagej.nih.gov/ij/ ).",OADS,/arxiv_data1/oa_pdf/7b/02/main.PMC4796801.pdf
Functional enrichment analysis of gene listswas performed by using the DAVID bioinformatics databases [26] (http://david.abcc.ncifcrf.gov/ ).,OADS,/arxiv_data1/oa_pdf/7b/02/main.PMC4796801.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.02.001,OADS,/arxiv_data1/oa_pdf/04/3c/main.PMC4796802.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/74/main.PMC4796803.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.01.005,OADS,/arxiv_data1/oa_pdf/67/74/main.PMC4796803.pdf
But apparently I did not.Applied & Translational Genomics 8 (2016) 31 –32 1(http://www.hhs.gov/ocr/privacy/hipaa/understanding/special/CLIA/index.html ; http://www.ncbi.nlm.nih.gov/pubmed/25255365 ).,Non-OADS,/arxiv_data1/oa_pdf/a2/63/main.PMC4796804.pdf
http://dx.doi.org/10.1016/j.atg.2016.01.011 2212-0661/© 2016 The Author.,Non-OADS,/arxiv_data1/oa_pdf/a2/63/main.PMC4796804.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/63/main.PMC4796804.pdf
4A n g r i s tP L o SO n e .2 0 1 4M a r .1 9 ;9 ( 3 ) :e 9 2 0 6 0 ; http://www.nature.com/news/ scientists-hope-to-attract-millions-to-dna-land-1.18514 .32 Anonymous / Applied & Translational Genomics 8 (2016) 31 –32,Non-OADS,/arxiv_data1/oa_pdf/a2/63/main.PMC4796804.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/ff/main.PMC4796806.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.01.004,OADS,/arxiv_data1/oa_pdf/f7/ff/main.PMC4796806.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Personal genomicsAttitudes of older adultsEthics Personalized medicine PrivacyResearch participation 1.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1016/j.atg.2016.01.009 2212-0661/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
"GIM 491 –494, http://dx.doi.org/10.1038/gim.2013.175 .",Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1097/GIM.0b013e3181eb51c6 .,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
"http://dx.doi.org/10.1136/jmedgenet-2012-101207 (Jun).Bloss, C.S., Schork, N.J., Topol, E.J., 2014.",OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1111/cge.12419 (Mar).,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
March 2010 http://www.bfs.admin.ch/bfs/portal/de/index/news/publikationen.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1038/gim.2015.34 (Mar 26).,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
PLoS One 5 http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1159/ 000375441 .,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1155/2012/309109 .,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1371/journal.pone.0108484 .,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
"7 (1), 74. http://dx.doi.org/10.1186/s13073 – 015-0188-5 (Aug 1).14 L. Mählmann et al.",OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
http://dx.doi.org/10.1159/000431250 .,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
Ethics http://dx.doi.org/10.1136/medethics-2014-102026 .,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
Power of one million 18 June Accessed https://blog.23andme.com/ news/one-in-a-million/ .15 L. Mählmann et al.,Non-OADS,/arxiv_data1/oa_pdf/d1/2f/main.PMC4796807.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/89/main.PMC4796808.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.01.007,OADS,/arxiv_data1/oa_pdf/de/89/main.PMC4796808.pdf
"Nat Commun 6, 6605. http://dx.doi.org/10.1038/ncomms7605 .",OADS,/arxiv_data1/oa_pdf/de/89/main.PMC4796808.pdf
1476-5586http://dx.doi.org/10.1016/j.neo.2016.02.003,OADS,/arxiv_data1/oa_pdf/f9/42/main.PMC4796809.pdf
"Results High Expression of CD151 in Aggressive Glioma Subtypes and GSCs The Repository for Molecular Brain Neoplasia Data (REMBRANDT) database (National Cancer Institute, https://caintegrator.nci.nih.gov/ rembrandt/ ), representing 28 nonneoplastic brain and 443 glioma tissue samples, was used to compare the expression profile of CD151 in normalbrain and glioma tissues.",OADS,/arxiv_data1/oa_pdf/f9/42/main.PMC4796809.pdf
"A similar statistically significant correlation between highCD151 expression and poor survival was identified using The Cancer Genome Atlas (TCGA) glioblastoma dataset (National Cancer Institute, https://tcga-data.nci.nih.gov/tcga )(Figure 1 C).We examined CD151 expression in G BM-derived neurosphere lines (GBM1A and GBM1B) and low passage GBM-derived primary neuro-spheres (612) enriched in GSCs.",Non-OADS,/arxiv_data1/oa_pdf/f9/42/main.PMC4796809.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on The ISME Journal website (http:/ /www.nature.com/ismej)Accumulibacter transcriptomics BO Oyserman et al 822 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/7a/1d/ismej2015155a.PMC4796919.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Bacterial diversity from seasurface to subseafloor EA Walsh et al 989 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/0f/65/ismej2015175a.PMC4796937.pdf
"The primers weredesigned to be specific to the BSEPE genome sequence, and primer specificity was verified by comparison with sequence data of other knownorganisms via a BLASTN search against the NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.",OADS,/arxiv_data1/oa_pdf/26/47/ismej2015176a.PMC4796938.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Th e ISME Journal website (http://www.nature.com/ismej)Genomic heterogeneity in a vent mussel symbiont T Ikuta et al 1001 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/26/47/ismej2015176a.PMC4796938.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/34/rjw036.PMC4796940.pdf
Available at: http://www.internaware.,Non-OADS,/arxiv_data1/oa_pdf/fa/6c/10.1177_0038038515574456.PMC4797193.pdf
Available at:  http://www.ippr.org/images/media/files/publication/2011/05/Why%20interns%20need%20a%20fair%20wage_1788.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fa/6c/10.1177_0038038515574456.PMC4797193.pdf
Available at: http://www.skills-thirdsector.,Non-OADS,/arxiv_data1/oa_pdf/fa/6c/10.1177_0038038515574456.PMC4797193.pdf
Available at: http://www.third- sector.co.uk/Management/article/1207509/analysis-rise-rise-unpaid-charity-intern/.,Non-OADS,/arxiv_data1/oa_pdf/fa/6c/10.1177_0038038515574456.PMC4797193.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/94/fb/10.1177_2325967116635515.PMC4797230.pdf
"MATERIALS AND METHODS EMERGE To start EMERGE, the user needs an inventory of predic- tordatasetsinBEDformat,commonlyusedtodenotespe-cific genomic regions of interest ( https://genome.ucsc.edu/ FAQ/FAQformat.html ).",OADS,/arxiv_data1/oa_pdf/e0/ad/gkv1144.PMC4797259.pdf
are available from http://download.hfrc.nl .,Non-OADS,/arxiv_data1/oa_pdf/e0/ad/gkv1144.PMC4797259.pdf
"For an overview of these datasets, see Supplemental Table S1.All the datasets that were used in this study can be down- loaded as BED files from ‘ http://download.hfrc.nl ’ under the ‘EMERGE BED files’ header.",OADS,/arxiv_data1/oa_pdf/e0/ad/gkv1144.PMC4797259.pdf
ChIP-on-ChIP datasets on D. melanogaster mesoderm tissue were downloaded from the Furlong laboratory web-site (http://furlonglab.embl.de/data/download )(33).,OADS,/arxiv_data1/oa_pdf/e0/ad/gkv1144.PMC4797259.pdf
AllBEDfilesusedinthisstudyareavailablefordownload athttp://download.hfrc.nl .,Non-OADS,/arxiv_data1/oa_pdf/e0/ad/gkv1144.PMC4797259.pdf
"Recently two cEt ASOs (AZD5321, https: //clinicaltrials.gov/ct2/show/NCT02144051 and AZD9150, https://clinicaltrials.gov/ct2/show/NCT01839604 )h a v ee n - teredphaseIclinicaltrialinpatientswithandrogenreceptor tumorsandhepatocellularcarcinoma,respectively.Todate,some patients have been treated with up to 1000 mg /kg for at least 3 cycles of treatment with cEt ASOs without ev- idence of dose limiting hepatotoxicity (unpublished data) demonstrating that stringent preclinical ASO selection can result in well tolerated and potent BNA ASOs ( 16).",Non-OADS,/arxiv_data1/oa_pdf/5f/22/gkv1210.PMC4797265.pdf
Result of the meta-caller was desirable to detect more candidate fusion transcripts with high confi-dence.Rpackage FusionMetaCaller isavailableonourweb- sitehttp://tsenglab.biostat.pitt.edu/software.htm .,OADS,/arxiv_data1/oa_pdf/5e/01/gkv1234.PMC4797269.pdf
http://cgap.nci.nih.gov/Chromosomes/Mitelman .,Non-OADS,/arxiv_data1/oa_pdf/5e/01/gkv1234.PMC4797269.pdf
The gels were scanned us- ing an FLA-9000 Starion (Fujifilm) and quantified using ImageJ ( http://imagej.nih.gov/ij/ )(26).,OADS,/arxiv_data1/oa_pdf/0b/67/gkv1529.PMC4797282.pdf
All plots were visualized using R 3.2.1 (http://www.R-project.org/ )(33).,OADS,/arxiv_data1/oa_pdf/0b/67/gkv1529.PMC4797282.pdf
"The data were processed with Top-Spin 3.0 (Bruker BioSpin Gmbh) software and analyzed with CARA ( http://cara.nmr.ch ) or FELIX (Felix NMR, Inc.) software.",OADS,/arxiv_data1/oa_pdf/91/3d/gkv1534.PMC4797283.pdf
"Bioinformatic analysis Secondary structure elements in the HalV 5 /primeUTR and proximal coding sequence (Genbank acces- sion #JN000306) were modeled essentially as de- scribed ( 12,39), using probabilistic (Pfold: http: //www.daimi.au.dk/ ∼compbio/pfold/ (40); and Con- trafold: http://contra.stanford.edu/contrafold/ (41)) and posterior decoding approaches (Centroidfold:http://www.ncrna.org/centroidfold (42)), and were ver- ified and refined by free energy minimization using Mfold (http://mfold.rna.albany.edu/?q1/4mfold (43)) in all in- stances using default parameters.",OADS,/arxiv_data1/oa_pdf/33/78/gkw016.PMC4797288.pdf
List of other oligonucleotides used in the study are available on request.Library construction The nucleotide sequence of promoter regions of stress responsive genes were aligned using online bioinformat- ics program ClustalW2 ( http://www.ebi.ac.uk/Tools/msa/ clustalw2 ).,OADS,/arxiv_data1/oa_pdf/5d/a8/gkw029.PMC4797293.pdf
Curvature analysis of FQ-responsive genetic element We used online bioinformatics tool ( http://www.lfd.uci.,OADS,/arxiv_data1/oa_pdf/5d/a8/gkw029.PMC4797293.pdf
"edu/∼gohlke/dnacurve/ http://hydra.icgeb.trieste.it/dna/ index.php ) that compiles the curvature values and calcu- lates the global 3D structure of a DNA molecule from itsnucleotidesequence ( 24,25).",OADS,/arxiv_data1/oa_pdf/5d/a8/gkw029.PMC4797293.pdf
"Nucleotide sequence analysis of the selected ge- netic element through promEC [ http://margalit.huji.ac.il/ promec] and BLAST with E.coligenome database did not returnanysequencesbearingsignificanthomologywithany known promoters in specific and whole genome in general; thus showing that the selected sequence was novel and of non-genomicorigin (SupplementaryFigure S5).Specificityof theinducible regulatory element E. colicells harboring the p Nal::ibsC and pRx::ibsC were tested in the presence of sub-lethal concentrationof known stress inducing chemicals (cadmium chloride, sodiumaresenite,ethanol,norfloxacin,ciprofloxacin,tetra- cycline, mitomycin-C, chloramphenicol, polymyxin andnovobiocin).",OADS,/arxiv_data1/oa_pdf/5d/a8/gkw029.PMC4797293.pdf
"Interestingly it has been observed that the inactive and constitutive variantsof spacer regions (‘all A’ and ‘all T’, respectively) failed to showanybindinginthemobilityshiftassays(Figure 8Band C).WeusedDNAcurvesoftware( http://www.lfd.uci.edu/ ∼ gohlke/dnacurve/ ) to assess the bending region(s) of FQ- responsive promoter (Nal) and their variants (Supplemen-tary Figure S8) ( 24,25).",OADS,/arxiv_data1/oa_pdf/5d/a8/gkw029.PMC4797293.pdf
PON-mt- tRNA is available at http://structure.bmc.lu.se/PON- mt-tRNA/ .,OADS,/arxiv_data1/oa_pdf/60/11/gkw046.PMC4797295.pdf
"Thevariation data set is available from VariBench, a database of benchmark variation data sets ( http://structure.bmc.lu.",OADS,/arxiv_data1/oa_pdf/60/11/gkw046.PMC4797295.pdf
The randomForest package (version4.6–12) in theRstatisticalsoftware(version3.0.2) (https://www.r-project.org/ ) was used to implement the RF algorithm.,OADS,/arxiv_data1/oa_pdf/60/11/gkw046.PMC4797295.pdf
"The evi-dencefieldisoptionalasthedataarenotalwaysavailable.If theevidenceisprovided,PON-mt-tRNAintegratestheevi- dencewithpredictionsofMLmethodtoclassifythevaria- tions,otherwisethepredictionsoftheMLmethodareused forclassification.Thepredictionsforallpossiblenucleotidesubstitutions in mt-tRNA genes are available for down- load athttp://structure.bmc.lu.se/PON-mt-tRNA/datasets.",OADS,/arxiv_data1/oa_pdf/60/11/gkw046.PMC4797295.pdf
AVAILABILITY PON-mt-tRNA is available at http://structure.bmc.lu.se/ PON-mt-tRNA/ .,OADS,/arxiv_data1/oa_pdf/60/11/gkw046.PMC4797295.pdf
"According to the HIV Drug Resistance Database ( http://hivdb.stanford.edu/ ), K101Q, E138Q and exchanges at position V179 are also detected in patients treated with EFV.",Non-OADS,/arxiv_data1/oa_pdf/d1/5b/gkw060.PMC4797301.pdf
"However, in subtype B the MR-RTexchangeV179toGly(V179G)hasnotbeenfound(http://hivdb.stanford.edu/ ).",Non-OADS,/arxiv_data1/oa_pdf/d1/5b/gkw060.PMC4797301.pdf
The P236L mutation charac- teristic for delavirdine (DLV) resistance is absent in MR- RT (http://hivdb.stanford.edu/ ).,Non-OADS,/arxiv_data1/oa_pdf/d1/5b/gkw060.PMC4797301.pdf
"This might be the reason for the selection of the discrimi- nation substitutions since according to the HIV Drug Re- sistance Database ( http://hivdb.stanford.edu/ ) Q151M and theQ151Mcomplexsupportlowtomoderateresistanceto3TC and efficient discrimination of various other NRTIs whichhavealsobeenusedduringongoingtherapy(Supple- mentaryTableS2)( 26).Inaddition,theenzymealsocarries the codon K65R which was suggested to antagonize AZTexcision ( 22,23,61).",Non-OADS,/arxiv_data1/oa_pdf/d1/5b/gkw060.PMC4797301.pdf
"the HIV Drug Re-sistance Database ( http://hivdb.stanford.edu/ ), which give highAZTresistancemutationscoresforQ151Moccurring incoexistencewiththeTAMsT215FandM41L.However,wecanshowhere,thatthesemutationsdonotcreateanad- ditiveimpact on AZT resistance.",Non-OADS,/arxiv_data1/oa_pdf/d1/5b/gkw060.PMC4797301.pdf
"cerevisiae Hi-C contact data ( HindIII, pre-FDR, no masking) from ( 7) (Supplementary Data) were down- loaded from https://noble.gs.washington.edu/proj/yeast- architecture/sup.html .",OADS,/arxiv_data1/oa_pdf/51/b4/gkw070.PMC4797302.pdf
The HiCNorm source code was downloaded fromhttp://www.people.fas.harvard.edu/ ∼junliu/HiCNorm/ .,OADS,/arxiv_data1/oa_pdf/51/b4/gkw070.PMC4797302.pdf
"ChIP-seq data normalization The raw ChIP-seq data set ( 18), which contains three in- put samples (Swi6, Tup1 and RNA polymerase II phos- phorylated at serine 5 (Pol2ser5p)) and a mock immuno-precipitation (IP) control sample (DMSO, Illumina), was obtained from GEO (data set GSE51251; http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/51/b4/gkw070.PMC4797302.pdf
‘spp’ was downloaded from http://compbio.med.,OADS,/arxiv_data1/oa_pdf/51/b4/gkw070.PMC4797302.pdf
"Primer pairs (Supplementary Table S1) were from the literature (PR-3 /4) (6) or designed us- ingPrimer3web( http://primer3.ut.ee/ )andselectedthefor- ward and reverse primers from different exons of mature targetmRNA.Aftercheckingforspecificitybygel,melting curve analysis and sequencing, the primers used in qPCR werefoundtohavegoodlinearcorrelationsandequalprim- ingefficiencyforthedifferentdilutionscomparedtotheCtvalues (slope, −3.4 to −3.2).",OADS,/arxiv_data1/oa_pdf/1f/34/gkw076.PMC4797303.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/00/nihms708954.PMC4797338.pdf
"*Correspondence: htpetrie@scripps.edu.5Present address: Department of Microbiology and Immunology, School of Medicine, University of Texas Health Science Center at  San Antonio, 7703 Floyd Curl Drive-MC 7758, San Antonio, TX 78229, USA SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and one figure and can be found with this article online at  http://dx.doi.org/10.1016/j.celrep.2015.07.008 .",Non-OADS,/arxiv_data1/oa_pdf/dd/00/nihms708954.PMC4797338.pdf
We first improved statistical accuracy in our publicly available data (GEO:  GSE18281) by selecting the five arrays for each sample type with the best MAS5 scaling  factors ( http://www.bioconductor.org/packages/release/bioc/html/affy.html ).,OADS,/arxiv_data1/oa_pdf/dd/00/nihms708954.PMC4797338.pdf
"Gene lists derived from principle components (e.g., the top or bottom  5% of genes in PC1, for Figure 1) were analyzed using Ingenuity Pathway Analysis software  (http://www.qiagen.com ) for pathway enrichment using default parameters.",OADS,/arxiv_data1/oa_pdf/dd/00/nihms708954.PMC4797338.pdf
"Body Atlas Data Complete MOE430 (mouse) and U133 (human) microarray tissue atlas data sets ( Wu et al.,  2009 ) were downloaded from the repository ( http://www.biogps.org ).",OADS,/arxiv_data1/oa_pdf/dd/00/nihms708954.PMC4797338.pdf
Available from: http://www.who.int/tb/ publications/mdr_surveillance/en/.,OADS,/arxiv_data1/oa_pdf/79/c0/LI-33-129.PMC4797428.pdf
Available from: http://www.ginasthma.com.,Non-OADS,/arxiv_data1/oa_pdf/89/43/LI-33-167.PMC4797436.pdf
Available from: http://www.fda.gov/downloads/drugs/  guidancecomplianceregulatoryinformation/guidances/  ucm073369.pd [Last accessed on 2015 Jan].,Non-OADS,/arxiv_data1/oa_pdf/71/31/IJPI-6-106.PMC4797487.pdf
Available from: http://www.statease.info/dx6files/manual/DX11- Details-Design.pdf [Last accessed on 2015 Jan].,Non-OADS,/arxiv_data1/oa_pdf/71/31/IJPI-6-106.PMC4797487.pdf
Available from: http://www.globocan.iarc.,Non-OADS,/arxiv_data1/oa_pdf/16/dd/CMJ-128-3298.PMC4797504.pdf
Available from: http://www.bjstats.gov.cn/nj/ main/2005-2008.,OADS,/arxiv_data1/oa_pdf/16/dd/CMJ-128-3298.PMC4797504.pdf
Available from: http://www.seer.cancer.gov/stdpopulations.,Non-OADS,/arxiv_data1/oa_pdf/16/dd/CMJ-128-3298.PMC4797504.pdf
Available from: http://www.surveillance.cancer.gov/joinpoint/.,Non-OADS,/arxiv_data1/oa_pdf/16/dd/CMJ-128-3298.PMC4797504.pdf
"Information was obtained from the two most commonly used  search engines in China, Baidu search (http://www.baidu.",OADS,/arxiv_data1/oa_pdf/af/0d/CMJ-128-3324.PMC4797508.pdf
com) and 360 search (http://www.so.com).,Non-OADS,/arxiv_data1/oa_pdf/af/0d/CMJ-128-3324.PMC4797508.pdf
Totally 92 of these disease‑causing genes have been  identified (http://hereditaryhearingloss.org).,Non-OADS,/arxiv_data1/oa_pdf/eb/08/CMJ-128-3345.PMC4797511.pdf
Further screening within the linked region on chromosome  9 was performed with markers from the Marshfield 9 map  (http://research.Marshfieldclinic.org/genetics) for fine  mapping.,Non-OADS,/arxiv_data1/oa_pdf/eb/08/CMJ-128-3345.PMC4797511.pdf
SNPs  and InDels (inserts and deletions) were detected using  GATK (http://www.broadinstitute.org/gatk/index.php).,OADS,/arxiv_data1/oa_pdf/eb/08/CMJ-128-3345.PMC4797511.pdf
"The gene was located between the D9S165  and D9S1874 interval, which is about 4.12 cM (the genetic  distance was calculated from http://www.ensemble.org/ per1) [Figure 1b and 1c].",OADS,/arxiv_data1/oa_pdf/eb/08/CMJ-128-3345.PMC4797511.pdf
"Since 2009, NGS has played a crucial role in studying the  genetics of HHI, with more than 10 genes having been  recently identified  (http://hereditaryhearingloss.org).",Non-OADS,/arxiv_data1/oa_pdf/eb/08/CMJ-128-3345.PMC4797511.pdf
Available from: http://www.knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/2a/71/CMJ-129-15.PMC4797536.pdf
"[4] Clean reads (in FASTQ format) were  aligned to the reference human genomic sequence (NCBI37/ gh19) of ADAR1  and ABCB6  genes by using BWA software  package (Burrows Wheeler Aligner, http://www.sourceforge.",OADS,/arxiv_data1/oa_pdf/f2/12/CMJ-129-33.PMC4797540.pdf
[5] Variants (single nucleotide  variants and small insertion) were identified using the  GATK Genotyper (http://www.broadinstitute.org/gsa/wiki/ index.php/).,OADS,/arxiv_data1/oa_pdf/f2/12/CMJ-129-33.PMC4797540.pdf
The potential influence of the detected  mutations on protein function was estimated using Sorting  Intolerant from Tolerant  (SIFT)  (http://sift.jcvi.org/www/ SIFT_BLink_submit.html) and PolyPhen‑2 (http://genetics.,OADS,/arxiv_data1/oa_pdf/41/14/CMJ-129-98.PMC4797552.pdf
"Polypeptides are smaller  Original Article Key Words anti-coagulants, bee venom, chromatography, LD 50ISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:007-011 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.031    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/9d/2093-6966-v18-n04-007.PMC4797586.pdf
"Tel: +98-26-3457-0038  Fax: +98-91-2345-1699Email: zolfagharianh@yahoo.com  ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1Department of Venomous Animals and Antivenom Production, Razi Vaccine and Serum Research Institute, Karaj, Iran 2Department of Toxicology, School of Pharmacy, Shahreza Branch, Islamic Azad University, Shahreza, Iran 3Young Researchers and Elites Club, Science and Research Branch, Islamic Azad University, Tehran, Iran Received: Sep 26, 2015    Reviewed: Oct 29, 2015    Accepted: Oct 29, 2015",Non-OADS,/arxiv_data1/oa_pdf/0c/9d/2093-6966-v18-n04-007.PMC4797586.pdf
"To separate the coagu- lation factor, we dissolved 300 mg of the crude BV in 4 mL 008 http://www.journal.ac Journal of Pharmacopuncture 2015;18(4):007-011",Non-OADS,/arxiv_data1/oa_pdf/0c/9d/2093-6966-v18-n04-007.PMC4797586.pdf
"http://www.journal.ac009  Journal of Pharmacopuncture 2015;18(4):007-011 of ammonium acetate buffer, which was then centrifuged  for 15 minutes at 14,000 rpm.",Non-OADS,/arxiv_data1/oa_pdf/0c/9d/2093-6966-v18-n04-007.PMC4797586.pdf
"010 http://www.journal.ac F4 had more anti-coagulation activity than F 1, F 1 also had  some anti-coagulation activity.",Non-OADS,/arxiv_data1/oa_pdf/0c/9d/2093-6966-v18-n04-007.PMC4797586.pdf
http://www.journal.ac011 with regard to anti-coagulation activities.,Non-OADS,/arxiv_data1/oa_pdf/0c/9d/2093-6966-v18-n04-007.PMC4797586.pdf
"Treatment of chronic diseases with modern med- icines is directed to the symptoms and not the root  Original Article Key Words blood glucose, diabetes, dyslipidemia, oral glucose tol-erance, oxidative stressISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:012-019 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.032    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
"Department of Biological Sciences University of Botswana, Boit-shoko Extension 10, Gaborone, Botswana.Tel: +26-7355-2750  Fax: +26-7355-4465E-mail: chaturve@mopipi.ub.bw ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Biological Sciences, University of Botswana, Gaborone, Botswana Received: Jun 17, 2015    Reviewed: Oct 26, 2015    Accepted: Nov 11, 2015",Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
http://www.journal.ac013 cause of the disease.,Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
"014 http://www.journal.ac Journal of Pharmacopuncture 2015;18(4):012-019 of 200 mg/kg BW, n = 5) while the SD experimental (SDE)  group was administered SRM at a dose of 300 mg/kg BW,  n = 5).",Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
"http://www.journal.ac015  Journal of Pharmacopuncture 2015;18(4):012-019 < 0.05), but the blood glucose levels were still very high  and indicated a diabetic condition.",Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
"016 http://www.journal.ac Figure 5  Plasma LDL levels, expressed as means ± SEMs, n  = 5 for each treatment (*P < 0.05, †P < 0.001), in rats treated  with SRM compared with their baseline values.",Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
http://www.journal.ac017 the MDC and the SDC groups.,Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
"http://www.journal.ac018 Wolf SP , Crabbe MJC, Thornalley PJ.",Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
http://www.journal.ac019 tomed.,Non-OADS,/arxiv_data1/oa_pdf/ed/e0/2093-6966-v18-n04-012.PMC4797587.pdf
"Original article Key Words alopecia, anagen, hair follicle, thread-embedding ther - apyISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:020-025 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.033    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
"Division of Applied Medicine, School of Korean Medicine, Pusan Na-tional University, Yangsan, Kyungnam 626-770, Korea.Tel: +82-51-510-8461  E-mail: jhsol33@pusan.ac.kr ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acReceived: Oct 07, 2015    Reviewed: Oct 24, 2015    Accepted: Oct 27, 20151Department of Pathology, College of Korean Medicine, Woosuk University, Jeonju, Korea 2Department of Ophthalmology, Otolaryngology and Dermatology, Korean Medicine Hospital, Pusan National University, Yangsan, Korea 3Division of Applied Medicine, School of Korean Medicine, Pusan National University, Yangsan, Korea 4Department of Anatomy, College of Korean Medicine, Woosuk University, Jeonju, Korea 5Department of Molecular Biology, Chonbuk National University, Jeonju, Korea 6Department of Medical Classics and History, College of Korean Medicine, Dongguk University, Gyeongju, Korea 7Division of Longevity and Biofunctional Medicine, School of Korean Medicine, Pusan National University, Yangsan, Korea",Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
http://www.journal.ac021 1.,Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
"022 http://www.journal.ac Journal of Pharmacopuncture 2015;18(4):020-025 tion of FGF-7, or fibroblast growth factor-5 (FGF-5) anti- body (1 : 200, Santa Cruz, CA, U.S.A.) for the detection of  FGF-5.",Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
http://www.journal.ac023  Journal of Pharmacopuncture 2015;18(4):020-025 neous tissues beneath acupoints or skin.,Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
"024 http://www.journal.ac cells in the hair matrix, thereby increasing the hair’s thick - ness during the anagen phase.",Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
http://orcid.org/0000-0003-2410-4704.,Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
http://www.journal.ac025 1999;341(13):964-73.,Non-OADS,/arxiv_data1/oa_pdf/d2/98/2093-6966-v18-n04-020.PMC4797588.pdf
"Among  these etiologies is the complex interaction between the  gastrointestinal, genitourinary, musculoskeletal, nerv - ous, and endocrine systems, in addition to sociocul- Original Article Key Words acupuncture evaluation, chronic pelvic pain, myofas - cial abdominal syndrome, trigger points ISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:026-031 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.034     This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/2093-6966-v18-n04-026.PMC4797589.pdf
"Department of Gynecology and Obstetrics of Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirao Preto 14049-900, Brazil.Tel: +55-163-602-2231  Fax: +55-163-633-2804E-mail: andreiams@usp.br ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Gynecology and Obstetrics of Faculty of Medicine of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil Received:  Aug 26, 2015    Reviewed:  Sep 28, 2015    Accepted: Oct 28, 2015",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/2093-6966-v18-n04-026.PMC4797589.pdf
http://www.journal.ac027 tural influences.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/2093-6966-v18-n04-026.PMC4797589.pdf
"028 http://www.journal.ac Journal of Pharmacopuncture 2015;18(4):026-031 sequently, the balance of each function depends on the  balance of the other functions, which are interconnected  within the “yin-yang” , and “zang-fu” theories [19].",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/2093-6966-v18-n04-026.PMC4797589.pdf
http://www.journal.ac029  Journal of Pharmacopuncture 2015;18(4):026-031 4.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/2093-6966-v18-n04-026.PMC4797589.pdf
"030 http://www.journal.ac more than 92% of the trigger points correspond to points  of acupuncture in anatomical locations and that 79.5%  of those were similar to corresponding myofascial trigger  points, as observed in the present study.",Non-OADS,/arxiv_data1/oa_pdf/c0/8e/2093-6966-v18-n04-026.PMC4797589.pdf
http://www.journal.ac031 2000.,Non-OADS,/arxiv_data1/oa_pdf/c0/8e/2093-6966-v18-n04-026.PMC4797589.pdf
"Pharmacopuncture treatment is performed  by injecting small amounts of herbal medicinal mate- rials at acupuncture points or affected areas in order  to benefit from the effects of both herb medicine and  Original article Key Words aqua acupuncture, herbal acupuncture, intravenous  toxicity, radix ginsengISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:038-044 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.036    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
"Korean Pharmacopuncture Institute, 4F, Association of Korean Oriental Medicine B/D, 26-27, Gayang-dong, Gangseo-gu, Seoul 157-200, Korea.Tel: +82-33-744-9304   Fax: +82-33-744-9305E-mail: drkwon5031@daum.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2 Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 3 Department of Acupuncture and Moxibustion, College of Korean Medicine, Sangji University, Wonju, Korea 4 Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received: Dec 15, 2014     Reviewed: Jan 28, 2015     Accepted: Apr 24, 2015",Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
http://www.journal.ac039 acupuncture [1].,Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
040  http://www.journal.ac  3.,Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
http://www.journal.ac041 Figure 3 Tissue from a kidney in the intravenous single-dose toxicity study of WSGP in SD rats.,Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
"http://www.journal.ac042 FemaleG1 (0) 147.6 ± 5.6 158.4 ± 7.7 175.6 ± 10.2 202.4 ± 25.8 54.8 ± 22.3 G2 (0.1) 146.0 ± 5.9 157.1 ± 4.0 172.9 ± 3.6 193.5 ± 4.4 47.4 ± 5.0 G3 (0.5) 144.0 ± 3.4 155.1 ± 3.6 166.4 ± 6.2 187.2 ± 12.3 43.2 ± 10.0 G4 (1.0) 144.4 ± 5.3 156.2 ± 5.7 169.0 ± 7.3 189.4 ± 8.1 45.0 ± 7.8 Table 3 Mean hematology parameters in male, female SD rats (Male) (Female)Group/Dose (mL/animal)RBC (×106  cells/µL)HGB (g/dL)HCT (%)RBC IndicesPLT (× 103 cells/µL)Reti (%)MCV (fL)MCH (pg)MCHC (g/dL) G1 (0) 7.00 ± 0.20 14.1 ± 0.5 44.2 ± 1.5 63.2 ± 2.0 20.2 ± 0.8 32.0 ± 0.3 1287 ± 146 5.7 ± 0.7 G2 (0.1) 6.98 ± 0.25 14.1 ± 0.6 44.2 ± 1.6 63.3 ± 0.4 20.2 ± 0.2 32.0 ± 0.2 1326 ± 67 6.2 ± 0.1 G3 (0.5) 7.05 ± 0.25 13.8 ± 0.2 43.5 ± 1.1 61.8 ± 2.9 19.7 ± 0.9 31.8 ± 0.3 1348 ± 110 5.5 ± 0.7 G4 (1.0) 6.82 ± 0.15 13.9 ± 0.4 43.4 ± 1.2 63.7 ± 1.0 20.4 ± 0.3 32.1 ± 0.5 1340 ± 93 5.5 ± 0.8 Group/Dose(mL/animal)RBC (×10 6  cells/µL)HGB (g/dL)HCT (%)RBC IndicesPLT (× 103 cells/µL)Reti (%)MCV (fL)MCH (pg)MCHC (g/dL) G1 (0) 7.32 ± 0.43 14.2 ± 0.6 43.4 ± 1.8 59.4 ± 2.2 19.5 ± 0.7 32.8 ± 0.6 1281 ± 77 2.9 ± 1.1 G2 (0.1) 7.33 ± 0.26 14.5 ± 0.5 44.1 ± 1.4 60.2 ± 1.5 19.8 ± 0.6 33.0 ± 0.2 1235 ± 119 2.9 ± 0.5 G3 (0.5) 7.59 ± 0.22 15.0 ± 0.4 45.7 ± 0.7 60.3 ± 2.1 19.8 ± 0.8 32.9 ± 0.4 1375 ± 154 3.2 ± 0.4 G4 (1.0) 7.48 ± 0.24 14.4 ± 0.7 44.1 ± 2.0 59.0 ± 1.1 19.3 ± 0.4 32.8 ± 0.1 1242 ± 120 2.9 ± 0.6Group/Dose(mL/animal)WBC (×10 3  cells/µL)NEUWBC Differential Counting (%) PT (sec)APTT (sec) LYM MONO EOS BASO G1 (0) 7.88 ± 1.03 14.1 ± 6.0 81.5 ± 6.0 2.4 ± 0.5 0.4 ± 0.1 0.2 ± 0.1 17.0 ± 0.7 13.0 ± 1.8 G2 (0.1) 8.67 ± 2.26 15.1 ± 3.5 80.5 ± 2.7 2.4 ± 0.5 0.4 ± 0.1 0.2 ± 0.1 16.8 ± 0.9 12.2 ± 1.5 G3 (0.5) 8.01 ± 3.20 15.8 ± 3.0 79.6 ± 3.2 2.6 ± 0.6 0.6 ± 0.3 0.2 ± 0.1 17.4 ± 0.6 14.5 ± 0.9 G4 (1.0) 8.48 ± 2.05 13.1 ± 5.4 83.1 ± 5.5 1.9 ± 0.6 0.4 ± 0.1 0.2 ± 0.1 17.2 ± 0.4 14.7 ± 1.3 Group/Dose(mL/animal)WBC (×10 3  cells/µL)NEUWBC Differential Counting (%) PT (sec)APTT (sec) LYM MONO EOS BASO G1 (0) 4.27 ± 1.00 20.0 ± 5.3 75.6 ± 5.4 2.1 ± 0.8 1.3 ± 0.5 0.1 ± 0.0 18.6 ± 1.6 13.3 ± 1.4 G2 (0.1) 3.63 ± 1.56 16.8 ± 8.1 79.5 ± 7.6 1.7 ± 0.9 1.0 ± 0.6 0.1 ± 0.0 18.6 ± 0.6 14.5 ± 1.0 G3 (0.5) 4.36 ± 1.30 19.0 ± 4.3 77.1 ± 4.4 2.0 ± 0.4 0.8 ± 0.5 0.1 ± 0.1 17.9 ± 1.1 15.6 ± 1.9 G4 (1.0) 4.26 ± 1.98 14.2 ± 4.7 82.3 ± 4.7 1.7 ± 0.6 0.9 ± 0.5 0.1 ± 0.1 18.3 ± 0.6 14.2 ± 1.6 SD, Sprague-Dawley; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV , mean corpuscular volume; MCH, mean corpuscu- lar hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelets; Reti, reticulocytes; PT, prothrombin time; APTT, activated partial thromboplastin time; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV , mean corpuscular volume; MCH,  mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet; Reti, reticulocytes; PT, prothrom- bin time; APTT activated partial thromboplastin time.Journal of Pharmacopuncture 2015;18(4):038-044",Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
"http://www.journal.ac043 Table 4 Mean clinical chemistry in male, female SD rats (Male) Group/Dose (mL/animal)ALT (U/L)AST (U/L)ALP (U/L)GGT (U/L)Glu (mg/ dL)BUN (mg/dL)Crea (mg/dL)T-Bili (mg/dL)T-Chol (mg/ dL) G1 (0) 23.4 ± 1.3 85.9 ± 12.6 831.2 ± 162.0 0.39 ± 0.14 144 ± 16 11.2 ± 1.7 0.37 ± 0.03 0.01 ± 0.01 71 ± 11 G2 (0.1) 26.8 ± 3.1 79.2 ± 4.8 805.4 ± 159.6 0.28 ± 0.10 133 ± 9 10.7 ± 1.6 0.37 ± 0.02 0.03 ± 0.01 80 ± 12 G3 (0.5) 24.8 ± 2.0 88.7 ± 19.4 786.0 ± 159.0 0.42 ± 0.06 135 ± 16 11.1 ± 1.6 0.37 ± 0.02 0.02 ± 0.01 86 ± 18 G4 (1.0) 25.7 ± 4.2 77.3 ± 20.8 893.4 ± 164.6 0.42 ± 0.14 145 ± 18 10.8 ± 1.3 0.37 ± 0.03 0.03 ± 0.01 84 ± 19 Group/Dose(mL/animal)ALT (U/L)AST (U/L)ALP (U/L)GGT (U/L)Glu (mg/dL)BUN (mg/ dL)Crea (mg/dL)T-Bili (mg/dL)T-Chol (mg/dL) G1 (0) 23.2 ± 5.7 111.3±40.1 484.1±102.8 0.55±0.22 111±17 12.6±0.7 0.40±0.04 0.04±0.03 81±21 G2 (0.1) 20.9 ± 2.0 85.9±10.0 635.3±129.1 0.64±0.13 118±10 12.2±1.7 0.38±0.04 0.02±0.01 81±13 G3 (0.5) 18.5 ± 1.4 76.6±22.1 563.9±134.6 0.60±0.20 134±24 12.7±0.8 0.39±0.02 0.02±0.01 86±13 G4 (1.0) 18.9 ± 1.7 77.4±14.1 610.4±181.2 0.66±0.25 117±13 13.2±1.3 0.41±0.04 0.02±0.01 88±23Group/Dose(mL/animal)TG (mg/dL)TP (g/dL)Alb (g/dL)A/G ratioP (mg/dL)Ca (mg/dL)Na (mmol/L)K (mmol/L)Cl (mmol/L) G1 (0) 39 ± 10 5.2 ± 0.1 2.3 ± 0.1 0.76 ± 0.03 8.92 ± 0.32 9.8 ± 0.2 140 ± 1 4.9 ± 0.3 104 ± 1 G2 (0.1) 47 ± 11 5.3 ± 0.1 2.4 ± 0.1 0.80 ± 0.05 8.81 ± 0.15 10.0 ± 0.4 140 ± 2 4.8 ± 0.4 103 ± 1 G3 (0.5) 44 ± 17 5.1 ± 0.2 2.2 ± 0.1 0.77 ± 0.01 8.63 ± 0.36 9.8 ± 0.4 139 ± 2 4.9 ± 0.4 104 ± 2 G4 (1.0) 46 ± 25 5.2 ± 0.0 2.2 ± 0.1 0.76 ± 0.07 9.05 ± 0.24 10.0 ± 0.4 139 ± 1 4.9 ± 0.3 102 ± 1 Group/Dose(mL/animal)TG (mg/dL)TP (g/dL)Alb (g/dL)A/G ratioP (mg/dL)Ca (mg/dL)Na (mmol/L)K (mmol/L)Cl (mmol/L) G1 (0) 21 ± 25 5.6 ± 0.2 2.5 ± 0.1 0.81 ± 0.04 7.19 ± 0.63 9.6 ± 0.3 140 ± 2 4.8 ± 0.2 105 ± 1 G2 (0.1) 11 ± 2 5.4 ± 0.2 2.4 ± 0.0 0.82 ± 0.05 7.66 ± 0.32 9.6 ± 0.1 140 ± 2 4.8 ± 0.4 105 ± 1 G3 (0.5) 15 ± 4 5.5 ± 0.2 2.5 ± 0.1 0.83 ± 0.02 7.79 ± 0.34 9.8 ± 0.3 140 ± 2 4.5 ± 0.2 107 ± 2 G4 (1.0) 13 ± 2 5.5 ± 0.3 2.6 ± 0.2 0.87 ± 0.06 7.47 ± 0.73 9.8 ± 0.4 140 ± 1 4.6 ± 0.3 106 ± 1(Female) (Continued)ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP , alkaline phosphatase; GGT, glutamyl transpeptidase; Glu, glu- cose; BUN, blood urea nitrogen; Crea, creatinine; T-Bili, total bilirubin; A/G gamma ratio, albumin globulin ratio; P , phosphorus; Ca, calcium; Na, sodium; K, potassium; Cl, chloride.",Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
"http://www.journal.ac044 Injection siteInfiltration,  inflammatory cells,  perivascular,  lateral vein0 0 0 1 0 1 1 2 No.",Non-OADS,/arxiv_data1/oa_pdf/76/21/2093-6966-v18-n04-038.PMC4797590.pdf
"Introduction Gami-jakyak gamcho buja decoction (Mecasin) was  developed for treating amyotrophic lateral sclerosis  Original article Key Words four week repeated tox icity test, gami jakyak gam- cho buja decoction (mecasin), herbal medicine,  sprague-dawley ratISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:045-050 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.037    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
"Department of Aupuncture & Moxibustion Medicine, Wonkwang Gwang-ju Oriental Medical Hospital, 543-8 Juweol 1-dong, Nam-gu, Gwangju 503-310, Korea.Tel: +82-62-670-6441  Fax: +82-62-670-6767E-mail: kscndl@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acReceived: Sep 20, 2015    Reviewed: Oct 12, 2015    Accepted: Nov 11, 20151Department of Acupuncture & Moxibustion Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 2 Nervous & Muscular System Disease Clinical Research Center of Wonkwang University Gwangju Korean Medical Hospital, Gwangju,  Korea 3 Department of Nursing, Gwang-Ju Womens University, Gwangju, Korea 4 Department of Neurology, Inam Neuroscience Research Center, Sanbon Medical Center, College of Medicine, Wonkwang University,   Iksan, Korea 5 Department of Internal Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 6 Department of Radiology, College of Korean Medicine, Wonkwang University, Iksan, Korea",Non-OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
"Blood samples were collected into tubes  containing ethylene diamine tetraacetic acid (EDTA) and were analyzed by using a blood counting analyzer (AD-046 http://www.journal.ac Journal of Pharmacopuncture 2015;18(4):045-050 GroupMecasin administration (mg/kg BW)  Number of animals (serial number) Male Female G1: Control group 0 5 (1101 — 1105) 5 (2101 — 2105) G2: Low-dose group 500 5 (1201 — 1205) 5 (2201 — 2205) G3: Mid-dose group 1,000 5 (1301 — 1305) 5 (2301 — 2305) G4: High-dose group 2,000 5 (1401 — 1405) 5 (2401 — 2405)Table 1 Groups of animals Mecasin, gami-jakyak gamcho buja decoction; BW, body weight.",Non-OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
"http://www.journal.ac047  Journal of Pharmacopuncture 2015;18(4):045-050 VIA 120, Siemens, U.S.A.) to determine the red blood cell  count (RBC), hemoglobin concentration (HGB), hemat - ocrit (HCT), mean corpuscular cell volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular cell  hemoglobin concentration (MCHC), platelet count (PLT),  white blood cell count (WBC), reticulocytes (Reti), pro- thrombin time (PT), and activated partial thromboplastin  time (APTT).",OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
048 http://www.journal.ac epididymis were fixed with Bouin solution.,Non-OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
http://www.journal.ac049 4.,Non-OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
http://www.journal.ac050 opment and assessment of a complete-detoxi arthritis  cation strategy for fuzi (lateral root of aconitum car - michaeli) and its application in rheumatoid therapy.,Non-OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
http://orcid.org/0000-0003-3580-5290.,Non-OADS,/arxiv_data1/oa_pdf/17/63/2093-6966-v18-n04-045.PMC4797591.pdf
"Materials and Methods Original Article Key Words Bufonis venonum , chan-su, pharmacopuncture, toxic - ity testISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:051-058 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.038    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
"Korean Pharmacopuncture Institute, 4F, Association of Korean Oriental Medicine B/D, 26-27, Gayang-dong, Gangseo-gu, Seoul 157-200, Korea.Tel: +82-33-744-9304  Fax: +82-33-744-9305E-mail: drkwon5031@daum.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 3Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 4Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received:  Apr 09, 2015    Reviewed:  Aug 14, 2015    Accepted: Aug 29, 2015",Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
"http://www.journal.ac052 Twenty-four SD rats of each gender were obtained from  Orientbio Inc. (Gyeong-gi, Korea) at 5 weeks of age and  were used after a week of quarantine and acclimatization.",Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
http://www.journal.ac053 Table 1 Summary of mortalities Table 2 Mean body weightsSexGroup / Dose  (mL/animal)No.,Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
054 http://www.journal.ac Journal of Pharmacopuncture 2015;18(4):051-058 Table 3 Mean hematology parameters Group/ Dose  (mL/animal)Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
http://www.journal.ac055  Journal of Pharmacopuncture 2015;18(4):051-058 G3 (0.25) Mean 7.22 14.6*40.6 56.3 20.2 35.9 1044 2.47 S.D.,Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
056 http://www.journal.ac Group/ Dose  (mL/animal)Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
http://www.journal.ac057 Table 5 Summary of necropsy findingsG3 (0.25)Mean 16 5.7 2.6 0.83 7.57 9.8 140 4.5 106 S.D.,Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
"http://www.journal.ac058 Xie JT, Maleckar SA, Yuan CS.",Non-OADS,/arxiv_data1/oa_pdf/91/d6/2093-6966-v18-n04-051.PMC4797592.pdf
"A Study on the Single-dose Oral Toxicity of Super Key in Sprague-Dawley Rats Jinhee Kim1, Jongcheol Lee2,3, Sungchul Kim2,3* The original article ‘ A Study on the Single-dose Oral  Toxicity of Super Key in Sprague-Dawley Rats’ (J Phar - macopuncture 2015;18(3):63-67, DOI: http://dx.doi.org/10.3831/KPI.2015.18.026) by Jinhee Kim, Jongcheol  Lee, Sungchul Kim was published with an incorrect Ac - knowledgements due to a production error.",Non-OADS,/arxiv_data1/oa_pdf/41/cb/2093-6966-v18-n04-063.PMC4797594.pdf
"Correction Key Words herbal medicine, oral toxicity, super key (processed sul- fur), toxicity testISSN 2093-6966 [Print], ISSN 2234-6856 [Online] Journal of Pharmacopuncture 2015;18[4]:063-063 DOI:   http://dx.doi.org/10.3831/KPI.2015.18.040    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)which permits unrestricted noncommercial use, distribution, and reproduction in anymedium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/cb/2093-6966-v18-n04-063.PMC4797594.pdf
"Department of Acupuncture & Moxibustion Medicine, Wonkwang Uni-versity Gwangju Korean Medical Hospital, 543-8 Juweol 1-dong, Nam-gu, Gwangju 503-310, Korea.Tel: +82-62-670-6441  Fax: +82-62-670-6767E-mail: kscndl@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Korean Rehabilitation Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 2  Department of Acupuncture & Moxibustion Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 3   Nervous & Muscular System Disease Clinical Research Center of Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea Received:  Mar 19, 2015    Reviewed:  Jul 21, 2015    Accepted: Jul 21, 2015",Non-OADS,/arxiv_data1/oa_pdf/41/cb/2093-6966-v18-n04-063.PMC4797594.pdf
"E-mail: shenq3@ uthscsa.edu Submission: 08-10-2015 Revised: 08-01-2016 Accepted: 12-01-20161Research Imaging  Institute, 2Departments  of Ophthalmology  and 3Radiology,  University of Texas  Health Science  Center, 4Department of  Veterans Affairs, South  Texas Veterans Health  Care System, San  Antonio, Texas, USAAccess this article online Quick Response Code: Website: http://www.braincirculation.org DOI: 10.4103/2394-8108.178544 How to cite this article:  Shen Q, Duong TQ.",Non-OADS,/arxiv_data1/oa_pdf/8e/4e/BC-2-20.PMC4797655.pdf
"[http://dx.doi.org/10.1016/S0161-6420(00)00526-1 ] [PMID: 11158813 ] [2] Shields CL, Shields JA, Cater J, et al.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1001/archopht.118.9.1219 ] [PMID: 10980767 ] [3] Horgan N, Shields CL, Mashayekhi A, Teixeira LF, Materin MA, Shields JA.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1097/IAE.0b013e31814b1b75 ] [PMID: 18301032 ] [4] Shah NV, Houston SK, Markoe AM, Feuer W, Murray TG.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.2147/OPTH.S34949 ] [PMID: 23152651 ] [5] Horgan N, Shields CL, Mashayekhi A, Shields JA.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1097/ICU.0b013e3283386687 ] [PMID: 20393294 ] [6] Wen JC, McCannel TA.",Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1097/ICU.0b013e328329b62d ] [PMID: 19349865 ] [7] Kocak N, Saatci AO, Arikan G, Bajin FM.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1007/s12009-006-0013-2 ] [PMID: 17416962 ] [8] Finger PT, Chin K. Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1001/archopht.125.6.751 ] [PMID: 17562985 ] [9] Gupta A, Muecke JS.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1097/IAE.0b013e3181706302 ] [PMID: 18698298 ] [10] Mason JO III, Albert MA Jr, Persaud TO, Vail RS.",Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1097/IAE.0b013e31806e6042 ] [PMID: 17891015 ] [11] Finger PT, Chin KJ.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1001/archophthalmol.2009.376 ] [PMID: 20142553 ] [12] Finger PT, Chin KJ.",Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
[http://dx.doi.org/10.5301/ejo.5000333 ] [PMID: 23813109 ] [13] European Environment Agency.,Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
[http://dx.doi.org/10.1001/archopht.117.5.609 ] [PMID: 10326957 ],Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1136/bjo.86.4.448 ] [PMID: 11914216 ] [16] Boyd SR, Tan DS, de Souza L, et al.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1136/bjo.86.4.440 ] [PMID: 11914215 ] [17] Stitt AW, Simpson DA, Boocock C, Gardiner TA, Murphy GM, Archer DB.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B ] [PMID: 10211121 ] [18] Missotten GS, Notting IC, Schlingemann RO, et al.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1001/archopht.124.10.1428 ] [PMID: 17030710 ] [19] Finger PT, Chin KJ, Semenova EA.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
[http://dx.doi.org/10.5301/ejo.5000670 ] [PMID: 26391167 ] [20] Haller JA.,OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1016/j.ophtha.2013.01.057 ] [PMID: 23642784 ] [21] Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1056/NEJMoa1102673 ] [PMID: 21526923 ] [22] Shienbaum G, Gupta OP, Fecarotta C, Patel AH, Kaiser RS, Regillo CD.",OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1016/j.ajo.2011.08.011 ] [PMID: 21996309 ] Received: October 30, 2015 Revised: December 9, 2015 Accepted: January 13, 2016 © Stacey and Demirci; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/06/6e/TOOPHTJ-10-103.PMC4797673.pdf
"[http://dx.doi.org/10.1007/s00405-013-2551-8 ] [PMID: 23665746 ] [2] Takatsu M, Higaki M, Kinoshita H, Mizushima Y, Koizuka I.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
[http://dx.doi.org/10.1097/01.mao.0000178138.19848.bd ] [PMID: 16015180 ],Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1007/s10067-014-2485-6 ] [PMID: 24435352 ] [4] Murdin L, Patel S, Walmsley J, Yeoh LH.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1007/s10067-007-0802-z ] [PMID: 18071780 ] [5] Bayazit YA, Yilmaz M, Gunduz B, et al.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1159/000101544 ] [PMID: 17409782 ] [6] Tilstra JS, Lienesch DW.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1016/j.det.2015.03.004 ] [PMID: 26143419 ] [7] Belloso A, Morar P, Estrach C, Helliwell T, Jackson S. Rheumatoid nodule of the nasal septum.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
[http://dx.doi.org/10.1258/0022215011909170 ] [PMID: 11668008 ] [8] García-Patos V. Rheumatoid nodule.,Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1016/j.sder.2007.02.007 ] [PMID: 17544962 ] [9] Ozcan M, Karakuş MF, Gündüz OH, Tuncel U, Sahin H. Hearing loss and middle ear involvement in rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1007/s00296-002-0185-z ] [PMID: 12120906 ] [10] Poorey VK, Khatri R. Study of Auditory function in Rheumatoid Arthritis.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1007/s00405-009-0975-y ] [PMID: 19360433 ] [13] Jung TT, Rhee CK, Lee CS, Park YS, Choi DC.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1080/00016480410016225 ] [PMID: 15267179 ] [15] Toone E, Hayden D, Ellman H. Ototoxicity of chloroquine.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1016/S0301-0082(00)00027-7 ] [PMID: 10880852 ] [17] Seçkin  U,  Ozoran  K,  Ikinciogullari  A,  Borman  P,  Bostan  EE.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1007/s002960000054 ] [PMID: 10984140 ] [18] Bortoli R, Santiago M. Chloroquine ototoxicity.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
[http://dx.doi.org/10.1007/s10067-007-0662-6 ] [PMID: 17594118 ] [19] Mukherjee DK.,Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1017/S0022215100087740 ] [PMID: 490032 ] [20] Tavernier L, Ranfaing E. Rheumatoid arthritis involved in the ear drum.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
[http://dx.doi.org/10.1097/MAO.0b013e3181d2f039 ] [PMID: 20142795 ] [21] Fotolia.,Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
Available from: https://eu.fotolia.com/id/41342727 [22] Turesson C. Extra-articular rheumatoid arthritis.,Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1097/BOR.0b013e32835f693f ] [PMID: 23425964 ] [23] Uribe-Escamilla R, Poblano A, Alfaro-Rodríguez A.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1007/s00420-005-0604-z ] [PMID: 15761747 ] [25] Nyhäll-Wåhlin BM, Jacobsson LT, Petersson IF, Turesson C. Smoking is a strong risk factor for rheumatoid nodules in early rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1136/ard.2005.039172 ] [PMID: 16166104 ] [26] Ribeiro SB, Jacob LC, Alvarenga KdeF, Marques JM, Campêlo RM, Tschoeke SN.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1016/S1808-8694(15)30097-5 ] [PMID: 17923916 ] [27] Bellé M, Sartori SdoA, Rossi AG.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1016/S1808-8694(15)31132-0 ] [PMID: 17505609 ] [28] Stucken EZ, Hong RS.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
[http://dx.doi.org/10.1097/MOO.0000000000000079 ] [PMID: 25188429 ] [29] Bielefeld EC.,Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1016/j.drudis.2015.01.010 ] [PMID: 25637168 ] [30] Pascual-Ramos V, Contreras-Yáñez I, Enríquez L, Valdés S, Ramírez-Anguiano J.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1097/RHU.0b013e31827732d3 ] [PMID: 23188202 ] [31] Goodwill CJ, Lord IJ, Jones RP.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1136/ard.31.3.170 ] [PMID: 5032449 ] [32] Magaro M, Zoli A, Altomonte L, et al.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1001/jama.1949.02900430001001 ] [PMID: 18150288 ] [34] Kastanioudakis I, Skevas A, Danielidis V, Tsiakou E, Drosos AA, Moustopoulos MH.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1017/S0022215100131135 ] [PMID: 7561491 ] [35] Mehrparvar AH, Mirmohammadi SJ, Davari MH, et al.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.5812/ircmj.9628 ] [PMID: 24719719 ] [36] Müller U, Barr-Gillespie PG.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1038/nrd4533 ] [PMID: 25792261 ] [37] Treviño-González  JL,  Villegas-González  MJ,  Muñoz-Maldonado  GE,  Montero-Cantu  CA,  Nava-Zavala  AH,  Garza-Elizondo  MA.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/ 10.1016/j.circir.2015.05.026 ] [PMID: 26141107 ] [38] Milisavljevic D, Stankovic I, Stankovic M. Is the treatment of hearing loss in rheumatoid arthritis effective?",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1017/S0022215106002593 ] [PMID: 17040588 ] [40] Gazeau P, Saraux A, Devauchelle-Pensec V, Cornec D. Long-term efficacy of infliximab in autoimmune sensorineural hearing loss associated with rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1093/rheumatology/keu025 ] [PMID: 24625506 ] [41] García Callejo FJ, Conill Tobías N, Muñoz Fernández N, de Paula Vernetta C, Alonso Castañeira I, Marco Algarra J.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1016/S2173-5735(07)70341-1 ] [PMID: 17663942 ] [42] García Callejo FJ, Corts J, de Paula Vernetta C, Laporta P, Ramírez Sabio J, Marco Algarra J. Cormobidity of sensorineural hearing loss and other autoimmune diseases.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.1196/annals.1351.019 ] [PMID: 16855148 ] [45] Karlsmose B, Lauritzen T, Parving A.",OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"[http://dx.doi.org/10.3109/03005364000000107 ] [PMID: 10656600 ] Received: August 14, 2015 Revised: December 11, 2015 Accepted: January 19, 2016 © Emamifar et al.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/45/TORJ-10-26.PMC4797675.pdf
[http://dx.doi.org/10.1016/j.apmr.2005.03.024 ] [PMID: 16084827 ] [2] Stewart DG.,OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/S0003-9993(99)90095-3 ] [PMID: 10326897 ] [3] Lattari E, Pereira-Junior PP, Neto GA, et al.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.2174/1745017901410010126 ] [PMID: 25419223 ] [4] Mura G, Sancassiani F, Migliaccio GM, Collu G, Carta MG.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.2174/1745017901410010036 ] [PMID: 24707314 ] [5] Carta MG, Hardoy MC, Pilu A, et al.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1186/1745-0179-4-1 ] [6] Van Leeuwen R, Inglis JT.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1179/ptr.1998.3.1.47 ] [7] Jackson PL, Lafleur MF, Malouin F, Richards C, Doyon J.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1053/apmr.2001.24286 ] [PMID: 11494195 ] [8] Nair DG, Purcott KL, Fuchs A, Steinberg F, Kelso JA.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/S0926-6410(02)00197-0 ] [PMID: 12527099 ] [9] Jackson PL, Lafleur MF, Malouin F, Richards CL, Doyon J. Functional cerebral reorganization following motor sequence learning through mental practice with motor imagery.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/S1053-8119(03)00369-0 ] [PMID: 14568486 ] [10] Malouin F, Richards CL, Jackson PL, Dumas F, Doyon J.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1002/hbm.10103 ] [PMID: 12731103 ] [11] Decety J, Grèzes J. Neural mechanisms subserving the perception of human actions.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/S1364-6613(99)01312-1 ] [PMID: 10322473 ] [12] Lotze M, Cohen LG.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1097/01.wnn.0000209875.56060.06 ] [PMID: 16957491 ] [13] Michelon P, Vettel JM, Zacks JM.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
[http://dx.doi.org/10.1152/jn.00488.2005 ] [PMID: 16207787 ] [14] Jeannerod M. Neural simulation of action: a unifying mechanism for motor cognition.,Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1006/nimg.2001.0832 ] [PMID: 11373140 ] [15] Lotze M, Montoya P, Erb M, et al.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1162/089892999563553 ] [PMID: 10511638 ] [16] Gerardin E, Sirigu A, Lehéricy S, et al.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1093/cercor/10.11.1093 ] [PMID: 11053230 ] [17] Kuhtz-Buschbeck  JP,  Mahnkopf  C,  Holzknecht  C,  Siebner  H,  Ulmer  S,  Jansen  O.  Effector-independent  representations  of  simple  and complex imagined finger movements: a combined fMRI and TMS study.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1111/j.1460-9568.2003.03066.x ] [PMID: 14686911 ] [18] Gerloff C, Corwell B, Chen R, Hallett M, Cohen LG.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1093/brain/121.9.1695 ] [PMID: 9762958 ] [19] Li S, Kamper DG, Stevens JA, Rymer WZ.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1523/JNEUROSCI.2781-04.2004 ] [PMID: 15509755 ] [20] Pascual-Leone A, Nguyet D, Cohen LG, Brasil-Neto JP, Cammarota A, Hallett M. Modulation of muscle responses evoked by transcranial magnetic stimulation during the acquisition of new fine motor skills.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"Available at: http://cirrie.buffalo.edu/database/829/ [22] Stevens JA, Stoykov ME.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/S0003-9993(03)00042-X ] [PMID: 12881842 ] [23] Weiss T, Hansen E, Rost R, et al.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
[http://dx.doi.org/10.3109/00207459408986054 ] [PMID: 7883452 ] [24] Page SJ.,Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/j.apmr.2004.10.002 ] [PMID: 15759218 ] [27] Page SJ, Levine P, Leonard A.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1161/01.STR.0000260205.67348.2b ] [PMID: 17332444 ] [28] Page SJ, Levine P, Khoury JC.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1161/STROKEAHA.108.528760 ] [PMID: 19109542 ] [29] Nilsen DM, Gillen G, DiRusso T, Gordon AM.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.5014/ajot.2012.003475 ] [PMID: 22549597 ] [30] Page SJ, Szaflarski JP, Eliassen JC, Pan H, Cramer SC.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1177/1545968308326427 ] [PMID: 19155350 ] [31] Riccio I, Iolascon G, Barillari MR, Gimigliano R, Gimigliano F. Mental practice is effective in upper limb recovery after stroke: a randomized single-blind cross-over study.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/j.apmr.2003.12.035 ] [PMID: 15375808 ] [33] Bovend’Eerdt TJ, Dawes H, Sackley C, Izadi H, Wade DT.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1016/j.apmr.2010.03.008 ] [PMID: 20510987 ] [34] Hemmen B, Seelen HA.",OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.1177/0269215507075502 ] [PMID: 17702700 ] [35] Stevenson T, Thalman L, Christie H, Poluha W. Constraint-induced movement therapy compared to dose-matched interventions for upper- limb dysfunction in adult survivors of stroke: a systematic review with meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
[http://dx.doi.org/10.3138/ptc.2011-24 ] [PMID: 23997396 ],Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"[http://dx.doi.org/10.2174/1871527314666150429112702 ] [PMID: 25921745 ] Received: December 26, 2014 Revised: July 12, 2015 Accepted: August 06, 2015 © Machado et al.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/29/d2/CPEMH-12-9.PMC4797678.pdf
[http://dx.doi.org/10.1007/s00221-008-1521-7 ] [PMID: 18696056 ] [2] Alexander NB.,Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1111/j.1532-5415.1994.tb06081.x ] [PMID: 8277123 ] [3] Shumway-Cook A, Woollacott M. Motor control: theory and practical applications.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
[http://dx.doi.org/10.1097/00005537-199909000-00019 ] [PMID: 10499055 ] [5] Jones GM.,Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.2165/00007256-200131060-00003 ] [PMID: 11394562 ] [8] Shaffer SW, Harrison AL.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.2522/ptj.20060083 ] [PMID: 17244695 ] [9] Booth FW, Weeden SH, Tseng BS.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1249/00005768-199405000-00006 ] [PMID: 8007802 ] [10] Thornell LE, Lindström M, Renault V, Mouly V, Butler-Browne GS.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1034/j.1600-0838.2003.20285.x ] [PMID: 12535317 ] [11] Williams GN, Higgins MJ, Lewek MD.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1258/0007142001903120 ] [PMID: 11092079 ] [14] Langhorne P, Bernhardt J, Kwakkel G. Stroke rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/S0140-6736(11)60325-5 ] [PMID: 21571152 ] [15] Costa AR, Silva F, Andrade LA.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1002/9780470696361 ] [17] Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/S1474-4422(04)00800-2 ] [PMID: 15207791 ] [18] de Oliveira CB, de Medeiros IR, Frota NA, Greters ME, Conforto AB.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1682/JRRD.2007.09.0150 ] [PMID: 19235121 ] [19] Chen IC, Cheng PT, Chen CL, Chen SC, Chung CY, Yeh TH.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.2147/CIA.S36027 ] [PMID: 23269865 ] [24] Marigold DS, Eng JJ.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
[http://dx.doi.org/10.1016/j.gaitpost.2005.03.001 ] [PMID: 16399522 ],OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1002/path.2122 ] [PMID: 17200949 ] [27] Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1111/j.1532-5415.1991.tb01616.x ] [PMID: 1991946 ] [28] Raymakers JA, Samson MM, Verhaar HJ.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/j.gaitpost.2003.11.006 ] [PMID: 15536033 ] [29] Duarte M, Freitas SM.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1590/S1413-35552010000300003 ] [PMID: 20730361 ] [30] Paillex R, So A. Posture debout chez des sujets adultes: spécificités de l’hémiplégie.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/S0168-6054(03)00002-3 ] [PMID: 12676410 ] [31] Alfieri FM, Riberto M, Gatz LS, Ribeiro CP, Lopes JA, Battistella LR.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.2147/CIA.S27747 ] [PMID: 22654512 ] [32] Alfieri FM, Riberto M, Gatz LS, Ribeiro CP, Lopes JA, Battistella LR.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.2147/CIA.S10223 ] [PMID: 20711437 ] [33] Rogers ME, Rogers NL, Takeshima N, Islam MM.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/S0091-7435(02)00028-2 ] [PMID: 12634016 ] [34] Howe TE, Rochester L, Jackson A, Banks PM, Blair VA.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1002/14651858.CD004963.pub2 ] [35] Lubetzky-Vilnai A, Kartin D. The effect of balance training on balance performance in individuals poststroke: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1097/NPT.0b013e3181ef764d ] [PMID: 20716987 ] [36] Billot  M,  Handrigan  GA,  Simoneau  M,  Corbeil  P,  Teasdale  N.  Short  term  alteration  of  balance  control  after  a  reduction  of  plantar mechanoreceptor sensation through cooling.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/j.neulet.2012.11.022 ] [PMID: 23305721 ] [37] Tung FL, Yang YR, Lee CC, Wang RY.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1177/0269215509360751 ] [PMID: 20410150 ] [38] Au-Yeung SS, Hui-Chan CW, Tang JC.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1177/1545968308326425 ] [PMID: 19129308 ] [39] Eng JJ, Chu KS, Kim CM, Dawson AS, Carswell A, Hepburn KE.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1249/01.MSS.0000079079.58477.0B ] [PMID: 12900678 ] [40] Noh DK, Lim JY, Shin HI, Paik NJ.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1177/0269215508091434 ] [PMID: 18955428 ] [41] Saeys W, Vereeck L, Truijen S, Lafosse C, Wuyts FP, Heyning PV.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1177/1545968311416822 ] [PMID: 21844283 ] [42] Kirker SG, Jenner JR, Simpson DS, Wing AM.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
[http://dx.doi.org/10.1191/0269215500cr370oa ] [PMID: 11128737 ] [43] Sackley CM.,Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.3109/03790799109166267 ] [PMID: 1917796 ] [44] Bensoussan L, Viton JM, Schieppati M, et al.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
[http://dx.doi.org/10.1016/j.apmr.2007.05.009 ] [PMID: 17678663 ],OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1093/gerona/51A.5.M226 ] [PMID: 8808994 ] [46] Perrin PP, Gauchard GC, Perrot C, Jeandel C. Effects of physical and sporting activities on balance control in elderly people.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1136/bjsm.33.2.121 ] [PMID: 10205695 ] [47] Park YH, Kim YM, Lee BH.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
[http://dx.doi.org/10.1589/jpts.25.1321 ] [PMID: 24259785 ] [48] Bohannon RW.,Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1519/00139143-200608000-00004 ] [PMID: 16914068 ] [49] Bonan IV, Colle FM, Guichard JP, et al.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/j.apmr.2003.06.017 ] [PMID: 14966712 ] [50] de Haart M, Geurts AC, Huidekoper SC, Fasotti L, van Limbeek J.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/j.apmr.2003.05.012 ] [PMID: 15179641 ] [51] Pérennou D, Bénaïm C, Rouget E, Rousseaux M, Blard JM, Pélissier J. Postural balance following stroke: towards a disadvantage of the right brain-damaged hemisphere.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.3171/jns.1986.64.5.0693 ] [PMID: 3517248 ] [55] Ustinova KI, Chernikova LA, Ioffe ME, Sliva SS.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1023/A:1010326332751 ] [PMID: 11430569 ] [56] Peurala SH, Könönen P, Pitkänen K, Sivenius J, Tarkka IM.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/j.gaitpost.2004.10.002 ] [PMID: 16214666 ] [58] Nagy E, Feher-Kiss A, Barnai M, Domján-Preszner A, Angyan L, Horvath G. Postural control in elderly subjects participating in balance training.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1007/s00421-007-0407-x ] [PMID: 17333243 ] [59] Islam MM, Nasu E, Rogers ME, Koizumi D, Rogers NL, Takeshima N. Effects of combined sensory and muscular training on balance in Japanese older adults.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1016/j.ypmed.2004.04.048 ] [PMID: 15539049 ] Received: June 29, 2015 Revised: August 1, 2015 Accepted: September 11, 2015 © Alfieri et al.",OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/57/69/TONEUJ-10-1.PMC4797679.pdf
"[http://dx.doi.org/10.1097/00005131-200408000-00002 ] [PMID: 15289684 ] [4] Ricci WM, Bellabarba C, Lewis R, et al.",OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"[http://dx.doi.org/10.1097/00005131-200102000-00003 ] [PMID: 11232660 ] [5] Harris I, Hatfield A, Walton J. Assessing leg length discrepancy after femoral fracture: clinical examination or computed tomography?",Non-OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"[http://dx.doi.org/10.1111/j.1445-2197.2005.03349.x ] [PMID: 15932444 ] [6] Reina R, Vilella FE, Ramírez N, Valenzuela R, Nieves G, Foy CA.",OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"[http://dx.doi.org/10.1097/BOT.0b013e3181f92d6e ] [PMID: 21654530 ] [11] Kocaoglu M, Eralp L, Kilicoglu O, Burc H, Cakmak M. Complications encountered during lengthening over an intramedullary nail.",Non-OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
[http://dx.doi.org/10.1097/00003086-199609000-00028 ] [PMID: 8804295 ],Non-OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"[http://dx.doi.org/10.1007/s11999-011-2204-4 ] [PMID: 22143986 ] [17] Simpson AH, Cole AS, Kenwright J.",Non-OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"[http://dx.doi.org/10.1302/0301-620X.81B6.9359 ] [PMID: 10615983 ] [18] Song H-R, Oh C-W, Mattoo R, et al.",OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"[http://dx.doi.org/10.1080/00016470510030652 ] [PMID: 16097552 ] Received: February 22, 2015 Revised: August 21, 2015 Accepted: August 26, 2015 © Boutsiadis et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/4c/TOORTHJ-10-12.PMC4797680.pdf
"[http://dx.doi.org/10.1038/nature06531 ] [PMID: 18235503 ] [2] Berardi, M.J.; Shih, W.M.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1038/nature10257 ] [PMID: 21785437 ] [3] OuYang, B.; Xie, S.; Berardi, M.J.; Zhao, X.; Dev, J.; Yu, W.; Sun, B.; Chou, J.J.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1038/nature12283 ] [PMID: 23739335 ] [4] Call, M.E.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/j.cell.2006.08.044 ] [PMID: 17055436 ] [5] Wang, J.; Pielak, R.M.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1038/nsmb.1707 ] [PMID: 19898475 ] [6] Call, M.E.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1038/ni.1943 ] [PMID: 20890284 ] [7] Chou, K.C.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/S0014-5793(97)01246-5 ] [PMID: 9426218 ] [8] Chou, K.C.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/S0014-5793(00)01333-8 ] [PMID: 10745077 ] [9] Chou, K.C.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1021/pr050145a ] [PMID: 16212421 ] [10] Wang, S.Q.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/j.bbrc.2009.06.016 ] [PMID: 19523442 ] [11] Chou, K.C.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.2174/0929867043364667 ] [PMID: 15279552 ] [12] Pronk, S.; Páll, S.; Schulz, R.; Larsson, P.; Bjelkmar, P.; Apostolov, R.; Shirts, M.R.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1093/bioinformatics/btt055 ] [PMID: 23407358 ] [13] Van Der Spoel, D.; Lindahl, E.; Hess, B.; Groenhof, G.; Mark, A.E.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/jcc.20291 ] [PMID: 16211538 ] [14] Froimowitz,  M.  HyperChem:  a  software  package  for  computational  chemistry  and  molecular  modeling.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://www.hyper.com/?tabid=360 [16] Charmm , Available form: http://www.charmm.org/  [Accessed April 15, 2014].",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available  from:  http://charm.cs.uiuc.edu/research/moldyn/ [Accessed April 15, 2014].",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://www.ks.uiuc.edu/Research/namd/  [Accessed April 15, 2014].",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
[http://dx.doi.org/10.1021/ct200563j ] [PMID: 22121340 ],Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1088/1749-4699/4/1/015002 ] [PMID: 21686063 ] [21] Jiang, W.; Hardy, D.J.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1021/jz101461d ] [PMID: 21572567 ] [22] Phillips, J.C.; Braun, R.; Wang, W.; Gumbart, J.; Tajkhorshid, E.; Villa, E.; Chipot, C.; Skeel, R.D.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/jcc.20289 ] [PMID: 16222654 ] [23] Lemak, A.S.; Balabaev, N.K.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/(SICI)1096-987X(19961130)17:15<1685::AID-JCC1>3.0.CO;2-L ] [24] Lemak, A.S.; Balabaev, N.K.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
[http://dx.doi.org/10.1080/08927029508022336 ] [25] NVIDIA CUDA Zone.,Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: https://developer.nvidia.com/cuda-zone  [Accessed April 15, 2014], 2015 .",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://www.ks.uiuc.edu/Research/vmd/  [Accessed April 15, 2014].",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/0263-7855(96)00018-5 ] [PMID: 8744570 ] [28] Hsin, J.; Arkhipov, A.; Yin, Y.; Stone, J.; Schulten, K. Using VMD –an introductory tutorial.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"5, Unit 5.7 [http://dx.doi.org/10.1002/0471250953.bi0507s24 ] [29] Stone, J.E.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1109/XSW.2013.10 ] [30] Knapp, B.; Lederer, N.; Omasits, U.; Schreiner, W. vmdICE: a plug-in for rapid evaluation of molecular dynamics simulations using VMD.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.6026/97320630008341 ] [PMID: 22553393 ] [32] Cross, S.; Kuttel, M.M.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/j.jmgm.2009.04.010 ] [PMID: 19473861 ] [33] CMView , [cited 2014 Oct 01].",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://www.bioinformatics.org/cmview/  [Accessed April 15, 2014].",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1093/bioinformatics/btr163 ] [PMID: 21471016 ] [35] Vriend, G. WHAT IF: a molecular modeling and drug design program.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/0263-7855(90)80070-V ] [PMID: 2268628 ] [36] Venselaar, H.; Te Beek, T.A.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1186/1471-2105-11-548 ] [PMID: 21059217 ] [37] Hekkelman, M.L.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/S1093-3263(99)00038-8 ] [PMID: 10840690 ] [39] Vriend, G.; Sander, C. Detection of common three-dimensional substructures in proteins.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/prot.340110107 ] [PMID: 1660134 ] [40] Rodriguez, R.; Chinea, G.; Lopez, N.; Vriend, G. Full window stereo.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/S1093-3263(99)00038-8 ] [PMID: 10840690 ] [41] QuteMol , [cited 2014 Oct 01].",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://qutemol.sourceforge.net/ [Accessed April 15, 2014].",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: https://distributed.ru/forum/?f=11  [Accessed April 15, 2014].",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://lmd.psn.ru/joomla/tamd/downloads  [Accessed April 15, 2014].",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1038/news021014-14 ] [45] Ivanov, A.S.; Dubanov, A.V.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1371/journal.pcbi.1002916 ] [PMID: 23468606 ] [48] Hehre, W.J.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: https://www.wavefun.com/support/AGuidetoMM.pdf [49] Wavefunction, Inc; c2015 , [cited 2014 Oct 01].",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://www.wavefun.com/  [Accessed April 15, 2014], 2015 .",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
Available from: http://www.ggasoftware.com/ .,Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"Available from: http://www.nvidia.com  [Accessed April 15, 2014], 2015 .",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/jcc.21766 ] [PMID: 21469156 ] [53] Gruber,  C.C.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/jcc.21645 ] [PMID: 20812321 ] [54] Kutzner, C.; van der Spoel, D.; Fechner, M.; Lindahl, E.; Schmitt, U.W.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/jcc.20703 ] [PMID: 17405124 ] [55] Noel,  J.K.;  Whitford,  P.C.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1021/ci900248f ] [PMID: 19852516 ] [58] Kota, P. GUIMACS - a Java based front end for GROMACS.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
Available from: http://www.hyper.com .,Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1002/jbm.a.30511 ] [PMID: 16138331 ] [61] Rodriguez, R.; Chinea, G.; Lopez, N.; Vriend, G. Full window stereo.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1016/S1093-3263(99)00038-8 ] [PMID: 10840690 ] Received: September 9, 2014 Revised: February 5, 2015 Accepted: April 7, 2015 © Likhachev et al.",OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/TOBIOCJ-10-1.PMC4797681.pdf
"[http://dx.doi.org/10.1161/01.CIR.93.5.1043 ] [PMID: 8598068 ] [2] Kiselev AR, Gridnev VI, Prokhorov MD, et al.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1111/j.1542-474X.2012.00514.x ] [PMID: 22816539 ] [3] Cohen MA, Taylor JA.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
[http://dx.doi.org/10.1113/jphysiol.2002.017483 ] [PMID: 12154170 ] [4] Malpas SC.,Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
[http://dx.doi.org/10.1113/expphysiol.2012.066977 ] [PMID: 23015734 ] [6] Heathers JA.,OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.3389/fphys.2014.00177 ] [PMID: 24847279 ] [7] Goldstein DS, Bentho O, Park MY, Sharabi Y. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outflows by baroreflexes.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1113/expphysiol.2010.056259 ] [PMID: 21890520 ] [8] Reyes del Paso GA, Langewitz W, Mulder LJ, van Roon A, Duschek S. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1111/psyp.12027 ] [PMID: 23445494 ] [9] Kiselev AR, Bespiatov AB, Posnenkova OM, et al.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1063/1.3187794 ] [PMID: 19791992 ] [11] Kiselev AR, Gridnev VI, Prokhorov MD, et al.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.2459/JCM.0b013e3283512199 ] [PMID: 22343262 ] [12] Kiselev AR, Gridnev VI, Prokhorov MD, et al.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.5152/akd.2014.5107 ] [PMID: 25188759 ] [13] Söderström T, Stefanovska A, Veber M, Svensson H. Involvement of sympathetic nerve activity in skin blood flow oscillations in humans.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1152/ajpheart.00826.2000 ] [PMID: 12679328 ] [14] Bandrivskyy A, Bernjak A, McClintock PV, Stefanovska A. Wavelet phase coherence analysis: application to skin temperature and blood flow.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1023/B:CARE.0000025126.63253.43 ] [15] Anschütz S, Schubert R. Modulation of the myogenic response by neurogenic influences in rat small arteries.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1038/sj.bjp.0706323 ] [PMID: 16025142 ] [16] Bernjak A, Clarkson PB, McClintock PV, Stefanovska A. Low-frequency blood flow oscillations in congestive heart failure and after β1- blockade treatment.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1016/j.mvr.2008.07.006 ] [PMID: 18721820 ] [17] Linder JR, Stauss HM, Gindes H, et al.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1186/1471-2261-14-180 ] [PMID: 25487432 ] [18] Chen X, Liu N, Huang Y, Yun F, Wang J, Li J.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1007/s10877-014-9641-z ] [PMID: 25408376 ] [19] Massin MM, Derkenne B, von Bernuth G. Correlations between indices of heart rate variability in healthy children and children with congenital heart disease.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1159/000006889 ] [PMID: 10449882 ] [20] Durnova NY, Dovgalevskiy YP, Burlaka AN, Kiselev AR, Furman NV.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
[http://dx.doi.org/10.5543/tkda.2013.37676 ] [PMID: 23703553 ] [22] Taylor R. Interpretation of the correlation coefficient: a basic review.,OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1177/875647939000600106 ] [23] da Silva VP, de Oliveira NA, Silveira H, Mello RG, Deslandes AC.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1111/anec.12237 ] [PMID: 25424360 ] [24] Henríquez OC, Báez SM, Von Oetinger A, Cañas JR, Ramírez CR.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.5604/20831862.1044429 ] [PMID: 24744476 ] [25] Bhardwaj S, Verma N, Anjum B, Bhardwaj K. Variations in 7-day/24-h circadian pattern of ambulatory blood pressure and heart rate of type 2 diabetes patients.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1111/jdi.12224 ] [PMID: 25422775 ] [26] Gapon  LI,  Sereda  TV,  Leont’eva  AV.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.18565/cardio.2014.8.32-36 ] [PMID: 25464608 ] [27] Afsar B. Disruption of circadian blood pressure, heart rate and the impact on glycemic control in type 1 diabetes.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1016/j.dsx.2014.05.002 ] [PMID: 25470635 ] [28] Santos WB, Matoso JM, Maltez M, et al.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"[http://dx.doi.org/10.1038/jhh.2014.119 ] [PMID: 25518896 ] [29] Pagani M, Malliani A. Interpreting oscillations of muscle sympathetic nerve activity and heart rate variability.",OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
[http://dx.doi.org/10.1097/00004872-200018120-00002 ] [PMID: 11132592 ] [30] Billman GE.,OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
[http://dx.doi.org/10.3389/fphys.2013.00026 ] [PMID: 23431279 ],Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/97/03/TOCMJ-10-35.PMC4797682.pdf
[http://dx.doi.org/10.1016/j.dental.2009.06.004 ] [PMID: 19595446 ] [2] Strassler  HE.,OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
Available  at: http://www.ineedce.com/courses/2052/PDF/1104cei_glassionomer_web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
[http://dx.doi.org/10.1016/S0109-5641(99)00093-7 ] [PMID: 11203534 ] [4] Anusavice KJ.,OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1111/j.1834-7819.2009.01125.x ] [PMID: 19709111 ] [7] Bouschlicher MR, Vargas MA, Denehy GE.",Non-OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
[http://dx.doi.org/10.1016/S0142-9612(97)00126-9 ] [PMID: 9645552 ] [9] Sidhu SK.,OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1111/j.1834-7819.2010.01293.x ] [PMID: 21564113 ] [10] Tyas MJ, Burrow MF.",OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1111/j.1834-7819.2004.tb00059.x ] [PMID: 15497354 ] [11] Gale MS, Darvell BW.",OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1016/S0300-5712(98)00037-2 ] [PMID: 10071465 ] [12] Chammas MB, Valarini N, Maciel SM, Poli-Frederico PC, Oltramari-Navarro PV, Conti AC.",OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1016/j.dental.2009.12.004 ] [PMID: 20053434 ] [14] Xu HH, Eichmiller FC, Smith DT, Schumacher GE, Giuseppetti AA, Antonucci JM.",Non-OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1023/A:1016504530133 ] [PMID: 15348553 ] [15] Fleming GJ, Farooq AA, Barralet JE.",Non-OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
[http://dx.doi.org/10.1016/S0142-9612(03)00301-6 ] [PMID: 12853247 ] [16] Ferracane JL.,OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1016/j.dental.2010.10.020 ] [PMID: 21093034 ] [17] Curtis AR, Palin WM, Fleming GJ, Shortall AC, Marquis PM.",OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1016/j.dental.2008.06.003 ] [PMID: 18656255 ] [18] Prentice LH, Tyas MJ, Burrow MF.",OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
[http://dx.doi.org/10.1016/j.dental.2004.07.016 ] [PMID: 15904692 ],Non-OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1590/S1678-77572008000200005 ] [PMID: 19089200 ] [21] Wilson AD, Mclean JW.",OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1016/j.dental.2010.03.004 ] [PMID: 20621775 ] [23] Fusayama T, Katayori T, Nomoto S. Corrosion of gold and amalgam placed in contact with each other.",OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"[http://dx.doi.org/10.1177/00220345630420051301 ] [PMID: 14061939 ] Received: December 12, 2014 Revised: November 5, 2015 Accepted: November 6, 2015 © Souza et al.",Non-OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/86/bf/TODENTJ-10-58.PMC4797684.pdf
"Conclusions: These ﬁndings suggest that stimulation thresholds of 0.3 –0.5 mA may not reliably determine close needle-nerve contact during popliteal sciatic nerve block, particularly in patients with diabetic neuropathy.Clinical trial registration: NCT01488474 Key words: diabetic neuropathies; nerve block; peroneal nerve; tibial nerve †Study registered online Dec 02, 2011 at ClinicalTrials.gov: Identi ﬁer NCT01488474, Principal Investigator Marcel Rigaud ( https://clinicaltrials.gov/ct2/show/ NCT01488474?term=NCT01488474&rank=1 ).",Non-OADS,/arxiv_data1/oa_pdf/3c/f8/aew027.PMC4797685.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/li- censes/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly ci ted.",Non-OADS,/arxiv_data1/oa_pdf/3c/f8/aew027.PMC4797685.pdf
"[http://dx.doi.org/10.1016/j.jacc.2012.03.074 ] [2] Lloyd-Jones D, Adams RJ, Brown TM, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192666 ] [3] Carta MG, Pala AN, Finco G, Musu M, Moro MF.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.2174/1745017901511010144 ] [4] Brott TG, Halperin JL, Abbara S, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1161/STROKEAHA.114.005145 ] [6] Vallina-Victorero  M,  Vaquero  F,  Alvarez  A,  Ramos  MJ,  Vicente  M,  Alvarez  J.  Carotid  bifurcation  atherosclerosis  in  the  over-65s:  a prevalence study.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1161/STROKEAHA.110.581058 ] [8] Morr S, Lin N, Siddiqui AH.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1056/NEJMoa0912321 ] [11] Constantinou J, Jayia P, Hamilton G. Best evidence for medical therapy for carotid artery stenosis.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/j.jvs.2013.06.085 ] [12] Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
[http://dx.doi.org/10.1016/j.hrtlng.2008.05.002 ] [13] Roberts RE.,OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
[http://dx.doi.org/10.1016/0165-1781(80)90069-4 ],Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1001/archpsyc.61.4.369 ] [15] Haas DC, Davidson KW, Schwartz DJ, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2004.10.032 ] [16] Elovainio M, Keltikangas-Järvinen L, Kivimäki M, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1097/01.psy.0000170340.74035.23 ] [17] Whipple MO, Lewis TT, Sutton-Tyrrell K, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1161/STROKEAHA.109.554519 ] [18] Rice SC, Zonderman AB, Metter EJ, Najjar SS, Waldstein SR.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1097/PSY.0b013e3181865f73 ] [19] Hamer M, Malan NT, Harvey BH, Malan L. Depressive symptoms and sub-clinical atherosclerosis in Africans: role of metabolic syndrome, inflammation and sympathoadrenal function.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/j.physbeh.2011.07.024 ] [20] Lee YH, Shin MH, Choi JS, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.3346/jkms.2014.29.11.1507 ] [21] Whooley MA, De JP, Vittinghoff E, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1001/jama.2008.711 ] [22] Vieweg WV, Julius DA, Fernandez A, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/j.amjmed.2006.02.037 ] [23] Sneed JR, Culang-Reinlieb ME.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1097/JGP.0b013e318202fc8a ] [24] Alexopoulos GS, Kiosses DN, Choi SJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1176/appi.ajp.159.11.1929 ] [25] Carta MG, Aguglia E, Bocchetta A, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.2174/1745017901006010094 ] [26] First M, Spitzer R, Gibbon M, Williams J.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1186/1745-0179-1-8 ] [28] Saba L, Anzidei M, Sanfilippo R, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/j.atherosclerosis.2011.08.048 ] [29] Ware J Jr, Kosinski M, Keller SD.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1097/00005650-199603000-00003 ] [30] Carta MG, Preti A, Moro MF, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.3109/09540261.2014.927753 ] [31] Carta MG, Moro MF, Lorefice L, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/j.jad.2014.05.024 ] [32] Carta MG, Sorbello O, Moro MF, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1186/1471-244X-12-52 ] [33] Carta MG, Moro MF, Aguglia E, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
[http://dx.doi.org/10.2174/1745017901208010169 ],Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/0924-977X(95)00036-O ] [36] Hardoy MC, Carta MG, Marci AR, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1007/s00127 -005-0837-x ] [37] Fiedorowicz  JG,  Solomon  DA,  Endicott  J,  et  al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
[http://dx.doi.org/10.1097/PSY.,Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1159/000334779 ] [40] Chiarani F, Tramontina JF, Ceresér KM, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1590/1516-4446-2012-0797 ] [41] Subramaniam H, Dennis MS, Byrne EJ.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1002/gps.1730 ] [42] Schoepf D, Heun R. Bipolar disorder and comorbidity: increased prevalence and increased relevance of comorbidity for hospital-based mortality during a 12.5-year observation period in general hospital admissions.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1016/j.jad.2014.08.025 ] [43] Carta MG, Moro MF, Lorefice L, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"J Affect Disord 2014; 155: 255-60. c [http://dx.doi.org/10.1016/j.jad.2013.11.008 ] [44] Mantovani G, Astara G, Lampis B, et al.",OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1007/BF01845762 ] [45] Mantovani G, Astara G, Lampis B, et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1002/(SICI)1099- 1611(199606) 5:2<127::AID- PON220>3.0.CO; 2-L ] Received: May 7, 2015 Revised: May 20, 2015 Accepted: May 20, 2015 © Lecca et al.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"This is an open access articles licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  that  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/32/CPEMH-12-1.PMC4797686.pdf
"[http://dx.doi.org/10.1056/NEJMra1104650 ] [PMID: 22316447 ] [2] Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1097/BOR.0b013e3283412f4a ] [PMID: 21045701 ] [3] Hamano H, Kawa S, Horiuchi A, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1056/NEJM200103083441005 ] [PMID: 11236777 ] [4] Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases.",Non-OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1097/PAS.0b013e3181f7266b ] [PMID: 21107087 ] [5] Deshpande V, Zen Y, Chan JK, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1038/modpathol.2012.72 ] [PMID: 22596100 ] [6] Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis.",Non-OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1097/BOR.0b013e3283413469 ] [PMID: 21124093 ] [7] Zen Y, Inoue D, Kitao A, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1097/PAS.0b013e3181bd535b ] [PMID: 19898222 ] [8] Matsui S, Hebisawa A, Sakai F, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
[http://dx.doi.org/10.1111/resp.12016 ] [PMID: 23145930 ] [9] American  Thoracic  Society/European  Respiratory  Society.,Non-OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1164/ajrccm.165.2.ats01 ] [PMID: 11790668 ] [10] Shrestha B, Sekiguchi H, Colby TV, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1097/PAS.0b013e3181ac43b6 ] [PMID: 19623032 ] [11] Raghu G, Collard HR, Egan JJ, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1164/rccm.2009-040GL ] [PMID: 21471066 ] [12] Inoue D, Zen Y, Abo H, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
[http://dx.doi.org/10.1148/radiol.2511080965 ] [PMID: 19221056 ],Non-OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1097/PAS.0b013e318172622f ] [PMID: 18753944 ] [14] Wibmer T, Kropf-Sanchen C, Rüdiger S, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1186/2049-6958-8-22 ] [PMID: 23509921 ] [15] Hermet M, Andre M, Kemeny JL, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1111/j.1365-2249.1991.tb05647.x ] [PMID: 1848489 ] [17] Song JW, Do K-H, Kim M-Y, Jang SJ, Colby TV, Kim DS.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1378/chest.08-2572 ] [PMID: 19255290 ] [18] Takato H, Yasui M, Ichikawa Y, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.2169/internalmedicine.47.0411 ] [PMID: 18277032 ] [19] Jinnur PK, Yi ES, Ryu JH, Iyer VN.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.12659/AJCR.894015 ] [PMID: 26196118 ] [20] Yamamoto M, Takahashi H, Ohara M, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.3109/s10165-006-0518-Y ] [PMID: 17164992 ] [21] Tanaka K, Nagata K, Tomii K, Imai Y.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1378/chest.11-1858 ] [PMID: 22796844 ] [22] Hirano K, Kawabe T, Komatsu Y, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1111/j.1445-5994.2006.01009.x ] [PMID: 16409315 ] [23] Taniguchi T, Ko M, Seko S, et al.",OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.4046/trd.2014.77.2.85 ] [PMID: 25237380 ] Received: October 28, 2015 Revised: December 11, 2015 Accepted: December 15, 2015 © Schneider et al.",Non-OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/03/TORJ-10-33.PMC4797687.pdf
"[http://dx.doi.org/10.1016/j.ahj.2009.12.027 ] [PMID: 20362708 ] [2] Prabhudesai A, Khan MZ.",OADS,/arxiv_data1/oa_pdf/9f/bd/TOCMJ-10-44.PMC4797688.pdf
[http://dx.doi.org/10.1016/j.jvs.2011.12.015 ] [PMID: 22265797 ],OADS,/arxiv_data1/oa_pdf/9f/bd/TOCMJ-10-44.PMC4797688.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/bd/TOCMJ-10-44.PMC4797688.pdf
Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201509702 .,Non-OADS,/arxiv_data1/oa_pdf/a6/e6/ANIE-55-3328.PMC4797704.pdf
"[*]Prof. Dr.P.Melchiorre ICREA—C atalan Institution forResearch andAdvanced Studies Passeig Llu(o[’xs Companys 23,08010, Barcelona (Spain) Dr.L.Dell’Amico, Dr.A.Vega-Pe Çaloza, S.Cuadros, Prof. Dr.P.Melchiorre ICIQ—Ins titute ofChemical Research ofCatalonia Barcelona Institute ofScience andTechnology Avenida Pa(o[’vsos Catalans 16,43007, Tarragona (Spain) E-mail :pmelchiorre @iciq.es Homepag e:http://www .iciq.org/resea rch/rese arch_group/p rof- paolo-mel chiorre/ Supportin ginformation andORCID(s )from theauthor(s) forthis article areavailable ontheWWW under http://dx.doi.org/ 10.1002/ anie.201509 472.",Non-OADS,/arxiv_data1/oa_pdf/8e/2e/ANIE-55-3313.PMC4797706.pdf
"Dr.M.Wagner Institut f(o252rAnorg anische und Analyt ische Chem ie Goeth e-Univ ersit(o22wt Frankfu rt Max-vo n-Laue-St rasse7,60438 Frankfurt amMain (Germany) Fax:(+49)69-798- 29260 E-mail :Matthi as.Wagner@ch emie.un i-frankfur t.de Supportin ginformat ionforthisarticle isavailab leontheWWW under http://dx.doi.or g/10.10 02/chem.20 1504791.",Non-OADS,/arxiv_data1/oa_pdf/31/75/CHEM-22-3478.PMC4797709.pdf
"[*]Dr.E.A.Crane, Prof. Dr.K.Gademann Department ofChemist ry Universit yofBasel(Switzerland ) Prof. Dr.K.Gademann Department ofChemist ry,University ofZ(o[z[rich Winterthurerst rasse 190, CH-8057 Z(o[z[rich (Switzerl and) E-mail :karl.gadema nn@uzh.ch Homepag e:http://www .chem.uzh .ch/researc h/gademann .html ORCID(s )from theauthor(s) forthisarticle is/are available onthe WWW under http://dx.doi.org/ 10.1002/ani e.201505863 .",Non-OADS,/arxiv_data1/oa_pdf/f7/3c/ANIE-55-3882.PMC4797711.pdf
"[25]Thereaction didnotbenefit from additives ,[*]Dr.S.N.Kessler ,Prof.Dr.J.-E.B(o[[wckvall Department ofOrganic Chemistry ,Arrhenius Laboratory Stockholm University ,Stockholm SE-10691 (Sweden) E-mail :jeb@organ.s u.se Supportin ginformation forthisarticle isavailable ontheWWW under http://dx.doi.org/ 10.1002/ani e.201511139 .",Non-OADS,/arxiv_data1/oa_pdf/96/25/ANIE-55-3734.PMC4797716.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_li- brary/Press_release/2009/11/wC500015110.pdf 46.,Non-OADS,/arxiv_data1/oa_pdf/ba/2c/yjbm_89_1_37.PMC4797835.pdf
"Available from: http://www.nap.edu/catalog.php?record_id=18341 28. vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, et al.",OADS,/arxiv_data1/oa_pdf/50/06/yjbm_89_1_5.PMC4797837.pdf
Available from: http://www.fasebj.org/content/early/2003/05/02/fj.02- 0881fje.,Non-OADS,/arxiv_data1/oa_pdf/50/06/yjbm_89_1_5.PMC4797837.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01760005?term=sola nezumab&rank=417 Arbor et al.,OADS,/arxiv_data1/oa_pdf/50/06/yjbm_89_1_5.PMC4797837.pdf
Available at http://pymol.org.,Non-OADS,/arxiv_data1/oa_pdf/50/06/yjbm_89_1_5.PMC4797837.pdf
Available from: http://www.asam.org/for-the-public/definition-of-addiction  3.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.rcpsych.ac.uk/pdf/Substance%20misuse%20in%20  Older%20People_an%20information%20guide.pdf 7.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.ash.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: https://www.england.nhs.uk/london/wp- content/uploads/sites/8/2015/03/lndn-prim-care-doc.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.euro.who.int/__data/assets/pdf_file/0018/150552/ RC61_R4.pdf 18. International Centre for Drug Policy.,OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.sgul.ac.uk/im - ages/docs/idcp%20pdfs/Substance%20misuse%20in%20t he%20undergrad%20medical%20curiculum/Sub - stance_Misuse_Guidance_Undergraduate_Medical_Cur- riculum_2007.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.addiction-ssa.org/index.php/factsheets  21.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from  http://www.rcpsych.ac.uk/files/pdfversion/cr165.pdf.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.medicine.yale.edu/psychi- atry/education/clinfell/addiction/index.aspx.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.casacolumbia.org/templates/NewsRoom.aspx?ar- ticleid=678&zoneid=51.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
Available from: http://www.addiction- ssa.org/commentary/treatment-effectiveness-in-older-peo - ple-with-substance-problems.,Non-OADS,/arxiv_data1/oa_pdf/35/1c/yjbm_89_1_97.PMC4797843.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/73/cvw031.PMC4798047.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d3/30/jpr-9-137.PMC4798195.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Pain Research 2016:9 137–146submit your manuscript | www.dovepress.co m Dove press  137 http: //dx.doi.org/10.2147/JPR.S8365 3Psychosocial management of chronic pain in  patients with rheumatoid arthritis: challenges  and solutions Louise Sharpe School of Psychology, The University  of Sydney, Sydney, NSw , Australia Correspondence: Louise Sharpe   School of Psychology, Brennan  MacCallum Building A17, The University  of Sydney, Sydney, NSw 2006, Australia   T el +61 2 9351 4558   email louise.sharpe@sydney.edu.a uAbstract:  There are numerous reviews and meta-analyses that confirm that psychological  therapy is efficacious for patients with rheumatoid arthritis (RA) in terms of managing pain.",Non-OADS,/arxiv_data1/oa_pdf/d3/30/jpr-9-137.PMC4798195.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/d3/30/jpr-9-137.PMC4798195.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/30/jpr-9-137.PMC4798195.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/a7/cia-11-307.PMC4798196.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical interventions in aging 2016:11 307–311submit your manuscript | www.dovepress.co m Dove press  307 http: //dx.doi.org/10.2147/CIA.S10257 7effectiveness and safety of oxycodone/naloxone in  the management of chronic pain in patients with  systemic sclerosis with recurrent digital ulcers:  two case reports Nicola Ughi Chiara Crotti Francesca ingegnoli Division of rheumatology,   Department of Clinical sciences and  Community Health, Gaetano Pini  institute, The University of Milan,   Milan, italyAbstract:  Digital ulcers (DUs) are a severe and frequent clinical feature of patients with systemic  sclerosis (SSc).",Non-OADS,/arxiv_data1/oa_pdf/c3/a7/cia-11-307.PMC4798196.pdf
"In addition to vasodilator therapy, wound care  is pivotal, and sometimes surgical debridement is required (eg, underlying calcinosis),  but such procedures may be exquisitely painful.10 As pain management has a key role  in wound healing and standard therapy (ie, nonsteroidal anti-inflammatory drugs) is  often inadequate or dose limited by side effects, opioids are likely to be used.Correspondence: Francesca ingegnoli Division of rheumatology, Department  of Clinical sciences and Community  Health, Gaetano Pini institute, The  University of Milan, Piazza Cardinal  Ferrari 1, Milan 20122, italy Tel +39 02 5829 6456 Fax +39 02 5829 6604 email francesca.ingegnoli@unimi.i t Journal name: Clinical Interventions in Aging Article Designation: Case Series Y ear: 2016 Volume: 11 Running head verso: Ughi et al Running head recto: Oxycodone/naloxone in systemic sclerosis with digital ulcers DOI: http://dx.doi.org/10.2147/CIA.S102577",Non-OADS,/arxiv_data1/oa_pdf/c3/a7/cia-11-307.PMC4798196.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c3/a7/cia-11-307.PMC4798196.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c3/a7/cia-11-307.PMC4798196.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/50/opth-10-437.PMC4798197.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 437–443submit your manuscript | www.dovepress.co m Dove press  437 http: //dx.doi.org/10.2147/OPTH.S8367 7Dove press Reviewopen access to scientific and medical research Open Access Full T ext Article Boston type 1 keratoprosthesis from patient  selection through postoperative management:  a review for the keratoprosthetic surgeon Samantha L williamson1 M Soledad Cortina2 1Department of Ophthalmology,   Kaiser Permanente Mid-Atlantic  Medical Group, Baltimore, MD, USA;   2Department of Ophthalmology and  visual Sciences, University of illinois  eye and ear infirmary, Chicago,   iL, USAAbstract:  For the anterior segment surgeon, the implantation of Boston type 1 keratoprosthesis is  a multistep process that begins with careful patient selection.",Non-OADS,/arxiv_data1/oa_pdf/5f/50/opth-10-437.PMC4798197.pdf
"Studies suggest patients with Stevens–Johnson syndrome and ocular  cicatricial pemphigoid fare worse than those with non-cicatrizing etiologies, such as  repeated graft failure for infections or dystrophies, with chemical burns and aniridia fall - ing somewhere in the middle of the spectrum.1,2 The Boston type 1 keratoprosthesis Study  Group identified three risk factors for Kpro device loss, including autoimmune etiology  (eg, ocular cicatricial pemphigoid, Stevens–Johnson syndrome), ocular surface exposure Correspondence: M Soledad Cortina Department of Ophthalmology and visual  Sciences, University of illinois eye &  Ear Infirmary, 1855 W Taylor Street,  Suite 1059, Chicago, IL 60612, USA Tel +1 312 996 8937 Fax +1 312 355 5254 email mcortina@uic.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Williamson and Cortina Running head recto: Review of current trends in Boston type 1 keratoprosthesis DOI: http://dx.doi.org/10.2147/OPTH.S83677",Non-OADS,/arxiv_data1/oa_pdf/5f/50/opth-10-437.PMC4798197.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5f/50/opth-10-437.PMC4798197.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/50/opth-10-437.PMC4798197.pdf
Available from: http://www.masseyeandear.org/ ~/media/testupload/ files/2010-kpro-newsletter.pdf?la =en.,Non-OADS,/arxiv_data1/oa_pdf/5f/50/opth-10-437.PMC4798197.pdf
Available from: http://www.masseye - andear.org/ ~/media/testupload/files/2011-kpro-newsletter.pdf?la =en.,Non-OADS,/arxiv_data1/oa_pdf/5f/50/opth-10-437.PMC4798197.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/4d/ijn-11-1025.PMC4798198.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1025International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/62/4d/ijn-11-1025.PMC4798198.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 1025CorrIgeNdumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S10401 5Photothermal treatment of liver cancer with albumin-conjugated gold  nanoparticles initiates Golgi Apparatus–ER dysfunction and caspase-3  apoptotic pathway activation by selective targeting of Gp60 receptor  [Corrigendum] Mocan L, Matea C, Tabaran FA, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/4d/ijn-11-1025.PMC4798198.pdf
"Author contributions All authors made substantial contributions to conception and  design, acquisition of data, or analysis and interpretation Journal name: International Journal of Nanomedicine Article Designation: Corrigendum Y ear: 2016 Volume: 11 Running head verso: Mocan et al Running head recto: Photothermal treatment of liver cancer with albumin-conjugated gold nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S104015 of data; took part in either drafting the article or revising  it critically for important intellectual content; gave final  approval of the version to be published; and agree to  be accountable for all aspects of the work.",Non-OADS,/arxiv_data1/oa_pdf/62/4d/ijn-11-1025.PMC4798198.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/3d/ott-9-1461.PMC4798199.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2016:9 1461–1469OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1461Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9414 4effects of CYP3A5  genetic polymorphism and  smoking on the prognosis of non-small-cell  lung cancer li-Peng Jiang1 Zhi-T u Zhu2 chun-Yan he3 1Department of radiation Oncology,   2Department of Oncology, First  affiliated hospital of liaoning  Medical University, 3Department  of Prosthodontics, second affiliated  hospital of liaoning Medical  University, Jinzhou, People’s republic  of chinaObjective:  We aimed to explore the impacts of the rs776746 polymorphism in the CYP3A5   gene and smoking on the prognosis of non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/48/3d/ott-9-1461.PMC4798199.pdf
"Keywords:  cytochrome P450 3A5, non-small-cell lung cancer, smoking, polymorphism,  prognosis, chemotherapy, surgery Introduction With its high incidence and mortality, lung cancer has been one of the most frequent  malignant cancers worldwide for several decades.1 In 2008, more than 1.6  million  individuals were diagnosed with lung cancer, which comprised 13% of all newly  diagnosed cancer.2 Of the subtypes of lung cancer, non-small-cell lung cancer  (NSCLC) which consists of two main histological types – squamous cell carcinoma  and adenocarcinoma – accounts for approximately 85% of new cases.3,4 The geographic  epidemic of lung cancer has been caused by cigarette smoking to some extent, and  approximate 80%–90% of lung cancers, predominantly NSCLC, are likely attributed  to cigarette smoking.5 Lung cancer incidence is increasing in the People’s Republic  of China and several Asian and African countries in which the prevalence of tobacco correspondence: Zhi-Tu Zhu Department of Oncology, First Affiliated  hospital of liaoning Medical University,   2 renmin street, Jinzhou, liaoning  121000, People’s republic of china Tel +86 180 4160 2727 email zhuzhitu0806@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Jiang et al Running head recto: CYP3A5  SNP, smoking, and NSCLC DOI: http://dx.doi.org/10.2147/OTT.S94144",Non-OADS,/arxiv_data1/oa_pdf/48/3d/ott-9-1461.PMC4798199.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/48/3d/ott-9-1461.PMC4798199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/3d/ott-9-1461.PMC4798199.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/67/dmso-9-055.PMC4798200.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/06/67/dmso-9-055.PMC4798200.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 55–62Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  55Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S9629 9effects of long-term exercise training on adipose  tissue expression of fractalkine and McP-1 in  patients with type 2 diabetes and stable coronary  artery disease: a substudy of a randomized  controlled trial ida Unhammer njerve1–3 rune Byrkjeland1–3 harald arnesen1–3 Sissel Åkra1,2 Svein Solheim1,2 ingebjørg Seljeflot1–3 1Department of cardiology, center  for clinical heart research, Oslo  University hospital, Ullevål, 2center  for heart Failure research, Oslo  University hospital, 3Faculty of  Medicine, University of Oslo, Oslo,   norway correspondence: ida Unhammer njerve   Department of cardiology, center for  clinical heart research, Oslo University  hospital, Ullevål, PB 4956 nydalen, 0424  Oslo, norway   T el +47 2 211 9261   Fax +47 2 211 9181   email i.u.njerve@medisin.uio.n oPurpose:  Adipose tissue inflammation plays a role in atherosclerosis and type 2 diabetes  (T2DM).",Non-OADS,/arxiv_data1/oa_pdf/06/67/dmso-9-055.PMC4798200.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy  is an international, peer-reviewed open-access journal committed  to the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/06/67/dmso-9-055.PMC4798200.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/67/dmso-9-055.PMC4798200.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/83/1f/dddt-10-1111.PMC4798201.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1111–1118Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1111Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5530 8Laquinimod in the treatment of multiple sclerosis:  a review of the data so far Jan Thöne1 Ralf A Linker2 1Department of Neurology, University  Hospital essen, essen, 2Department  of Neurology, University Hospital  of erlangen, Friedrich-Alexander  University erlangen-Nürnberg (FAU),   erlangen, GermanyAbstract:  Laquinimod (ABR-215062) is a new orally available carboxamide derivative,  which is currently developed for relapsing remitting (RR) and chronic progressive (CP) forms  of multiple sclerosis (MS; RRMS or CPMS) as well as neurodegenerative diseases.",Non-OADS,/arxiv_data1/oa_pdf/83/1f/dddt-10-1111.PMC4798201.pdf
"However, even if the majority of available therapies may reduce inflammation and  relapse frequency, some patients continue to develop progressive neurodegeneration,  which in turn drives disability.4 Thus, neurodegeneration should be considered as a Correspondence: Jan Thöne Department of Neurology, University  Hospital essen, Hufelandstrasse 55,  D-45147 essen, Germany email jan_thoene@gmx.d e Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Thöne and Linker Running head recto: Laquinimod in the treatment of multiple sclerosis DOI: http://dx.doi.org/10.2147/DDDT.S55308",Non-OADS,/arxiv_data1/oa_pdf/83/1f/dddt-10-1111.PMC4798201.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/83/1f/dddt-10-1111.PMC4798201.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/1f/dddt-10-1111.PMC4798201.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ijn-11-1003.PMC4798202.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1003–1011International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1003OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10255 2In vivo osseointegration of Ti implants with  a strontium-containing nanotubular coating Y onggang Dang1 li Zhang1 Wen song1 Bei chang1 Tianxiao han1 Yumei Zhang1 lingzhou Zhao2 1Department of Prosthetic Dentistry,   2Department of Periodontology,   school of stomatology, state Key  laboratory of Military stomatology,   The Fourth Military Medical  University, Xi’an, People’s republic  of chinaAbstract:  Novel biomedical titanium (Ti) implants with high osteogenic ability for fast and  good osseointegration under normal as well as osteoporotic conditions are urgently needed.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ijn-11-1003.PMC4798202.pdf
"Nanotopographical modifications specifically designed to emulate the proper - ties of natural extracellular matrix and for bioactive element delivery represent an  effective method for improving the bioactivity of biomaterials.4 For example, titania correspondence: lingzhou Zhao Department of Periodontology, school  of stomatology, state Key laboratory  of Military stomatology, The Fourth  Military Medical University, No 145 West  changle road, Xi’an 710032, People’s  republic of china email zhaolingzhou1983@hotmail.co m  Yumei Zhang Department of Prosthetic Dentistry,  school of stomatology, state Key  laboratory of Military stomatology,  The Fourth Military Medical University,  No 145 West changle road, Xi’an  710032, People’s republic of china email wqtzym@fmmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Dang et al Running head recto: In vivo osseointegration of Ti implants with NT-Sr coating DOI: http://dx.doi.org/10.2147/IJN.S102552",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ijn-11-1003.PMC4798202.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ijn-11-1003.PMC4798202.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/c1/ijn-11-1003.PMC4798202.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cd/97/copd-11-527.PMC4798204.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 527–533International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  527OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9954 7Microparticles in sputum of COPD patients:  a potential biomarker of the disease?",Non-OADS,/arxiv_data1/oa_pdf/cd/97/copd-11-527.PMC4798204.pdf
"altomare” Via  napoli 20, 71100 Foggia, Italy Tel +39 0881 588 023 Fax +39 0881 588 037 email chiara.porro@unifg.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lacedonia et al Running head recto: Microparticles in COPD DOI: http://dx.doi.org/10.2147/COPD.S99547",Non-OADS,/arxiv_data1/oa_pdf/cd/97/copd-11-527.PMC4798204.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/cd/97/copd-11-527.PMC4798204.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/97/copd-11-527.PMC4798204.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/0b/ppa-10-321.PMC4798205.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 321–327Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  321OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10184 4Psychometric properties of the chinese version  of the Self-Efficacy for Appropriate Medication  Use scale in patients with stroke Xiao-fang Dong1 Yan-jin liu2 Ai-xia Wang1 Pei-hua lv1 1neurology Department, 2nursing  Department, The First Affiliated  hospital of Zhengzhou University,   Zhengzhou, People’s republic  of chinaBackground:  It has been reported that stroke has a higher incidence and mortality rate in the  People’s Republic of China compared to the global average.",Non-OADS,/arxiv_data1/oa_pdf/46/0b/ppa-10-321.PMC4798205.pdf
"Approximately 610,000 of these are first  attacks, and 185,000 are recurrent.5 This risk can be appreciably reduced by preven - tive treatment aimed at lowering blood pressure and reducing blood cholesterol along  with antiplatelet and/or anticoagulation treatment.6 All of these can be achieved by correspondence: Yan-jin liu Nursing Department, The First Affiliated  hospital of Zhengzhou University,  1 Jianshe road, Zhengzhou, henan  Province, 450052, People’s republic  of china Tel +86 135 2354 8732 Fax +86 371 6691 3035 email luomeiruxue139@sina.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Dong et al Running head recto: Chinese version of SEAMS DOI: http://dx.doi.org/10.2147/PPA.S101844",Non-OADS,/arxiv_data1/oa_pdf/46/0b/ppa-10-321.PMC4798205.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/46/0b/ppa-10-321.PMC4798205.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/a3/jaa-9-045.PMC4798207.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Journal of Asthma and Allergy 2016:9 45–53Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  45Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S8625 1Nasal polyps in patients with asthma: prevalence,  impact, and management challenges Cristobal Langdon1,2 Joaquim Mullol1–3 1Rhinology Unit and Smell Clinic,   Otorhinolaryngology Department,   Hospital Clínic, 2Clinical and  experimental Respiratory  immunoallergy ( iRCe), institut  d’investigacions Biomèdiques August  Pi i Sunyer (iDiBAPS), 3Centre for  Biomedical Research in Respiratory  Diseases (CiBeReS), Barcelona,   Catalonia, Spain Correspondence: Joaquim Mullol   Rhinology Unit and Smell Clinic,  Department of Otorhinolaryngology,  Hospital Clínic i Universitari, c/ villarroel  170, Barcelona 08036, Catalonia, Spain   T el + 34 93 227 9872   Fax + 34 93 227 9813   email jmullol@clinic.ub.e sAbstract:  Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) often have coex - isting asthma under the concept of “United Airway Disease”, being the combination of both  diseases, which is one of the most challenging phenotypes to treat.",Non-OADS,/arxiv_data1/oa_pdf/5a/a3/jaa-9-045.PMC4798207.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/5a/a3/jaa-9-045.PMC4798207.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/a3/jaa-9-045.PMC4798207.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ott-9-1477.PMC4798208.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1477–1487submit your manuscript | www.dovepress.co m Dove press  1477 http: //dx.doi.org/10.2147/OTT .S9549 0Dove press Original researchopen access to scientific and medical research Open access Full T ext article Prognostic role of hypoxia-inducible factor-1 alpha  expression in osteosarcoma: a meta-analysis hai-Y ong ren1 Yin-hua Zhang1,2 heng-Yuan li1 Tao Xie1 ling-ling sun1 Ting Zhu1 sheng-Dong Wang1 Zhao-Ming Ye1 1Department of Orthopaedics,   second affiliated hospital, college  of Medicine, Zhejiang University,   hangzhou, 2The First Department  of Orthopaedics, hospital of  Zhejiang general corps of armed  Police Forces, Jiaxing, People’s  republic of chinaBackground:  Hypoxia-inducible factor-1 α (HIF-1 α) plays an important role in tumor  progression and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ott-9-1477.PMC4798208.pdf
"Keywords:  HIF-1 α, osteosarcoma, prognosis, meta-analysis Introduction Osteosarcoma is the most common primary bone tumor in children and young  adults.1 The incidence of osteosarcoma in the general population is two to three cases  per million per year, but in adolescence, the annual incidence is higher and peaks at  eight to eleven cases per million per year at 15–19 years of age.2 It is characterized  by the proliferation of malignant mesenchymal cells that form osteoid bone.3,4 The  tumor occurs predominantly in the metaphysis (the sites of bone growth), presum - ably because proliferation makes the osteoblastic cells in this region acquire muta - tions that could lead to cell transformation.5,6 In all, 10%–15% of patients with newly  diagnosed osteosarcoma have detectable metastases at diagnosis, of which .90%  occur in the lungs.7,8 Treatment of the disease was mainly limb amputation, and the  survival rate was 10%–20% before 1970s when chemotherapy was not included as  part of therapeutic protocols.5,9 With the introduction of multidrug chemotherapy  and advanced surgery, the 5-year survival rate has significantly improved to  60%–80%.10–13 However, the treatment of osteosarcoma is still unsatisfactory for the  risk of local relapse and the development of metastasis.12,14 For these patients, they  have ,20% chance of long-term survival, despite aggressive therapies that have correspondence: Zhao-Ming Ye Department of Orthopaedics,  Second Affiliated Hospital, College of  Medicine, Zhejiang University, no 88,  Jiefang road, hangzhou 310009, People’s  republic of china Tel +86 571 8778 3567 Fax +86 571 8778 3688 email yezhaomingzeyy@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Ren et al Running head recto: HIF-1 α indicates osteosarcoma prognosis DOI: http://dx.doi.org/10.2147/OTT.S95490",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ott-9-1477.PMC4798208.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/62/7b/ott-9-1477.PMC4798208.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/7b/ott-9-1477.PMC4798208.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/75/15/ijn-11-1027.PMC4798209.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1027–1037International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1027OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9624 3colloidal nanocarriers for the enhanced  cutaneous delivery of naftifine: characterization  studies and in vitro and in vivo evaluations M sedef erdal1 Gül Özhan2 M cem Mat3 Yıldız Özsoy1 sevgi güngör1 1Department of Pharmaceutical  T echnology, 2Department of  Pharmaceutical Toxicology, Faculty  of Pharmacy, 3Department of  Dermatology, Cerrahpaşa Medical  Faculty, Istanbul University, Istanbul,   T urkeyAbstract:  In topical administration of antifungals, the drugs should pass the stratum corneum  to reach lower layers of the skin in effective concentrations.",Non-OADS,/arxiv_data1/oa_pdf/75/15/ijn-11-1027.PMC4798209.pdf
"Naftifine  causes interruption of fungal ergosterol synthesis by inhibition of the enzyme squalene  epoxidase and leads to accumulation of intracellular squalene in fungal organisms.1  Currently, its conventional topical preparations are commercially available in market.correspondence: M sedef erdal Department of Pharmaceutical  Technology, Faculty of Pharmacy, Istanbul  University, 34116 Beyazıt, Istanbul,  Turkey Tel +90 212 440 0000 ext 13492 email serdal@istanbul.edu.t r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Erdal et al Running head recto: Colloidal nanocarriers of naftifine DOI: http://dx.doi.org/10.2147/IJN.S96243",Non-OADS,/arxiv_data1/oa_pdf/75/15/ijn-11-1027.PMC4798209.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/75/15/ijn-11-1027.PMC4798209.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/15/ijn-11-1027.PMC4798209.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/4b/ott-9-1489.PMC4798210.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1489–1498OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1489Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9993 1mir-32 inhibits proliferation, epithelial–mesenchymal  transition, and metastasis by targeting TWisT1 in  non-small-cell lung cancer cells lei li1,* Dapeng Wu2,* 1Department of Pneumology,   2Department of radiotherapy, huaihe  hospital of henan University, Kaifeng,   henan, People’s republic of china *These authors contributed equally  to this workBackground:  By analyzing published microRNA microarray studies, miR-32 was found to  be markedly reduced in non-small-cell lung cancer (NSCLC) tissues compared with that in  nontumor tissues.",Non-OADS,/arxiv_data1/oa_pdf/5b/4b/ott-9-1489.PMC4798210.pdf
"Many  recent studies have demonstrated that epithelial–mesenchymal transition (EMT) is one  of the major molecular mechanisms inducing cancer metastasis.4,5 TWIST1 is an EMT  regulator, which induces EMT through the suppression of E-cadherin expression.6 In the   EMT process, the epithelial cells with a cobblestone morphology gain the traits of  the mesenchymal cells with a spindle-shaped fibroblast-like phenotype.7 With the  changes in cellular morphology, the expression of proteins also has some changes, correspondence: lei li Department of Pneumology, huaihe  hospital of henan University, no 115,  Ximendajie street, Kaifeng 475000,  henan, People’s republic of china Tel +86 371 2390 6503 email lileihhdoc@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Li and Wu Running head recto: miR-32 inhibits proliferation, EMT, and metastasis in lung cancer DOI: http://dx.doi.org/10.2147/OTT.S99931",Non-OADS,/arxiv_data1/oa_pdf/5b/4b/ott-9-1489.PMC4798210.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/4b/ott-9-1489.PMC4798210.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/4b/ott-9-1489.PMC4798210.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ijn-11-1013.PMC4798211.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 1013–1023International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1013OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8202 3Spermine-modified Antheraea pernyi  silk fibroin as  a gene delivery carrier Yanni Yu1 Y ongpei hu1 Xiufang li1 Yu liu1 Mingzhong li1 Jicheng Yang2 Weihua sheng2 1National Engineering Laboratory  for Modern silk, college of Textile  and clothing engineering, soochow  University, 2cell and Molecular  Biology Institute, college of Medicine,   soochow University, suzhou,   People’s  Republic of ChinaAbstract:  The development of a novel cationized polymer used as a gene delivery carrier that  can conveniently and effectively transfect cells resulting in a stably expressed target gene remains  a challenge.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ijn-11-1013.PMC4798211.pdf
"Viral delivery systems have high  gene delivery efficiency,3 but they also have disadvantages, such as immunogenicity,  the possibility of permanent insertion into the host genome, and difficulties in han - dling.4 In contrast, nonviral delivery systems have received substantial attention  because they can be structurally varied, are relatively safe, and can carry large and  diverse amounts of genetic materials into cells.5 The effectiveness and biocompatibility  of nonviral plasmid DNA (pDNA) delivery systems based on cationized liposomes  or chemically synthesized polymers have developed over the past decade.6 Several  polymeric gene delivery systems have been investigated, such as polyethyleneimine  (PEI),7 poly-( l-lysine),8 chitosan,9 and dendrimers.10 Among these polymers, PEI is  a typical nonviral gene delivery carrier and is often considered the gold standard of  gene transfection.11 Branched PEI (25 kDa) has produced good results in gene therapy  experiments.12,13 It has a relatively high transfection efficiency based on the proton  sponge effect, which can protect DNA from endosomal or lysosomal degradation.14,15  Nevertheless, PEI with a high molecular weight is cytotoxic and is not easily correspondence: Mingzhong li National Engineering Laboratory  for Modern silk, college of  Textile and clothing engineering,  soochow University, No 199 ren’ai  road, Industrial Park, suzhou 215123,  People’s Republic of China Tel +86 512 6706 1150 Fax +86 512 6724 6786 email mzli@suda.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Yu et al Running head recto: Cationized Antheraea pernyi  silk fibroin as a gene delivery carrier DOI: http://dx.doi.org/10.2147/IJN.S82023",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ijn-11-1013.PMC4798211.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/41/8f/ijn-11-1013.PMC4798211.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/8f/ijn-11-1013.PMC4798211.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1b/68/copd-11-535.PMC4798212.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 535–542International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  535RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S9654 1The optimum timing to wean invasive ventilation  for patients with AeCOPD or COPD with  pulmonary infection Yuanlin Song,1 Rongchang  Chen,2 Qingyuan Zhan,3  Shujing Chen,1 Zujin Luo,4  Jiaxian Ou,1 Chen wang3 1Department of Pulmonary Medicine,   Zhongshan Hospital, Fudan University,   Shanghai, 2Guangzhou Institute of  Respiratory Disease, Guangzhou,   3Department of Respiratory and  Critical Care Medicine, Beijing  China-Japan Friendship Hospital,   4Department of Pulmonary Medicine,   Chaoyang Hospital, Beijing, People’s  Republic of ChinaAbstract:  COPD is characterized by a progressive decline in lung function and mental and  physical comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/1b/68/copd-11-535.PMC4798212.pdf
"In the People’s Republic of China alone, COPD-related mortality  was 27.3 in males and 21.3 in females per 100,000 heads according to a national, Correspondence: Chen wang Department of Respiratory and  Critical Care Medicine, Beijing  China-Japan Friendship Hospital,  2 east Yinghua Road, Beijing, 100029,  People’s Republic of China email cyh-birm@263.ne t Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Song et al Running head recto: AECOPD or COPD patients with pulmonary infection DOI: http://dx.doi.org/10.2147/COPD.S96541 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/1b/68/copd-11-535.PMC4798212.pdf
Or use: http://youtu.be/KNFo236SFq Avideo abstract,Non-OADS,/arxiv_data1/oa_pdf/1b/68/copd-11-535.PMC4798212.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1b/68/copd-11-535.PMC4798212.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/68/copd-11-535.PMC4798212.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/ec/ndt-12-625.PMC4798215.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 625–639Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  625CliNiC al Trial repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10172 1Cognitive behavioral therapy in pharmacoresistant  obsessive–compulsive disorder Jana Vyskocilova1 Jan prasko2 Jiri Sipek3 1Faculty of Humanities, Charles  University in prague, prague,  2Department of p sychiatry, Faculty  of Medicine and Dentistry, palacky  University olomouc, University  Hospital olomouc, olomouc,  3Department of p sychology, Faculty  of arts, Charles University in prague,   prague, Czech republicBackground:  The aim of the study was to determine whether patients with obsessive–compulsive  disorder (OCD) resistant to drug therapy may improve their condition using intensive, systematic  cognitive behavioral therapy (CBT) lasting for 6 weeks, and whether it is possible to predict the thera - peutic effect using demographic, clinical, and selected psychological characteristics at baseline.",Non-OADS,/arxiv_data1/oa_pdf/7d/ec/ndt-12-625.PMC4798215.pdf
"Many authors even recommend supramaximal doses of SSRIs  in treatment-resistant patients (often twice the recommended maximum dose).1Correspondence: Jan prasko Department of psychiatry, Faculty  of Medicine and Dentistry, palacky  University olomouc, University Hospital  olomouc, ip pavlova 6, olomouc 775 20,  Czech republic email praskojan@seznam.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Clinical Trial Report Y ear: 2016 Volume: 12 Running head verso: Vyskocilova et al Running head recto: CBT in OCD DOI: http://dx.doi.org/10.2147/NDT.S101721",Non-OADS,/arxiv_data1/oa_pdf/7d/ec/ndt-12-625.PMC4798215.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7d/ec/ndt-12-625.PMC4798215.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/ec/ndt-12-625.PMC4798215.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/de/35/ott-9-1449.PMC4798217.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1449–1459OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1449Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10187 4Predictive value of mutant p53 expression  index obtained from nonenhanced computed  tomography measurements for assessing  invasiveness of ground-glass opacity nodules correspondence: Wei Wang Department of radiation Oncology,  Tianjin Medical University cancer  institute and hospital, national clinical  research center of cancer, Key  laboratory of cancer Prevention and  Therapy, huan-hu-Xi road, Ti-Yuan-Bei,  he Xi District, Tianjin 300060, People’s  republic of china Tel/fax +86 22 2337 2192 email docwangwei@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: p53-EI prediction allows assessing pathology of GGO DOI: http://dx.doi.org/10.2147/OTT.S101874 Wei Wang1 Jian li2 ransheng liu1 aixu Zhang1 Zhiyong Yuan1 1Department of radiation Oncology,   Tianjin Medical University cancer  institute and hospital, national  clinical research center of cancer,   Key laboratory of cancer Prevention  and Therapy, Tianjin, People’s republic  of china; 2Department of radiology,   Tianjin hospital, Tianjin, People’s  republic of chinaPurpose:  To predict p53 expression index (p53-EI) based on measurements from computed  tomography (CT) for preoperatively assessing pathologies of nodular ground-glass opacities  (nGGOs).",Non-OADS,/arxiv_data1/oa_pdf/de/35/ott-9-1449.PMC4798217.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/de/35/ott-9-1449.PMC4798217.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/35/ott-9-1449.PMC4798217.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/73/03/ott-9-1471.PMC4798219.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1471–1476OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1471Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9616 0Efficacy of pemetrexed plus platinum doublet  chemotherapy as first-line treatment for advanced  nonsquamous non-small-cell-lung cancer:   a systematic review and meta-analysis Huai-Qing Xiao1 Rong-Hua Tian2 Zhi-Hao Zhang1 Kai-Qi Du1 Yi-Ming Ni3 1Department of Cardiothoracic  surgery, Zhejiang corps hospital,   chinese People’s armed Police Force,   Jiaxing, Zhejiang Province, People’s  Republic of China; 2Department of  respiratory, affiliated haian People’s  hospital of nantong University, haian,   Jiangsu, People’s Republic of China;   3Department of Cardiothoracic  surgery, The First affiliated hospital  of Zhejiang University, hangzhou,   Zhejiang Province, People’s  Republic of ChinaPurpose:  To assess the efficacy of pemetrexed plus platinum doublet chemotherapy as first-line  treatment for advanced nonsquamous non-small-cell lung cancer (NSCLC) through a trial-level  meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/73/03/ott-9-1471.PMC4798219.pdf
"Recent clinical  research related to histology has shown important differences within the population Correspondence: Yi-Ming Ni Department of Cardiothoracic Surgery,  The First Affiliated Hospital of Zhejiang  University, No 79 Qing Chun Road,  hangzhou 310003, Zhejiang Province,  People’s Republic of China Tel +86 571 8723 6352 Fax +86 571 8723 6114 email niyiming2014@sina.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Xiao et al Running head recto: Pemetrexed-platinum in advanced nonsquamous NSCLC DOI: http://dx.doi.org/10.2147/OTT.S96160",Non-OADS,/arxiv_data1/oa_pdf/73/03/ott-9-1471.PMC4798219.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/73/03/ott-9-1471.PMC4798219.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/03/ott-9-1471.PMC4798219.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/31/5c/tcrm-12-427.PMC4798220.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 427–433Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  427ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9022 0Prevalence of diabetes and determinants:  evidence from a minority region in People’s  Republic of China Qingyun Chen1, Yanhua Yi2,  ning Xia1, Chunling li3,  Zuojie luo1, gaoming  huang3, Ying Chen1, shumin  li4, luhua lai1, Mingdeng  Wang5, Jing Tan6, Jie Zhang1,  hanlei shen1, Bixun li7,  Feiqun su8, hua Wei5, Xia  Dai1, Fengji lu9, shuilian li8 1Department of endocrinology, First  affiliated hospital of guangxi Medical  University, 2school for international  education, guangxi Medical University,   nanning, 3Department of Public  health, guangxi Medical University,   nanning, 4The second People’s  hospital of Qinzhou, Qinzhou,   5affiliated hospital of Youjiang Medical  University for nationalities, Baise,   6nandan County People’s hospital,   nandan, 7Tumor hospital of guangxi  Zhuang autonomous Region, nanning,   8hezhou City People’s hospital,   hezhou, 9long’an County People’s  hospital, nanning, guangxi, People’s  Republic of ChinaBackground:  This study aimed to examine the prevalence of diabetes mellitus and other  categories of glucose intolerance (impaired glucose tolerance and impaired fasting glucose) and  explore the risk factors in an ethnic minority region, Guangxi Zhuang Autonomous Region,  People’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/31/5c/tcrm-12-427.PMC4798220.pdf
"Located in the south of People’s Republic of China, Guangxi Zhuang Autonomous  Region (hereafter referred to as Guangxi) is a multiethnic area.4 Bordering Vietnam to  the south, Guangxi has eleven ethnic minority groups, including Zhuang, Y ao, Miao,  Dong, Mulao, and other ethnic groups, accounting for 38% of its population, or 19.57  million people.5 The Zhuang is People’s Republic of China’s largest ethnic minority Correspondence: Qingyun Chen Department of endocrinology, First  Affiliated Hospital of Guangxi Medical  University, 6 shuangyong Road, nanning,  guangxi 530021, People’s Republic of  China email qychen8688@126.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Chen et al Running head recto: Prevalence of diabetes and determinants DOI: http://dx.doi.org/10.2147/TCRM.S90220",Non-OADS,/arxiv_data1/oa_pdf/31/5c/tcrm-12-427.PMC4798220.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/31/5c/tcrm-12-427.PMC4798220.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/5c/tcrm-12-427.PMC4798220.pdf
Available from: http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/31/5c/tcrm-12-427.PMC4798220.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 1-2 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1114 Journal of Microbiology & Biology Education   1 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/df/2d/jmbe-17-1.PMC4798787.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/df/2d/jmbe-17-1.PMC4798787.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 105-106 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1022 Journal of Microbiology & Biology Education   105 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e0/fd/jmbe-17-105.PMC4798788.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/e0/fd/jmbe-17-105.PMC4798788.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 107-109 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1023 Journal of Microbiology & Biology Education   107 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/16/9c/jmbe-17-107.PMC4798789.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/16/9c/jmbe-17-107.PMC4798789.pdf
http://www.pewresearch.org/ fact-tank/2013/10/16/12-trends-shaping-digital-news/.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/jmbe-17-107.PMC4798789.pdf
http://www.pewinternet.org/~/media//Files/Reports/2010/PIP_Understanding_the_Participatory_News_Consumer.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/jmbe-17-107.PMC4798789.pdf
http://www.journalism.org/files/2014/03/ Overview.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/jmbe-17-107.PMC4798789.pdf
http://www.pewinternet.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/jmbe-17-107.PMC4798789.pdf
http://www.rockman.com/publications/ articles/MediaBasedLearningScience.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/9c/jmbe-17-107.PMC4798789.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 110-114 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1026 Journal of Microbiology & Biology Education  Volume 17, Number 1 110*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/97/c6/jmbe-17-110.PMC4798790.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/97/c6/jmbe-17-110.PMC4798790.pdf
http://www.birds.cornell.edu/citsci/.,Non-OADS,/arxiv_data1/oa_pdf/97/c6/jmbe-17-110.PMC4798790.pdf
http://www.ucmp.berkeley.edu/ education/explorations/tours/geotime/index.html .,Non-OADS,/arxiv_data1/oa_pdf/97/c6/jmbe-17-110.PMC4798790.pdf
http://www.nap.edu/catalog/13403/thinking- evolutionarily-evolution-education-across-the-life-sciences- summary-of .,Non-OADS,/arxiv_data1/oa_pdf/97/c6/jmbe-17-110.PMC4798790.pdf
http://www.pewresearch.org/fact-tank/2014/09/23/ most-americans-believe-in-climate-change-but-give-it-low- priority/ .,Non-OADS,/arxiv_data1/oa_pdf/97/c6/jmbe-17-110.PMC4798790.pdf
http://climate.nasa.gov/evidence/ .,OADS,/arxiv_data1/oa_pdf/97/c6/jmbe-17-110.PMC4798790.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 115-116 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1064 Journal of Microbiology & Biology Education   115 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c2/ed/jmbe-17-115.PMC4798791.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/c2/ed/jmbe-17-115.PMC4798791.pdf
"ACKNOWLEDGMENTS Project BudBurst is part of the NEON network, funded  solely by the National Science Foundation, http://www.neoninc.org/ .",Non-OADS,/arxiv_data1/oa_pdf/c2/ed/jmbe-17-115.PMC4798791.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 117-119 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1082 Journal of Microbiology & Biology Education   117 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c5/7e/jmbe-17-117.PMC4798792.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/c5/7e/jmbe-17-117.PMC4798792.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 120-124 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1004 Journal of Microbiology & Biology Education  Volume 17, Number 1 120©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/4a/1a/jmbe-17-120.PMC4798793.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/4a/1a/jmbe-17-120.PMC4798793.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 125-128 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1005 Journal of Microbiology & Biology Education   125 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/jmbe-17-125.PMC4798794.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/6f/ac/jmbe-17-125.PMC4798794.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 129-132 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1028 Journal of Microbiology & Biology Education   129 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
"While it may be possible for citizen scientists to comb through images of distant Mars (http://beamartian.jpl.nasa.gov ), track honeybee populations  in their backyards ( http://beespotter.org/ ), or help solve  computationally intensive protein folding problems ( http:// fold.it/portal/ ), the opportunities for the citizen scientist to  explore the microbial communities of their own world or within their own bodies are scarce.",Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
"Of course, such citizen scientists can offer themselves up as the subjects of scientific inquiry (e.g., http://americangut.org/ ), but how then can they  be made into more active participants?",Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
"For the reader and potential novice explorer of microbial ecosystems, there are two excellent sources of available data for analysis that may be easily used: MG-RAST ( http://metagenomics.anl.gov/ ) and IMG/M  (https://img.jgi.doe.gov/cgi-bin/edu/main.cgi ).",Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
https://www.youtube.com/ watch?v=CgfZVNv6w2E.,Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
Microbial Bebop   CompositionLink Data Analysis Blues for Elle https://www.youtube.com/ watch?v=EwZJj2k61nsThis composition highlights seasonal patterns in marine physical parameters at  the L4 Station in the Western English Channel.,Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
"Fifty Degrees North, Four Degrees Westhttps://www.youtube.com/ watch?v=IRb3-J2ABYAAll of the data in this composition derive from 12 observed time points collected at monthly intervals at the L4 Station during 2007.",Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
Mycorrhizal Waltz https://www.youtube.com/ watch?v=V3GQ1HflNLk&  feature=youtu.beThis composition is drawn from the interaction between a soil fungus and gene  expression in tree roots (data unpublished).,OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
"A Microbiome Musical https://www.youtube.com/ watch?v=gJTBGtZIHFgFinal-year students at Stellenbosch University, South Africa, used the Microbial Bebop algorithm to generate a series of compositions derived from human gut microbiome data and had their compositions performed by students in the Eikestad Primary School Choir.",Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
“A Microbiome Musical” data and methods are detailed here: http://stellenboschmicrobiomemusical.blogspot.com .,Non-OADS,/arxiv_data1/oa_pdf/20/47/jmbe-17-129.PMC4798795.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 13-16 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1019 Journal of Microbiology & Biology Education   13 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"Along with the Audubon Society, The Cornell Lab of Ornithology also hosts a citizen-science website, eBird (http://ebird.org/content/ebird/), where bird watchers can record the presence or absence of species in their region (14).",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"Project BudBurst http://budburst.org/ Document the leafing, flowering, and fruiting of plants  to monitor climate change and its impact on plants (6).",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
FrogWatch USA https://www.aza.org/frogwatch/ Learn about wetlands in the community and report  data on the calls of local frogs and toads.,Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
Nature’s Notebook https://www.usanpn.org/natures_notebook Online program for recording observations of plants  and animals to generate long-term data sets used for  scientific discovery and decision making.,Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"NestWatch http://nestwatch.org/ Train online to become a certified Nest Watch monitor,  then find nests, monitor them, collect data, and upload  data online to help track successes and failures of  nesting birds.",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"One example of this type of project is Project MERCCURI (http://spacemicrobes.org/), which aims to examine the bacterial diversity of microbes on Earth and on the International Space Station.",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"Other projects, intended to characterize human microbes by sequencing the microbial genomes from mouth, skin, or fecal samples, are ongoing (http://ubiome.com/pages/buynow , https://fundrazr.com/ campaigns/4Tqx5 ).",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"A group of tools, Citizen Sort ( http://citizensort.org/ ), allows the public  to participate in classifying images as part of several video games that were developed specifically for this purpose.",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"In addition to these citizen-science games, a game called Phylo ( http://phylo.cs.mcgill.ca/ ) has been developed  to analyze genetic sequences (11).",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"A puzzle game called Fold it ( http://fold.it/ portal/info/science ) has also been developed, in this case  to predict how proteins fold (3, 4).",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"An online resource called SciStarter (http://scistarter.com) is a database of cur - rent and ongoing citizen-science projects where individuals, teachers, and scientists can search current citizen-science projects in which to participate.",Non-OADS,/arxiv_data1/oa_pdf/a2/91/jmbe-17-13.PMC4798796.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 133-136 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.983 Journal of Microbiology & Biology Education   133 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/bc/43/jmbe-17-133.PMC4798797.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/bc/43/jmbe-17-133.PMC4798797.pdf
Phylo Phylo ( http://phylo.cs.mcgill.ca/ ) is a web-based citizen- science project that allows users to perform a multiple  sequence alignment (MSA) without requiring significant background in biology or a high degree of technical knowl - edge of MSA algorithms used by computers.,OADS,/arxiv_data1/oa_pdf/bc/43/jmbe-17-133.PMC4798797.pdf
Foldit Foldit ( http://fold.it/portal/ ) is an online game that mod - els protein folding.,Non-OADS,/arxiv_data1/oa_pdf/bc/43/jmbe-17-133.PMC4798797.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 137-142 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1066 Journal of Microbiology & Biology Education   137 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/0e/c8/jmbe-17-137.PMC4798798.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/0e/c8/jmbe-17-137.PMC4798798.pdf
"We further introduce a web-based simulation, White Zed (http://cartwrig.ht/apps/whitezed/), that can be deployed in classrooms to allow students to explore models before implementing them.",Non-OADS,/arxiv_data1/oa_pdf/0e/c8/jmbe-17-137.PMC4798798.pdf
"The code for every compartmental model used during the workshop, as well as the hands-on section, was made available in both Python and R at the workshop’s GitHub repository ( https://github.com/elofgren/zombies )  for students to refer to later.",Non-OADS,/arxiv_data1/oa_pdf/0e/c8/jmbe-17-137.PMC4798798.pdf
The Biocomplexity Institute of Virginia Tech has  created a viral transmission simulation activity known as Virus Tracker  (https://virustracker.vbi.vt.edu ) that includes  sophisticated visualization and analysis of the epidemic’s spread.,Non-OADS,/arxiv_data1/oa_pdf/0e/c8/jmbe-17-137.PMC4798798.pdf
"SOFTWARE RESOURCES In order to facilitate the translation of our experiences  using zombie epidemics to teach infectious diseases, we have developed White Zed, a web-based application available at http://cartwrig.ht/apps/whitezed/ (Fig.",Non-OADS,/arxiv_data1/oa_pdf/0e/c8/jmbe-17-137.PMC4798798.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 143-155 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1036 Journal of Microbiology & Biology Education   143 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3d/7f/jmbe-17-143.PMC4798799.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/3d/7f/jmbe-17-143.PMC4798799.pdf
"The percentage of women (62%) in our study populace  (Table 3) is somewhat higher than the 2013 national average, where undergraduate enrollments consisted of 56% women (National Center for Education Statistics, http://nces.ed.gov/programs/coe/indicator_cha.asp ).",Non-OADS,/arxiv_data1/oa_pdf/3d/7f/jmbe-17-143.PMC4798799.pdf
"Reports vary on the  percentage of undergraduates consisting of first-generation students, but sources such as Diverse Education reported about 50% ( http://diverseeducation.com/article/50898/) ,  which is about 10% greater than the percentage of first-generation students in our study populace.",Non-OADS,/arxiv_data1/oa_pdf/3d/7f/jmbe-17-143.PMC4798799.pdf
Readers can view the SLCI at http://tinyurl.com/jmbeslciaccess .,Non-OADS,/arxiv_data1/oa_pdf/3d/7f/jmbe-17-143.PMC4798799.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 156-162 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1011 Journal of Microbiology & Biology Education  Volume 17, Number 1 156*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/18/89/jmbe-17-156.PMC4798800.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/18/89/jmbe-17-156.PMC4798800.pdf
http://visionandchange.org/finalreport/.,Non-OADS,/arxiv_data1/oa_pdf/18/89/jmbe-17-156.PMC4798800.pdf
http://home.ubalt.edu/ntsbarsh/Business-stat/otherapplets/goodness.htm .,Non-OADS,/arxiv_data1/oa_pdf/18/89/jmbe-17-156.PMC4798800.pdf
http://home.ubalt.edu/ntsbarsh/Business-stat/otherapplets/TwoPopTest.htm .,Non-OADS,/arxiv_data1/oa_pdf/18/89/jmbe-17-156.PMC4798800.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 163-171 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1001 Journal of Microbiology & Biology Education   163 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/33/c2/jmbe-17-163.PMC4798801.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/33/c2/jmbe-17-163.PMC4798801.pdf
"Additionally, the American Gut ( http://americangut.org/ ) and The Wild Life of Our  Homes (3) are CS projects focusing on sampling microbes.",Non-OADS,/arxiv_data1/oa_pdf/33/c2/jmbe-17-163.PMC4798801.pdf
"This free application can be downloaded in the App Store and in the Google Play store ( https://itunes.apple.com/us/ app/osd-citizen/id834353532?mt=8 , https://play.google.com/ store/apps/details?id=com.iw.esa&hl=en ).",Non-OADS,/arxiv_data1/oa_pdf/33/c2/jmbe-17-163.PMC4798801.pdf
An online web- form ( http://mb3is.megx.net/osd-app/myosd-form )—featur- ing the same input fields as the application—was provided for participants who do not possess a smartphone.,Non-OADS,/arxiv_data1/oa_pdf/33/c2/jmbe-17-163.PMC4798801.pdf
"The satellites’ daytime Level-3 data products with full  spatial coverage at 4 km resolution giving the mean SST temperature over 12 hours were downloaded from different sources: SST data from Aqua, Terra, and Aquarius (spatial resolution 100 km) were obtained from ftp://podaac-ftp.jpl.nasa.gov/OceanTemperature/modis/L3/aqua/11um/4km/daily/2014  on December 12, 2014, from ftp://podaac-ftp.",OADS,/arxiv_data1/oa_pdf/33/c2/jmbe-17-163.PMC4798801.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 17-22 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1032 Journal of Microbiology & Biology Education   17 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/45/25/jmbe-17-17.PMC4798802.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/45/25/jmbe-17-17.PMC4798802.pdf
"For example, the Massachusetts Institute of Technology (MIT) Open Courseware, through its Highlights for High School website ( http://ocw.mit.edu/high-school/ ), provides  resources to improve science, technology, engineering, and math (STEM) education at the high school level.",Non-OADS,/arxiv_data1/oa_pdf/45/25/jmbe-17-17.PMC4798802.pdf
"S’Cool http://scool.larc.nasa.gov/Students observe clouds at particular times focusing on types,    height, percentage cover, and thickness.",Non-OADS,/arxiv_data1/oa_pdf/45/25/jmbe-17-17.PMC4798802.pdf
High School FoldIt http://fold.it/portal/Students become familiar with synthesis and breakdown of   proteins including how structure affects function.,Non-OADS,/arxiv_data1/oa_pdf/45/25/jmbe-17-17.PMC4798802.pdf
http://www.learnnc.org/lp/pages/7210.,Non-OADS,/arxiv_data1/oa_pdf/45/25/jmbe-17-17.PMC4798802.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 172-182 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1008 Journal of Microbiology & Biology Education  Volume 17, Number 1 172*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/bc/c3/jmbe-17-172.PMC4798803.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/bc/c3/jmbe-17-172.PMC4798803.pdf
http://visionandchange.org/ files/2011/03/Revised-Vision-and-Change-Final-Report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bc/c3/jmbe-17-172.PMC4798803.pdf
http://campuspress.yale.edu/bascomslack/projects .,Non-OADS,/arxiv_data1/oa_pdf/bc/c3/jmbe-17-172.PMC4798803.pdf
http://www.whitehouse.gov/ sites/default/files/microsites/ostp/pcast-engage-to-excel-final_2-25-12.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bc/c3/jmbe-17-172.PMC4798803.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 183-185 Copyright © 2016 American Society for Microbiology Journal of Microbiology & Biology Education   183 Volume 17, Number 1Scientific Citizenship BOOKS  A Primer for Citizen Science Engagement DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1024 Review of: Be the Change: Saving the World with Citizen Science ;  Chandra Clarke; (2013).",Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmbe-17-183a.PMC4798804.pdf
DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1029 Review of: Diary of a Citizen Scientist Chasing Tiger Beetles  and Other New Ways of Engaging the World; Sharman Apt Russell; (2014).,Non-OADS,/arxiv_data1/oa_pdf/e4/c0/jmbe-17-183a.PMC4798804.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 183-185 Copyright © 2016 American Society for Microbiology Journal of Microbiology & Biology Education   183 Volume 17, Number 1Scientific Citizenship BOOKS  A Primer for Citizen Science Engagement DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1024 Review of: Be the Change: Saving the World with Citizen Science ;  Chandra Clarke; (2013).",Non-OADS,/arxiv_data1/oa_pdf/9c/6b/jmbe-17-183b.PMC4798805.pdf
DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1029 Review of: Diary of a Citizen Scientist Chasing Tiger Beetles  and Other New Ways of Engaging the World; Sharman Apt Russell; (2014).,Non-OADS,/arxiv_data1/oa_pdf/9c/6b/jmbe-17-183b.PMC4798805.pdf
"Jerry H. Kavouras Lewis University, Romeoville, ILE-mail: KavourJe@lewisu.edu A Framework for Inclusion and Diversity in Environ - mental Citizen Science   DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1009Review of: Citizen Science: Public Participation in Environmental   Research; Janis L. Dickinson and Rick Bonney; (2015).",Non-OADS,/arxiv_data1/oa_pdf/9c/6b/jmbe-17-183b.PMC4798805.pdf
"Jerry H. Kavouras Lewis University, Romeoville, ILE-mail: KavourJe@lewisu.edu A Framework for Inclusion and Diversity in Environ - mental Citizen Science   DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1009Review of: Citizen Science: Public Participation in Environmental   Research; Janis L. Dickinson and Rick Bonney; (2015).",Non-OADS,/arxiv_data1/oa_pdf/fa/4d/jmbe-17-184.PMC4798806.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 23-28 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.984 Journal of Microbiology & Biology Education   23 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/52/f1/jmbe-17-23.PMC4798807.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/52/f1/jmbe-17-23.PMC4798807.pdf
Project Description Web Site Wild Life of Our Homes Bacterial and fungal communities   associated with home dusthttp://homes.yourwildlife.org Home Microbiome Study Bacteria on home surfaces http://homemicrobiome.com The Microverse Microbes on buildings http://nhm.ac.uk/take-part/citizen-science/microverse.,Non-OADS,/arxiv_data1/oa_pdf/52/f1/jmbe-17-23.PMC4798807.pdf
html MERCCURI Microorganisms on the International  Space Stationhttp://spacemicrobes.org Belly Button Biodiversity Bacteria in navels http://navels.yourwildlife.org Autism Microbiome Gut-associated microbes and autism https://microbiome.stanford.edu American Gut Gut-associated microbial communities   in the US populationhttp://americangut.org μBiome Human-associated microbial communities http://ubiome.com Kitty Microbiome Gut-associated microbes in cats https://catbiome.wordpress.com Plankton Portal Identification of marine plankton www.planktonportal.org Wolbachia Project Wolbachia symbionts in arthropods http://discover.mbl.edu Clumpy Identification of bacterial infection   in plant cellshttp://clumpy.ex.ac.uk GoViral Flu outbreaks www.goviralstudy.com SEA-PHAGES Bacteriophage genomics www.hhmi.org/programs/science-education-alliance Drugs from Dirt Secondary metabolites from soil www.drugsfromdirt.org Citizen Science Soil Collection Program Fungal natural products from soil http://npdg.ou.edu/citizenscience State of the Oyster Bacterial contamination levels in   edible shellfishhttp://wsg.washington.edu/mas/ecohealth/state_of_ oyster.html BEACH Program Monitoring for fecal bacteria in beaches www.ecy.wa.gov/programs/eap/BEACH/,Non-OADS,/arxiv_data1/oa_pdf/52/f1/jmbe-17-23.PMC4798807.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 29-31 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1043 Journal of Microbiology & Biology Education   29 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/2f/ca/jmbe-17-29.PMC4798808.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/2f/ca/jmbe-17-29.PMC4798808.pdf
A great  place to start when searching for a citizen-science project is the SciStarter website ( http://scistarter.com/finder ).,Non-OADS,/arxiv_data1/oa_pdf/2f/ca/jmbe-17-29.PMC4798808.pdf
"They can then par- ticipate in a gut microbiome project, such as the American Gut Project ( http://americangut.org ), in which they can learn  about their own microbiome and compare their results to those of others of the same or different ages, the same or different locations, or other variables.",Non-OADS,/arxiv_data1/oa_pdf/2f/ca/jmbe-17-29.PMC4798808.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 3 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1081 Journal of Microbiology & Biology Education   3 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c4/81/jmbe-17-3.PMC4798809.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/c4/81/jmbe-17-3.PMC4798809.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 32-37 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1051 Journal of Microbiology & Biology Education  Volume 17, Number 1 32 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
We also created an ongoing FundRazr campaign to allow people to continue to join and support the project ( http://tinyurl.com/ kittybiome-fundrazr ).,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
http://blogs.biomedcentral.com/ gigablog/2015/05/26/community-microbiomes-chatting-scat-kittybiomes-holly-ganz/.,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
https://pando.com/2013/10/14/infographic- kickstarter-vs-indiegogo/.,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
https://nsfdeb.wordpress.com/2013/03/11/deb-numbers-revisiting- performance-of-pi-demographic-groups-part-1/.,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
https://nexus.od.nih.gov/all/2014/03/05/comparing-success-award-funding-rates/.,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
http://nexus.od.nih.gov/all/2013/09/24/one-nation-in-support-of- biomedical-research/.,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
http://news.sciencemag.org/sifter/2015/05/kittybiome- kickstarter-to-fund-research-on-cat-microbes.,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/jmbe-17-32.PMC4798810.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 38-40 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1018 Journal of Microbiology & Biology Education  Volume 17, Number 1 38©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/5a/5b/jmbe-17-38.PMC4798811.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/5a/5b/jmbe-17-38.PMC4798811.pdf
"Audubon Society   (www.audubon.org/conservation/science/christmas -bird-count,   @audubonsociety) Australian Citizen Science Association   (www.citizenscience.org.au/wordpress/ , @CitSciOZ) California Academy of Sciences   (http://calacademy.org/citizen-science-0, @calacademy) Citizen Science Association   (http://citizenscienceassociation.org/ , @CitSciAssoc ) Cornell Lab of Ornithology   (www.birds.cornell.edu/citscitoolkit, @CornellBirds) Denver Museum of Nature & Science   (www.dmns.org/science/museum -scientists/nicole-garneau/   the-genetics-lab , @DenverMuseumNS) European Citizen Science Association   (http://ecsa.biodiv.naturkundemuseum-berlin.de/) National Ecological Observatory Network   (www.neoninc.org/ , @NEONInc) National Wildlife Federation (www.nwf.org/Wildlife/Wildlife- Conservation/Citizen-Science.aspx, @NWF) North Carolina Museum of Natural Sciences   (http://naturalsciences.org/research-collections/citizen-science ,   @naturalsciences) PLOS Blogs CitizenSci  (http://blogs.plos.org/citizensci/ , @CoopSciScoop) SciStarter (http://scistarter.com/, @SciStarter) Socientize (http://pybossa.socientize.eu/pybossa/, @SOCIENTIZE) The Field Museum  (www.fieldmuseum.org/science/citizen-science , @FieldMuseum) Y our Wild Life Group (www.Y ourWildLife.org, @Y ourWild_Life)",Non-OADS,/arxiv_data1/oa_pdf/5a/5b/jmbe-17-38.PMC4798811.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 4-6 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1049 Journal of Microbiology & Biology Education  Volume 17, Number 1 4*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/d0/56/jmbe-17-4.PMC4798812.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/d0/56/jmbe-17-4.PMC4798812.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 41-45 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1020 Journal of Microbiology & Biology Education   41 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/7b/83/jmbe-17-41.PMC4798813.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/7b/83/jmbe-17-41.PMC4798813.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 46-50 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1034 Journal of Microbiology & Biology Education  Volume 17, Number 1 46*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/bb/46/jmbe-17-46.PMC4798814.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/bb/46/jmbe-17-46.PMC4798814.pdf
"This typically involves the contribution of obser - vational data, such as bird sightings or flu symptoms, in projects like Flu Near You ( https://flunearyou.org ), but may  also involve crowdsourced data collection, modeled by the Personal Genome Project ( www.personalgenomes.org ), or  even crowdsourcing data analysis, through platforms like the online games Foldit ( https://fold.it/portal/ ) and EteRNA  (http://eterna.cmu.edu/web/ ).",Non-OADS,/arxiv_data1/oa_pdf/bb/46/jmbe-17-46.PMC4798814.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 51-55 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.999 Journal of Microbiology & Biology Education   51 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3c/a2/jmbe-17-51.PMC4798815.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/3c/a2/jmbe-17-51.PMC4798815.pdf
http://www.nabt.org/websites/ institution/File/docs/Four%20Year%20Section/2012%20Proceedings/Orr %20and%20Baumgartner%20NABT%20 symposium.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3c/a2/jmbe-17-51.PMC4798815.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 56-59 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1037 Journal of Microbiology & Biology Education  Volume 17, Number 1 56Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/60/7b/jmbe-17-56.PMC4798816.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/60/7b/jmbe-17-56.PMC4798816.pdf
"Several marine non-profit organizations, including Reef Environmental Education Foun - dation (REEF) and Reef Check California, have successfully collected and submitted data using citizen-science methods for use in coastal management and marine biology studies (REEF.org: http://www.reef.org/db/publications  and Reef  Check: http://www.reefcheck.org/rcca/reports.php ).",Non-OADS,/arxiv_data1/oa_pdf/60/7b/jmbe-17-56.PMC4798816.pdf
"The freckling marks are similar to the unique fingerprint patterns found in humans and can be used for identification purposes (Sevengill Shark Sightings, Methodology: http://sevengillsharksightings.org/our-methodology-introduction/ ).",Non-OADS,/arxiv_data1/oa_pdf/60/7b/jmbe-17-56.PMC4798816.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 60-62 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1016 Journal of Microbiology & Biology Education  Volume 17, Number 1 60*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/34/32/jmbe-17-60.PMC4798817.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/34/32/jmbe-17-60.PMC4798817.pdf
Results of this citizen science are then reported through a user-friendly online form ( http://tinyurl.com/SoilMicrobes ) to research - ers studying rhizosphere recruitment dynamics of weeds and other successful plants.,Non-OADS,/arxiv_data1/oa_pdf/34/32/jmbe-17-60.PMC4798817.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 63-69 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1014 Journal of Microbiology & Biology Education   63 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/jmbe-17-63.PMC4798818.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/jmbe-17-63.PMC4798818.pdf
"Explore pursuing a science degree in college or  graduate school PROCEDURE Materials Global positioning system (GPS) deviceTick repellent (diethyltoluamide-DEET, permethrin) Tick drag cloth (Appendix 1)  Ziploc bag containing “Tick Kit” for collecting ticks in  the field: • Tick data sheet (Appendix 3) • Tick ID cards (http://www.health.state.mn.us/divs/idepc/dtopics/tickborne/card.html)  • Tweezers • Lab gloves • 1.5-milliliter (mL) Eppendorf tubes containing isopropanol or ethanol hand sanitizer • Markers • Pens Part 1.",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/jmbe-17-63.PMC4798818.pdf
": LYME DISEASE OUTREACH Volume 17, Number 166can continue to follow the Lyme research through a website  developed by an undergraduate http://d.umn.edu/lyme/ .",Non-OADS,/arxiv_data1/oa_pdf/e0/a3/jmbe-17-63.PMC4798818.pdf
http://nces.ed.gov/ pubsearch/pubsinfo.asp?pubid=2014024.,Non-OADS,/arxiv_data1/oa_pdf/e0/a3/jmbe-17-63.PMC4798818.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 7-12 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1052 Journal of Microbiology & Biology Education   7 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/09/fa/jmbe-17-7.PMC4798819.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/09/fa/jmbe-17-7.PMC4798819.pdf
These and a wide variety of citizen-science projects can be found on the SciStarter website ( http://scistarter.com/ ).,Non-OADS,/arxiv_data1/oa_pdf/09/fa/jmbe-17-7.PMC4798819.pdf
"Project Description Role of Citizen Scientist American Gut  http://humanfoodproject.com/americangut/Open-source, open-access research project  within the Human Food Project initiative  that aims to characterize human gut   microflora through wide-scale participation.Participants purchase a kit and send   personal samples through the mail.",Non-OADS,/arxiv_data1/oa_pdf/09/fa/jmbe-17-7.PMC4798819.pdf
http://microbe.net/2015/02/17/the-long-road-from-data-to-wisdom-and- from-dna-to-pathogen/ .,Non-OADS,/arxiv_data1/oa_pdf/09/fa/jmbe-17-7.PMC4798819.pdf
http://www.nws.noaa.gov/om/ coop/what-is-coop.html.,Non-OADS,/arxiv_data1/oa_pdf/09/fa/jmbe-17-7.PMC4798819.pdf
http://phenomena.nationalgeographic.com/2015/02/10/theres-no-plague-on-the-nyc-subway-no-platypuses-either/ .,Non-OADS,/arxiv_data1/oa_pdf/09/fa/jmbe-17-7.PMC4798819.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 70-73 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1002 Journal of Microbiology & Biology Education  Volume 17, Number 1 70*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/68/b2/jmbe-17-70.PMC4798820.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/68/b2/jmbe-17-70.PMC4798820.pdf
"The mechanism of sampling via crowdsourcing techniques has been effective in other microbial systems, including the American Gut Project (6), uBIOME ( http://ubiome.com ), and the Home  Microbiome Project ( http://microbe.net/citizen-science-2/ citizen-science-sampling-protocols/ ).",Non-OADS,/arxiv_data1/oa_pdf/68/b2/jmbe-17-70.PMC4798820.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 74-76 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1062 Journal of Microbiology & Biology Education  Volume 17, Number 1 74Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/a1/37/jmbe-17-74.PMC4798821.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/a1/37/jmbe-17-74.PMC4798821.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 77-80 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.996 Journal of Microbiology & Biology Education   77 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/75/41/jmbe-17-77.PMC4798822.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/75/41/jmbe-17-77.PMC4798822.pdf
"Also serving as inspi - ration were grant projects such as the Appalachian Rural System Initiative and the Appalachian Math Science Part - nership, which had successfully sought to address various issues in STEM education ( http://www.inverness-research.",Non-OADS,/arxiv_data1/oa_pdf/75/41/jmbe-17-77.PMC4798822.pdf
"The University of California at Los Angeles’ CityLab, whose local underprivileged urban high school students have many of the same socioeconomic issues as rural Appalachian students, provided a successful design example ( http://citylab.aud.ucla.edu ).",Non-OADS,/arxiv_data1/oa_pdf/75/41/jmbe-17-77.PMC4798822.pdf
http://eric.ed.gov/?id=ED531890 .,OADS,/arxiv_data1/oa_pdf/75/41/jmbe-17-77.PMC4798822.pdf
http://archive.tennessean.com/article/20140302/ NEWS01/303030012/In-Carter-County-fighting-meth-dirty-dangerous-business.,Non-OADS,/arxiv_data1/oa_pdf/75/41/jmbe-17-77.PMC4798822.pdf
http://www.hhs.gov/ash/oah/adolescent-health-topics/reproductive-health/teen-pregnancy/trends.html .,Non-OADS,/arxiv_data1/oa_pdf/75/41/jmbe-17-77.PMC4798822.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 81-85 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1013 Journal of Microbiology & Biology Education   81 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/90/64/jmbe-17-81.PMC4798823.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/90/64/jmbe-17-81.PMC4798823.pdf
"DIY-Bio has established a parallel infrastructure, including a Google group and listserv ( http://diybio.org ),  journal ( www.oreilly.com/biocoder/ ), and code of ethics  (http://diybio.org/codes ).",Non-OADS,/arxiv_data1/oa_pdf/90/64/jmbe-17-81.PMC4798823.pdf
"Recognizing the need for qualified safety professionals,  the DIY-Bio movement has instituted the “ask a biosafety ex - pert” service ( http://ask.diybio.org/ ), which allows members  of the community to get answers to questions that may arise.",Non-OADS,/arxiv_data1/oa_pdf/90/64/jmbe-17-81.PMC4798823.pdf
https://medium.com/backchannel/diybio-comes-of-age-4a5b15d1131f.,Non-OADS,/arxiv_data1/oa_pdf/90/64/jmbe-17-81.PMC4798823.pdf
http://www.the-scientist.com/?articles.,Non-OADS,/arxiv_data1/oa_pdf/90/64/jmbe-17-81.PMC4798823.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 86-89 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.997 Journal of Microbiology & Biology Education  Volume 17, Number 1 86Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/69/42/jmbe-17-86.PMC4798824.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/69/42/jmbe-17-86.PMC4798824.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 90-92 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.1067 Journal of Microbiology & Biology Education  Volume 17, Number 1 90 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/82/dd/jmbe-17-90.PMC4798825.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/82/dd/jmbe-17-90.PMC4798825.pdf
"Their activities have included basic electrophysiological demonstrations of action potentials using SpikerBoxes from Backyard Brains (https://backyardbrains.com/ ), dissections of sheep brains,  making models of brains and neurons, manipulation of the senses and discussions of the transduction of sensory stimuli, and watching and explaining videos of common neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/82/dd/jmbe-17-90.PMC4798825.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 93-97 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.990 Journal of Microbiology & Biology Education   93 Volume 17, Number 1 ©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/cc/8f/jmbe-17-93.PMC4798826.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/cc/8f/jmbe-17-93.PMC4798826.pdf
Title Author(s) Source (Year) Accessibility or Reference Gamers discover protein     structure that could help   war on HIVKyle Niemeyer Arts T echnica (2011) http://arstechnica.com/science/news/2011/09/gamers- discover-protein-structure-relevant-to-hiv-drugs.ars Conservation and the    Botanist EffectAhreds et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/8f/jmbe-17-93.PMC4798826.pdf
http://online.worcester.edu/faculty/kwurst/Course Materials/Spring 2010/UR 230/Position Paper Grading Rubric.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cc/8f/jmbe-17-93.PMC4798826.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, March 2016, p. 98-104 DOI: http://dx.doi.org/10.1128/jmbe.v17i1.995 Journal of Microbiology & Biology Education  Volume 17, Number 1 98©2016 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ce/76/jmbe-17-98.PMC4798827.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/ce/76/jmbe-17-98.PMC4798827.pdf
"Anthrax Influenza Enteroviruses/Polio Starting Point T elevision programming (watched in this order) a: http://www.youtube.com/watch?v=92Syc1agCBk http://www.youtube.com/watch?v=JH7Y0j0rjwk http://www.youtube.com/watch?v=uX_yoRxsuEU http://www.youtube.com/watch?v=mi3sYzDsSGIUnexpected current event  (2009 swine influenza or 2015  avian influenza outbreaks) Popular media and scientific  sources on EV-D68 cases    in North America (and   subsequent discussions on the  status of enteroviruses—and  polio specifically—in current  global contexts) Science Subjects Bioterrorism; epidemiology;   genetics; public healthAgriculture; epidemiology;  public healthEpidemiology; genetics;   neurology; public health Nature of Scientific   EvidenceCategories II and III   (scientific knowledge is available   but with gaps, and decision-making   may be based on nonscientific knowledge)Category II (scientific   knowledge is fairly   well-established, and   decision-making may be based  on nonscientific knowledge)Categories I and III (scientific  knowledge is available but   may be misreported or   misinterpreted, and decision- making requires weighing   different sources) Social Content Criminal systems; ethics;   government; law; politicsEconomics; transportation  infrastructureCivics; ethics; immigration;  international relations; politics Use of Scientific   KnowledgeCritical thinking; risk assessment; strengths   and weaknesses of current scientific   technology (and applications)Critical thinking; problem   solving; risk assessment;   scientific literacyCritical thinking; scientific  literacy Primary Conflict   Level(s)Structural Societal Individual, Societal, Structural a All videos were available as of May 2015",Non-OADS,/arxiv_data1/oa_pdf/ce/76/jmbe-17-98.PMC4798827.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Harris B.,Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Lausanne, Switzerland: Phillip Morris International, 2014. https://www.media-server.com/m/instances/ 8hjnb6wm/items/29n825fv/assets/vjr3btkp/0/ ﬁle.pdf 4 Cobben M. Capsule rollout.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Hampshire, United Kingdom: British American Tobacco, 2011. http://www.bat.com/group/sites/UK__8GLKJF.nsf/vwPagesWebLive/3FF4B58C81321BC8C12578880056EF37/$FILE/14_Mark%20Cobben%20-% 20Capsule%20Rollout.pdf?openelement 5 Hedley D. Game changers and category killers —the tobacco future.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"American Tobacco Company, 1966. http://news.google.com/newspapers?nid=888&dat=19660415&id=pxRAAAAIBAJ&sjid=InQDAAAAIBAJ&pg=3460,2275459 14 Kahnert S, Pötschke-Langer M, Schunk S, et al.Menthol capsules in cigarette ﬁlters —increasing the attractiveness of a harmful product .",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
http://www.talkingretail.com/products-news/tobacco/jti-introduces-silk-cut-superslims-choice/ 18 MacGuill S. Tobacco control in Chile —an unremarkable market becomes an unlikely bellwether .,Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Euromonitor International, 2013. http://blog.euromonitor.com/2013/04/ tobacco-control-in-chile-an-unremarkable-market-becomes-an-unlikely-bellwether.html 19 Gilmore AB.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Hampshire, UK: British American Tobacco, 2011. http://www.bat.com/group/sites/UK__8GLKJF.nsf/vwPagesWebLive/CA0DE1FAF692B52CC12578880058E882/$FILE/19_Jack% 20Bowles%20Managing%20the%20Challenges%20in%20Western%20Europe.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Hampshire, UK; British American Tobacco, 2011. http://www.bat.com/group/sites/UK__8GLKJF.nsf/vwPagesWebLive/ 167002DCAB80D05FC12578880056CA62/$FILE/10_Jean-Marc%20Levy%20% 20Consumer%20driven%20growth.pdf?openelement 22 Moodie C, Ford A, Mackintosh A, et al.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Cigarettes in Mexico, 2014. http://www.euromonitor.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Cuernavaca, México: Instituto Nacional de Salud Pública, 2013. http://globaltobaccocontrol.org/ tpackss/mexican-products/ 27 Saenz de Miera B, Thrasher JF, Chaloupka FJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Cigarettes in Australia, 2014. http://www.euromonitor.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Cigarettes in the US, 2014. http://www.euromonitor.com/ cigarettes-in-the-us/report 36 Hegarty R. All Pall Mall cigarettes to be ﬂavour-changers from October.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"http://www.thegrocer.co.uk/fmcg/pall-mall-cigarettes-to-be-ﬂavour-changers-from-october/349644.article 37 Wake ﬁeld M, Morley C, Horan JK, et al.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
"Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture,presentation and sale of tobacco and related products and repealing Directive 2001/37/EC, 2014. http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf Thrasher JF, et al.Tob Control 2016; 25:275–283.",Non-OADS,/arxiv_data1/oa_pdf/45/94/tobaccocontrol-2014-052064.PMC4798911.pdf
E-mail  address:  Pmssharma17@gmail.com  (P.M.  Suryanarayana  Sharma).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.06.0240019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/2a/db/main.PMC4798975.pdf
Available  at:  http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/2a/db/main.PMC4798975.pdf
2014.  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2a/db/main.PMC4798975.pdf
Shreetal).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.06.0200019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/4e/34/main.PMC4798976.pdf
http://dx.doi.org/10.1016/j.ihj.2015.06.004,OADS,/arxiv_data1/oa_pdf/a1/23/main.PMC4798977.pdf
E-mail  address:  dryadvinder@hotmail.com  (Y.  Singh).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.06.0320019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/12/9b/main.PMC4798978.pdf
Bhattacharyya).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.0080019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/d4/ba/main.PMC4798979.pdf
Patil).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.06.0330019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/25/c0/main.PMC4798980.pdf
E-mail  address:  saprarakesh@hotmail.com  (R.  Sapra).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.0090019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/c9/7b/main.PMC4798981.pdf
E-mail  address:  cardiologysvims@gmail.com  (D.  Rajasekhar).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.06.0250019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/d1/06/main.PMC4798982.pdf
E-mail  address:  drsk.shi@gmail.com  (S.  Kasturi).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.0160019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/1d/e6/main.PMC4799000.pdf
E-mail  address:  annapoorna.kini@mountsinai.org  (A.  Kini).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.10.3000019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/e1/1d/main.PMC4799001.pdf
E-mail  address:  benturgay@yahoo.com  (T.  Celik).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0040019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/df/03/main.PMC4799002.pdf
E-mail  address:  parisoha2013@gmail.com  (A.  Potdar).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.0140019-4832/ # 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/12/96/main.PMC4799003.pdf
E-mail  address:  dr_soumyapatra@rediffmail.com  (S.  Patra).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.08.0020019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/a2/b1/main.PMC4799004.pdf
E-mail  address:  maverickmedico1985@gmail.com  (S.  Goel).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.0350019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/eb/5a/main.PMC4799005.pdf
E-mail  address:  dilipcardio@gmail.com  (D.  Kumar).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0080019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/e8/b5/main.PMC4799006.pdf
Nayak).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.0160019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/b3/09/main.PMC4799007.pdf
http://www.genengnews.com/ gen-articles/pharma-innovation-in-critical-condition/3115/ (accessed  08.11.11).,Non-OADS,/arxiv_data1/oa_pdf/a2/58/main.PMC4799008.pdf
"1995;1:1122 –1125.Sundeep  Mishra Professor,  Department  of  Cardiology,  AIIMS,  New  Delhi,  India E-mail  addresses:  sundeepmishraihj@gmail.com , editorihj2015@gmail.com http://dx.doi.org/10.1016/j.ihj.2016.01.005 0019-4832/ #  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological Society  of  India.i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  7  (  2  0  1  5  )  s  1  –  s  3  S3",Non-OADS,/arxiv_data1/oa_pdf/a2/58/main.PMC4799008.pdf
E-mail  address:  narayanarajucardio@gmail.com  (N.  Raju).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0040019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/2c/96/main.PMC4799009.pdf
http://dx.doi.org/10.1016/ j.jcin.2013.12.012 .i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  7  (  2  0  1  5  )  s  7  1  –  s  7  3  S73,OADS,/arxiv_data1/oa_pdf/2c/96/main.PMC4799009.pdf
Pahwa).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0240019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/2e/81/main.PMC4799010.pdf
4).i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  7  (  2  0  1  5  )  s  1  1  7  –  s  1  1  9 a  r  t  i  c  l  e  i  n  f  o Article  history: Received  12  July  2015 Accepted  5  November  2015 Available  online  18  January  2016 *  Corresponding  author .Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.003 0019-4832/ #  2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/01/87/main.PMC4799011.pdf
"S.  Harikrishnan Additional  Professor  in  Cardiology,  Sree  Chitra  Tirunal  Institute  for Medical  Sciences  and  Technology,  Trivandrum,  Kerala,  India E-mail  address:  drharikrishnan@outlook.com Available  online  19  January  2016 http://dx.doi.org/10.1016/j.ihj.2016.01.004 0019-4832/ #  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological Society  of  India.i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  7  (  2  0  1  5  )  s  4  –  s  6 S6",Non-OADS,/arxiv_data1/oa_pdf/b7/25/main.PMC4799012.pdf
"E-mail  addresses:  kevinsinghkang@gmail.com  (K.  Kang),  ferrarorj@upmc.edu  (R.  Ferraro),  petrellarw@upmc.edu  (R.  Petrella), drpaulkang@gmail.com  (G.  Kang).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.08.0240019-4832/ # 2015  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/b2/12/main.PMC4799013.pdf
Abstract  retrieved  from http://www.karger.com/Journal/Issue/268891 .i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  7  (  2  0  1  5  )  s  3  6  –  s  3  8 S38,Non-OADS,/arxiv_data1/oa_pdf/b2/12/main.PMC4799013.pdf
E-mail  address:  drneeraj_12@yahoo.co.in  (N.  Aggarwal).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0150019-4832/ # 2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/7e/c3/main.PMC4799014.pdf
E-mail  address:  muhas.nainamuhammed@gmail.com  (M.  Nainamohamed).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0370019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/34/0e/main.PMC4799015.pdf
2011;2:129.  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/0e/main.PMC4799015.pdf
E-mail  address:  gaurangamajumdar@hotmail.com  (G.  Majumdar).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0180019-4832/ # 2016  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/6a/cf/main.PMC4799016.pdf
E-mail  address:  kaul.upendra@gmail.com  (U.  Kaul).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0060019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/29/92/main.PMC4799017.pdf
E-mail  address:  rajeevbhardwaj_dr@yahoo.com  (R.  Bhardwaj).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.0200019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/10/a4/main.PMC4799018.pdf
E-mail  address:  matteo.ziacchi@gmail.com  (M.  Ziacchi).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.10.3790019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/ab/ef/main.PMC4799019.pdf
E-mail  address:  khargej@gmail.com  (J.  Kharge).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.0040019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/37/53/main.PMC4799020.pdf
E-mail  address:  shilpaputhran41@gmail.com  (S.  Puthran).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.0250019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/c2/d8/main.PMC4799021.pdf
Gupta).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.0380019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/d8/37/main.PMC4799022.pdf
http://dx.doi.org/ 10.1016/j.jcmg.2011.09.018 .,OADS,/arxiv_data1/oa_pdf/d8/37/main.PMC4799022.pdf
E-mail  address:  dr.sdkamath@tatasteel.com  (S.  Kamath).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.0130019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/ef/69/main.PMC4799023.pdf
"E-mail  addresses:  dilipcardio@gmail.com  (D.  Kumar),  scmdmed@gmail.com  (S.  Chakraborty),  drsunip@yahoo.com  (S.  Banerjee).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.12.0230019-4832/ # 2015  Cardiological  Society  of  India.",Non-OADS,/arxiv_data1/oa_pdf/ac/c2/main.PMC4799024.pdf
http://dx.doi.org/10.1161/JAHA.115.002259 .,Non-OADS,/arxiv_data1/oa_pdf/d5/f3/main.PMC4799025.pdf
2015.  http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d5/f3/main.PMC4799025.pdf
"Rohit  Bhatia  MD,  DM,  DNB * Vipin  Ola  MD,  DM Department  of  Neurology,  Neurosciences  Centre,  All  India  Institute  of Medical  Sciences,  New  Delhi,  India *Corresponding  author E-mail  address:  rohitbhatia71@yahoo.com  (R.  Bhatia) http://dx.doi.org/10.1016/j.ihj.2016.01.008 0019-4832/ #  2016  Published  by  Elsevier  B.V.  on  behalf  of  Cardiological Society  of  India.i  n  d  i  a  n  h  e  a  r  t  j  o  u  r  n  a  l  6  7  (  2  0  1  5  )  s  7  –  s  1  0 S10",Non-OADS,/arxiv_data1/oa_pdf/d5/f3/main.PMC4799025.pdf
E-mail  address:  abhisekh.mhnt@gmail.com.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.040 0019-4832/ #  2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/91/53/main.PMC4799026.pdf
E-mail  address:  goutamdattadn@yahoo.in.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.07.025 0019-4832/ #  2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/08/8c/main.PMC4799027.pdf
E-mail  address:  rajeshvijay999@hotmail.com.Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.09.035 0019-4832/ #  2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/e4/da/main.PMC4799028.pdf
Raut).Available  online  at  www.sciencedirect.com ScienceDirect journal  homepage:  www.elsevier.com/locate/ihj http://dx.doi.org/10.1016/j.ihj.2015.11.0280019-4832/ # 2015  Cardiological  Society  of  India.,Non-OADS,/arxiv_data1/oa_pdf/fe/70/main.PMC4799029.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/22/ad/13555_2016_Article_103.PMC4799030.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/bf/0a/13555_2016_Article_93.PMC4799031.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriateDermatol Ther (Heidelb) (2016) 6:25–37 35",Non-OADS,/arxiv_data1/oa_pdf/01/65/13555_2016_Article_102.PMC4799032.pdf
http://www.prnewswire.com/news-releases/lillys-ixekizumab-met- primary-endpoint-in-a-phase-3-study-investigating- the-treatment-of-psori atic-arthritis-300068249.,Non-OADS,/arxiv_data1/oa_pdf/01/65/13555_2016_Article_102.PMC4799032.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide alink to the Creative Commons license, and indicate if changes were made.Dermatol Ther (Heidelb) (2016) 6:47–56 53",Non-OADS,/arxiv_data1/oa_pdf/15/37/13555_2016_Article_97.PMC4799034.pdf
32. https://rationale.com/expert-advice/protocol-sen sitive-skin .,Non-OADS,/arxiv_data1/oa_pdf/15/37/13555_2016_Article_97.PMC4799034.pdf
34. http://www.cosdna.com/eng/cosmetic_bb281217 29.html .,Non-OADS,/arxiv_data1/oa_pdf/15/37/13555_2016_Article_97.PMC4799034.pdf
35. http://www.physiogel.com/sg[Date .,Non-OADS,/arxiv_data1/oa_pdf/15/37/13555_2016_Article_97.PMC4799034.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/9b/95/13555_2016_Article_94.PMC4799035.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/bb/55/13555_2015_Article_91.PMC4799036.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e6/94/13555_2015_Article_92.PMC4799039.pdf
http://apps.who.int/ trialsearch/Trial2.aspx?TrialID=NCT02349451 .,OADS,/arxiv_data1/oa_pdf/e6/94/13555_2015_Article_92.PMC4799039.pdf
https://www.clinicaltrials.gov/ct2/ show/NCT02203032 .,Non-OADS,/arxiv_data1/oa_pdf/e6/94/13555_2015_Article_92.PMC4799039.pdf
http://www.pharma.us.,Non-OADS,/arxiv_data1/oa_pdf/e6/94/13555_2015_Article_92.PMC4799039.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b0/ab/13555_2015_Article_90.PMC4799040.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d4/b3/13555_2016_Article_101.PMC4799041.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/c8/14/13555_2016_Article_95.PMC4799042.pdf
Examples of delayed reactions include allergicEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 1944F0605D19D438 .,Non-OADS,/arxiv_data1/oa_pdf/04/96/13555_2016_Article_104.PMC4799043.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/04/96/13555_2016_Article_104.PMC4799043.pdf
Disponível em: http://www.ejbjs.org/cgi/content/extract/79/2/278.,Non-OADS,/arxiv_data1/oa_pdf/f8/3a/main.PMC4799060.pdf
*http://www.1.ibge.gov.br/home/estatistica/população/projecao_da_populacao/piramide/piramide.shtm,Non-OADS,/arxiv_data1/oa_pdf/e3/17/main.PMC4799077.pdf
Disponível em: http://www.ufrgs.,Non-OADS,/arxiv_data1/oa_pdf/f9/6d/main.PMC4799098.pdf
Disponível em: http://jus2.uol.com.,Non-OADS,/arxiv_data1/oa_pdf/f9/6d/main.PMC4799098.pdf
Disponível em: http://jus2.uol.com.br/doutrina/texto.,Non-OADS,/arxiv_data1/oa_pdf/f9/6d/main.PMC4799098.pdf
Disponível em: http://www.emedicine.,Non-OADS,/arxiv_data1/oa_pdf/cc/cc/main.PMC4799115.pdf
Disponível em: http://www.biomedcen- tral.com/1471-2431/8/28.,Non-OADS,/arxiv_data1/oa_pdf/e4/1d/main.PMC4799119.pdf
"These images were then analyzed us- ing the  Image J 1.41 software (Wayne Rasband, Re- search Services Branch, National Institute of Mental  Health, Bethesda, Maryland, USA), which is available  for download from the website http://rsbweb.nih.gov.",OADS,/arxiv_data1/oa_pdf/34/70/main.PMC4799122.pdf
Disponível em http://efdeortes.com/.,Non-OADS,/arxiv_data1/oa_pdf/32/60/main.PMC4799125.pdf
Disponível em: http://sescam.jccm.es/web/gaptalavera/prof-investigacion/des- viacionesRaquis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f3/40/main.PMC4799136.pdf
Available at: http://www.cartilage.org/_files/ content management/  ICRS_evaluation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/73/main.PMC4799151.pdf
Disponível em: http://www.ispub.com/journal/the_internet_jour-nal_of_surgery/volume_8_number_1/article/ruptured_pseudoaneurysm_of_the_gluteal_artery.html.,Non-OADS,/arxiv_data1/oa_pdf/d3/bd/main.PMC4799181.pdf
Disponívem  em: http://emedicine.medscape.com/article/825363-overview” 6.,Non-OADS,/arxiv_data1/oa_pdf/6c/28/main.PMC4799183.pdf
Available at: http://www.ispub.com/journal/the_internet_jour- nal_of_orthopedic_surgery/volume_9_number_2_6/article 15.,Non-OADS,/arxiv_data1/oa_pdf/71/02/main.PMC4799195.pdf
Available at: http://www.euro.who 8.,Non-OADS,/arxiv_data1/oa_pdf/cf/b2/main.PMC4799206.pdf
Available at: http://www.sel.eesc.sc.usp.br/labciber/alunos_pos/ortolan/arquivos/ p339.PDF 23.,Non-OADS,/arxiv_data1/oa_pdf/0e/a5/main.PMC4799207.pdf
Available at: http://www.sbis.org.br/cbis9/arquivos/553.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/0e/a5/main.PMC4799207.pdf
Avail-  Avail- Avail- able at: http://www.sbis.org.br/cbis/arquivos/972.pdf 25.,Non-OADS,/arxiv_data1/oa_pdf/0e/a5/main.PMC4799207.pdf
Available at: http://bibliotecadigital.sbc.org.br/?module=Pu blic&action=PublicationObject&subject=364&publicationobjectid=144 26.,Non-OADS,/arxiv_data1/oa_pdf/0e/a5/main.PMC4799207.pdf
Available at: http://portal.sbc.org.br/bibliotecadigital/?m odule=Public&action=SearchResult&author=2761COMPUTATIONAL ANALYSIS BASED ON ARTIFICIAL NEURAL NETWORKS FOR AIDING IN DIAGNOSING  OSTEOARTHRITIS OF THE LUMBAR SPINE,Non-OADS,/arxiv_data1/oa_pdf/0e/a5/main.PMC4799207.pdf
Disponível em: http://www.orthosupersite.com/view.aspx?rid=42846  6.,Non-OADS,/arxiv_data1/oa_pdf/4e/7f/main.PMC4799223.pdf
Disponível em: http://www.orthosupersite.com/view.aspx?rid=4284625.,Non-OADS,/arxiv_data1/oa_pdf/4e/7f/main.PMC4799223.pdf
Disponível em: http://www.biomedcentral.com/1471-2474/8/51  4.,Non-OADS,/arxiv_data1/oa_pdf/ad/e5/main.PMC4799277.pdf
Available from: http://www.walt.nu/images/stories/files/dosage-table-904nm.v1.1.pdf (15 mar.,Non-OADS,/arxiv_data1/oa_pdf/ad/e5/main.PMC4799277.pdf
Dispinível em: http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_sta-tistics_for_osteosarcoma_52.asp?sitearea.,Non-OADS,/arxiv_data1/oa_pdf/43/40/main.PMC4799283.pdf
Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/default.htm,Non-OADS,/arxiv_data1/oa_pdf/eb/5c/main.PMC4799300.pdf
Disponível em: http://www.bcbs.com/tec/vol18/18_02.html.,Non-OADS,/arxiv_data1/oa_pdf/02/82/main.PMC4799310.pdf
Disponível em: http://www.medscape.com/viewarticle/410431.,Non-OADS,/arxiv_data1/oa_pdf/88/f3/main.PMC4799317.pdf
Disponível em: http://www.ispub.com/journal/the_internet_journal_of_orthope- dic_surgery/volume_15_number_2_2/article/unusual-segmental-fracture-of-the- clavicle-associated-with-rib-fractures-and-pneumothorax.html 3.,Non-OADS,/arxiv_data1/oa_pdf/78/8a/main.PMC4799335.pdf
Disponível  em: http://www.ispub.com/journal/the_internet_journal_of_orthopedic_surgery/ volume_15_number_2_2/article/unusual-segmental-fracture-of-the-clavicle- associated-with-rib-fractures-and-pneumothorax.html 4.,Non-OADS,/arxiv_data1/oa_pdf/78/8a/main.PMC4799335.pdf
Disponível em: http://www.teses.usp.br/teses/disponiveis/5/5140/tde-28052007-173615/.,Non-OADS,/arxiv_data1/oa_pdf/8d/03/main.PMC4799346.pdf
Dis- ponível em: http://www.tugofwar-twif.org 7.,Non-OADS,/arxiv_data1/oa_pdf/e7/d2/main.PMC4799355.pdf
Disponível em: http://www.criancasegura.org.br.,Non-OADS,/arxiv_data1/oa_pdf/17/12/main.PMC4799381.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
"Prolongs acute inflammation (64 /C167) CR3, complement receptor 3; FMLP , N-formyl-methionyl-leucyl-phenylalanine; LPS, lipopolysaccharide; PPAD, peptidylarginine deiminase; TLR2, toll-like receptor 2; TREM-1, triggering receptor expressed on myeloid cells 1.Ingar Olsen and George Hajishengallis 2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
"gingivalis interactions Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
"Although the phagocyte-derived oxidative burst responseIngar Olsen and George Hajishengallis 4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
"gingivalis interactions Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
")Ingar Olsen and George Hajishengallis 6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/ 10.1111/j.1600-051X.2010.01678.x 3.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1007/s40496-014-0015-x 4.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1177/0022034513507956 6.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1126/scitranslmed.3007696 7.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1189/jlb.3VMR1014-468R 8.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1097/MOH.0000000000000198 9.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1016/j.it.2012.08.003 10.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1177/00220345 12453589 13.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1038/nrmicro2873 14.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1128/JCM.00317-06 16.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1016/j.chom.2011.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1089/dna.2009.0864 19.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
"gingivalis interactions Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1038/nri3785 21.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1038/nri3399 23.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1111/omi.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1128/IAI.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1016/j.chom.2014.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1128/IAI.02000-14 50.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1111/j.1600-0765.2008.01113.x 51.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
"Mol Microbiol 2002; 44: 479 /C188.Ingar Olsen and George Hajishengallis 8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1371/journal.ppat.002007653 53.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/ 10.2330/joralbiosci.53.233 54.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1038/ni.1923 55.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1038/nri2918 58.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/ 10.4049/jimmunol.0900378 60.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1128/IAI.00600-10 68.,Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
doi: http://dx.doi.org/10.1016/j.molmed.2014.11.004 69.,OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
"gingivalis interactions Citation: Journal of Oral Microbiology 2016, 8: 30936 - http://dx.doi.org/10.3402/jom.v8.30936 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/49/eb/JOM-8-30936.PMC4799392.pdf
Disponível em: http://www.isakos.com/assets/newsletter/sum10.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/df/7f/main.PMC4799416.pdf
Disponível em: http://www.aafs.org/jfs-searchable-index.,Non-OADS,/arxiv_data1/oa_pdf/5d/ab/main.PMC4799434.pdf
Available at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprov-alsandClearances/Recently-ApprovedDevices/ucm078189.htm.ELIGIBILITY FOR THE HIP-RESURFACING ARTHROPLASTY PROCEDURE: AN EV ALUATION ON 592 HIPS,Non-OADS,/arxiv_data1/oa_pdf/3f/f8/main.PMC4799436.pdf
Available at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClear-ances/Recently-ApprovedDevices/ucm076954.htm.,Non-OADS,/arxiv_data1/oa_pdf/3f/f8/main.PMC4799436.pdf
Disponível em: http://www.dmac.adelaide.edu.au/aoanjrr/ publications.jsp?section=reports2008.,Non-OADS,/arxiv_data1/oa_pdf/3f/f8/main.PMC4799436.pdf
Disponível em:: URL: http://www.scielo.br/acb.,Non-OADS,/arxiv_data1/oa_pdf/f9/df/main.PMC4799439.pdf
Disponível em: http://hps.org/hpspublications/articles/pregnancyandradia- tionexposureinfosheet.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/fc/main.PMC4799457.pdf
Disponível em: http://www.who.int/subtance_abuse/publications/globalstatusreportalcohol2004_drinkpatterns.pdf.15.,Non-OADS,/arxiv_data1/oa_pdf/b0/7d/main.PMC4799459.pdf
Disponível em: http://www.ibge.gov.br/cidadesat/link.php?uf=sp 26.,Non-OADS,/arxiv_data1/oa_pdf/b0/7d/main.PMC4799459.pdf
Avail-able from: http://www.orthosupersite.com/view.aspx?rid=84493#perspective.,Non-OADS,/arxiv_data1/oa_pdf/ed/84/main.PMC4799462.pdf
"The images were inserted into a graphics program (ImageJ 1.40 – National Institutes of Health, USA, http://rsb.info.nih.gov/ij/) for accurate quantification of each area.",OADS,/arxiv_data1/oa_pdf/fa/e1/main.PMC4799472.pdf
Disponível em: URL: http://www.sbacv-nac.org.br 30.,Non-OADS,/arxiv_data1/oa_pdf/71/da/main.PMC4799480.pdf
Disponível em: http://jbjs.org/data/Journals/JBJS/342/263.,Non-OADS,/arxiv_data1/oa_pdf/b1/80/main.PMC4799488.pdf
Disponível em: http://jbjs.org/data/Journals/JBJS/249/160.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/80/main.PMC4799488.pdf
Disponível em: http://www.shoulders-pecialist.org/pdf/treatment%20of%20the%20painful%20biceps%20tendon.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/80/main.PMC4799488.pdf
Disponível em: http://www.jshoul - derelbow.org/article/S1058-2746(07)00111-5/fulltext.,Non-OADS,/arxiv_data1/oa_pdf/b1/80/main.PMC4799488.pdf
Disponível em: <http://www.mtecbo.gov.br/cbosite/pages/informacoesGerais.jsf>.,Non-OADS,/arxiv_data1/oa_pdf/6e/94/main.PMC4799489.pdf
Available from: https://www.strobe-statement.org/index.,Non-OADS,/arxiv_data1/oa_pdf/a9/b1/JFDS-8-2.PMC4799514.pdf
Available  from: http://www.forensicdentistryonline.org/Fornsic_pages_1/ ident_guidelines.htm.,OADS,/arxiv_data1/oa_pdf/80/fa/JFDS-8-52.PMC4799520.pdf
Available from: http://www.securecare.com/resources/ active-rfid-vs-gps-alzheimers-tracking.,Non-OADS,/arxiv_data1/oa_pdf/80/fa/JFDS-8-52.PMC4799520.pdf
"Disaster Victim Identification Guide  (1997) http://www.interpol.int/Public/Disaster  Victim/guide/default.asp 5.Preethi  S, Einstein  A , Sivapathasundharam  B .",Non-OADS,/arxiv_data1/oa_pdf/53/85/JFDS-8-56a.PMC4799521.pdf
Available from: http://www.amber-net.org/.,Non-OADS,/arxiv_data1/oa_pdf/eb/f6/JFDS-8-7.PMC4799525.pdf
Available from:  http://www.mypreciouskid.com/toothprints.html.,Non-OADS,/arxiv_data1/oa_pdf/eb/f6/JFDS-8-7.PMC4799525.pdf
Available from: http://www.caninesforkids.,Non-OADS,/arxiv_data1/oa_pdf/eb/f6/JFDS-8-7.PMC4799525.pdf
Available from: http://www.mychip.org.,Non-OADS,/arxiv_data1/oa_pdf/eb/f6/JFDS-8-7.PMC4799525.pdf
"Genotyping Both exposed group and control group were evaluated for  53 single nucleotide polymorphisms (SNPs); reference  SNP numbers (rs number), a specific number listed for  each SNP, were searched and confirmed using PubMed  (http://www.ncbi.nlm.nih.gov/snp).",OADS,/arxiv_data1/oa_pdf/f3/b1/CMJ-129-174.PMC4799544.pdf
"Then, we used Chinese  Beijing (CHB) SNP genotype data downloaded from  HapMap database (http://www.hapmap.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/f3/b1/CMJ-129-174.PMC4799544.pdf
"Thus, we considered these genes and screened the  tag SNPs of these genes using the program Haploview  (http://www.broad.mit.edu/mpg/haploview/).",OADS,/arxiv_data1/oa_pdf/f3/b1/CMJ-129-174.PMC4799544.pdf
"Chinese Medical Journal ¦ January 20, 2016 ¦ V olume 129 ¦ Issue 2 176(http://analysis.bio‑x.cn/SHEsisMain.htm, Bio‑X Research  Institute, Shanghai Jiao Tong University, Shanghai, China),  which implemented an expectation maximization algorithm.",Non-OADS,/arxiv_data1/oa_pdf/f3/b1/CMJ-129-174.PMC4799544.pdf
doi:  http://dx.doi.org/10.1053/gast.1997.v112.pm9041264.,OADS,/arxiv_data1/oa_pdf/f3/b1/CMJ-129-174.PMC4799544.pdf
Available from:  http://crstodayeurope.com/pdfs/CRSTE_0311_feature_werner.pdf  [Last accessed on 2015 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/56/f3/CMJ-129-206.PMC4799549.pdf
"[27,28] 010020030040050060070080090010001100 1990 1991 1992 19931994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Figure 1:  The number of publications (y-axis) using “carotid  intima-media thickness (not animal)” in the title or abstract as assessed  using PubMed database (http://www.ncbi.nlm.nih.gov/sites/entrez), by  year of publication (x-axis), (December 16, 2014).",OADS,/arxiv_data1/oa_pdf/20/fc/CMJ-129-215.PMC4799550.pdf
Available  from: http://www.who.int/whr/en/.,OADS,/arxiv_data1/oa_pdf/20/fc/CMJ-129-215.PMC4799550.pdf
Available from: http://www.afro.,Non-OADS,/arxiv_data1/oa_pdf/02/ed/CMJ-129-237.PMC4799553.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/02/ed/CMJ-129-237.PMC4799553.pdf
We looked into the variants in two lists of  pathogenic variants from MitoMap (http://www.mitomap.,Non-OADS,/arxiv_data1/oa_pdf/c9/7e/CMJ-129-259.PMC4799567.pdf
org/) and mtDB (http://www.genpat.uu.se/mtDB/).,OADS,/arxiv_data1/oa_pdf/c9/7e/CMJ-129-259.PMC4799567.pdf
"Trial Registration:  ClinicalTrials.gov, NCT01751555; https://clinicaltrials.gov/ct2/show/NCT01751555.",Non-OADS,/arxiv_data1/oa_pdf/6d/0c/CMJ-129-304.PMC4799574.pdf
Available from: http://www.cms.gov/ Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ NationalHealthExpendData/NationalHealthAccountsHistorical.html.,OADS,/arxiv_data1/oa_pdf/37/65/SJA-10-127.PMC4799601.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/37/65/SJA-10-127.PMC4799601.pdf
Available from: http://www.pafmj.org/showdetails.php?id=271&t=o 11.,Non-OADS,/arxiv_data1/oa_pdf/b8/16/SJA-10-138.PMC4799603.pdf
Available from: http://www.aagbi.org/sites/default/ files/epidural_analgesia_2011.pdf.,OADS,/arxiv_data1/oa_pdf/85/30/SJA-10-149.PMC4799605.pdf
Available from: http://www.rcoa.ac.uk/index.,Non-OADS,/arxiv_data1/oa_pdf/85/30/SJA-10-149.PMC4799605.pdf
Available from: http://www.dx.doi.org/10.4172/2155- 6148.1000231.,Non-OADS,/arxiv_data1/oa_pdf/c2/4e/SJA-10-154.PMC4799606.pdf
Available  from: https://www.ispub.com/IJA/21/1/9826.,Non-OADS,/arxiv_data1/oa_pdf/30/4d/SJA-10-187.PMC4799612.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/30/4d/SJA-10-187.PMC4799612.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/30/4d/SJA-10-187.PMC4799612.pdf
"airwayelearning.com website, through the following URL:  http://www.airwayelearning.com/awel/articles/articles-1.aspx?Action=1&NewsId=2298&PID=71655.",Non-OADS,/arxiv_data1/oa_pdf/27/e4/SJA-10-218.PMC4799618.pdf
Available from: http://www.unaids.org/en/media/unaids/ contentassets/documents/epidemiology/2013/gr2013/UNAIDS_ Global_Report_2013_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/IJCM-41-126.PMC4799635.pdf
Available from: http://nascp.gov.ng/demo/wp-content/ uploads/2014/02/NARHS-Plus-2012-Final-18112013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/IJCM-41-126.PMC4799635.pdf
Available from:  http://www.utwente.nl/cw/theorieenoverzicht/Theory%20 Clusters/Health%20Communication/Health_Belief_Model/.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/IJCM-41-126.PMC4799635.pdf
Available from: http://deepblue.lib.umich.edu/bitstream/,OADS,/arxiv_data1/oa_pdf/85/7c/IJCM-41-126.PMC4799635.pdf
Available from: http://apps.who.int/ iris/handle/10665/40062.,OADS,/arxiv_data1/oa_pdf/85/7c/IJCM-41-126.PMC4799635.pdf
Available from: http://www.unaids.org/sites/ default/files/en/media/unaids/contentassets/documents/ factsheet/2012/20120417_FS_adolescentsyoungpeoplehiv_ en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/7c/IJCM-41-126.PMC4799635.pdf
Available from:  http://recapp.etr.org/recapp/index.cfm?fuseaction=pages.theorie sdetail&PageID=13#definition.,OADS,/arxiv_data1/oa_pdf/85/7c/IJCM-41-126.PMC4799635.pdf
Available from: http://www.who.int/injection_safety/toolbox/en/ AM_HCW_Safety_EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/ce/IJCM-41-141.PMC4799637.pdf
Available from: http://www.naco.gov.in/upload/ Publication/Basic%20Services/Training%20modules%20on%20 HIV%20care%20and%20treatment/Training%20Module%20 for%20Medical%20Officers%20on%20HIV%20Care%20 and%20Treatment/Training%20Module%20for%20Medical%20 Officers%20on%20HIV%20Care%20and%20Treatment.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ee/ce/IJCM-41-141.PMC4799637.pdf
Available from:  http://www.ncsf.org/enew/articles/articles-CaffeineConsum ptionChildrenAdolescents.aspx#.,Non-OADS,/arxiv_data1/oa_pdf/5f/0e/IJCM-41-151.PMC4799639.pdf
Available from: http://www.ars.usda.gov/ba/bhnrc/ndl#.,Non-OADS,/arxiv_data1/oa_pdf/5f/0e/IJCM-41-151.PMC4799639.pdf
Available from: http://www.cseindia.org/userfiles/PMLreport_Caffeine_Content_in_Energy_ Drinks.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/0e/IJCM-41-151.PMC4799639.pdf
Available from: http://www.coca-cola.,Non-OADS,/arxiv_data1/oa_pdf/5f/0e/IJCM-41-151.PMC4799639.pdf
Available from: http://www.cdc.gov/nchs/ nhanes/nhanes2009–2010/DR1TOT_F .html.,OADS,/arxiv_data1/oa_pdf/5f/0e/IJCM-41-151.PMC4799639.pdf
Available  from: http://www.ars.usda.gov/ba/bhnrc/ndl.,Non-OADS,/arxiv_data1/oa_pdf/5f/0e/IJCM-41-151.PMC4799639.pdf
Available from: http://www.ico.org/news/icc-112-4e- consumption-asia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/0e/IJCM-41-151.PMC4799639.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/IJCM-41-154.PMC4799640.pdf
Available from: http://www.rchiips.org/nfhs/ nutrition_report_for_website_18sep09.Pdf.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/IJCM-41-154.PMC4799640.pdf
Available from: http://www.nfhsindia.org/NFHS.../ NFHS-3%20 Nutrional%20Status%20of%20Adultsppt.,Non-OADS,/arxiv_data1/oa_pdf/4b/75/IJCM-41-154.PMC4799640.pdf
Available  from: http://www.tripuranrhm.gov.in/Guidlines/WIFS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/57/IJCM-41-158.PMC4799641.pdf
Available from: http://www.sihfwrajasthan.com/ ppts/full/WIFS.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/57/IJCM-41-158.PMC4799641.pdf
Available  from: http://www.pib.nic.in/newsite/erelease.aspx?relid=82516.,Non-OADS,/arxiv_data1/oa_pdf/7c/57/IJCM-41-158.PMC4799641.pdf
Available  from: http://health.bih.nic.in/Docs/Guidelines/Guidelines- NPCDCS.pdf [Last cited on 2014 Feb 14].,Non-OADS,/arxiv_data1/oa_pdf/9a/0d/IJCM-41-162.PMC4799642.pdf
Available from: http://www.idf.org/ atlasmap/atlasmap [Last cited on 2014 Feb 14].,OADS,/arxiv_data1/oa_pdf/9a/0d/IJCM-41-162.PMC4799642.pdf
Available  from: http://www.who.int/immunization/newsroom/press/ immunization_coverage_july_2015/en/.,Non-OADS,/arxiv_data1/oa_pdf/67/a9/IJCM-41-89.PMC4799646.pdf
Available from:  http://data.worldbank.org/indicator/SH.DYN.MORT.,OADS,/arxiv_data1/oa_pdf/67/a9/IJCM-41-89.PMC4799646.pdf
Available  from: http://data.worldbank.org/indicator/SP .DYN.IMRT.IN).,OADS,/arxiv_data1/oa_pdf/67/a9/IJCM-41-89.PMC4799646.pdf
Available from: http://health.bih.nic.in/docs/ guidelines-npcdcs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/37/IJCM-41-98.PMC4799648.pdf
Available from:  http://www.whoindia.org/linkfiles/ncd_surveillance_ncd_rf_ surveillance_report.pdf.,OADS,/arxiv_data1/oa_pdf/ac/37/IJCM-41-98.PMC4799648.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/c7/jiv557.PMC4799663.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/6a/jiv586.PMC4799667.pdf
"This is anOpen Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distributionof the work, in any medium, provided the original work isnot altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/48/jiw037.PMC4799673.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.OMICS A Journal of Integrative Biology Volume 20, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/omi.2015.0185 127",Non-OADS,/arxiv_data1/oa_pdf/52/c6/omi.2015.0185.PMC4799697.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribut ion, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF NEUROTRAUMA 33:439–459 (March 1, 2016) Mary Ann Liebert, Inc.DOI: 10.1089/neu.2015.3956 439",Non-OADS,/arxiv_data1/oa_pdf/9a/1f/neu.2015.3956.PMC4799702.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.OMICS A Journal of Integrative Biology Volume 20, Number 3, 2016Mary Ann Liebert, Inc.DOI: 10.1089/omi.2015.0168 139",Non-OADS,/arxiv_data1/oa_pdf/86/cc/omi.2015.0168.PMC4799705.pdf
"IPA has a powerful, manually curated database with deﬁned ontology classes that incorporate evidence from articles to generate a com-plex network that carries various types of annotations.DAVID has many sources of functional annotations that have not been updated recently (last update was on 2009, https://david.ncifcrf.gov/content.jsp?ﬁle = update.html).",OADS,/arxiv_data1/oa_pdf/86/cc/omi.2015.0168.PMC4799705.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ZEBRAFISH Volume 13, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/zeb.2016.1239 142",Non-OADS,/arxiv_data1/oa_pdf/d8/2c/zeb.2016.1239.PMC4799706.pdf
"Available at: https://www.rmf.harvard.edu/~/media/Files/ _Global/KC/PDFs/ed_white_paper_min_diagnosis_errors.pdf  [Accessed Jun 4, 2014] 4.",Non-OADS,/arxiv_data1/oa_pdf/c1/ba/nihms766283.PMC4799785.pdf
"Available from http://www.page-number.org/pdf_assets/ 7555-PAGE%20Tanezumab%20poster%_2009 15 Ekman EF, Gimbel JS, Bello AE, Smith MD, Keller DS, Annis KM, Brown MT, West CR, Verburg KM.",Non-OADS,/arxiv_data1/oa_pdf/b3/dc/BCP-81-688.PMC4799925.pdf
"Available fromhttp://www.ema.europa.eu/docs/en_GB/ document_library/Scienti ﬁc_guideline/2009/09/ WC500003067.pdf 18L i n d b o mL ,P i h l g r e nP ,J o n s s o nE N .P s N - T o o l k i t –a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.",Non-OADS,/arxiv_data1/oa_pdf/b3/dc/BCP-81-688.PMC4799925.pdf
Available from http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ ArthritisDrugsAdvisory Committee/UCM295205.pdf E. N. Jonsson et al.,OADS,/arxiv_data1/oa_pdf/b3/dc/BCP-81-688.PMC4799925.pdf
"The corresponding drugs were selected in a step-wise approach, which included review of drugs listed in the draft guidance of the US Food and DrugAdministration (FDA) for drug interaction studies [12], drugs listed at http://medicine.iupui.edu/clinpharm/ DDIs/table.asp (as included on 9 December 2009) andselection of additional drugs from published reports.",Non-OADS,/arxiv_data1/oa_pdf/fc/1b/BCP-81-724.PMC4799939.pdf
"Competing Interests All authors have completed the Uni ﬁed Competing Inter- est form at http://www.icmj e.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: RK, SH, GH, MRL, LGM, AS and AGGT had editorial support from Yong-Ling Liu for the submittedwork; GH and AS have been employees of Bayer HealthCare Pharmaceuticals in the previous 3 years; no other relationships or activities that could appear to haveinﬂuenced the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/fc/1b/BCP-81-724.PMC4799939.pdf
Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatory Information/Guidances/UCM292362.pdf (last accessed 15 June 2015).,Non-OADS,/arxiv_data1/oa_pdf/fc/1b/BCP-81-724.PMC4799939.pdf
"Global Health Observatory (GHO) d ata HIV/AIDS 2015 http://www.who.int/gho/hiv/en/   (accessed on January 9, 2016).",Non-OADS,/arxiv_data1/oa_pdf/99/d4/pharmpract-14-631.PMC4800010.pdf
"Available at: http://www.cdc.gov/hiv/basics/transmission.html  (accessed on  February 26, 2015).",Non-OADS,/arxiv_data1/oa_pdf/99/d4/pharmpract-14-631.PMC4800010.pdf
"Available from:  http://hivinsite.ucsf.edu/InSi te?page=kb-00&doc=kb-03-02-09  (accessed Jan 12, 2016).",OADS,/arxiv_data1/oa_pdf/99/d4/pharmpract-14-631.PMC4800010.pdf
"Pharmac ists: Partners in Health Care for HIV-Infected Patients  2006 http://www.hivguidelines.org/clin ical-guidelines/hiv-and-pharma cy/pharmacists-partners- in-health-care-for-hiv- infected-patients/  (accessed January 5, 2016).",Non-OADS,/arxiv_data1/oa_pdf/99/d4/pharmpract-14-631.PMC4800010.pdf
"World Bank GDP per capita 2014. http://www.data.worldbank.org/indicator/NY.GPD.PCAP.CD  (accessed  September 6, 2014).",OADS,/arxiv_data1/oa_pdf/99/d4/pharmpract-14-631.PMC4800010.pdf
"https://www.nice.org.uk/Guidance/CG76   (accesed October 21,  2015).",Non-OADS,/arxiv_data1/oa_pdf/f6/98/pharmpract-14-639.PMC4800011.pdf
"Sabaté E eGWH, Organization;  2003. http://www.who.int/chp/knowledg e/publications/adherence_introdu ction.pdf    (accessed May 1, 2015).",Non-OADS,/arxiv_data1/oa_pdf/f6/98/pharmpract-14-639.PMC4800011.pdf
2013; Available from:  http://www.infarmed.pt/infomed/ download_ficheiro.php?med_id=340 63&tipo_doc=rcm  (accessed on 1-Jul-2015).,OADS,/arxiv_data1/oa_pdf/57/08/pharmpract-14-648.PMC4800012.pdf
"Questionnaire  To identify the learning styles, the Honey-Alonso  Learning Styles Questionnaire (Cuestionario de  Honey y Alonso de Estilos de Aprendizaje [CHAEA]  http://www.estilosdeaprendizaje.es/) was applied.3  The questionnaire comprises 80 brief and  dichotomous items structured into four groups of 20  items, each item corresponding to the four learning  styles: activist, reflector, theorist, and pragmatist.",Non-OADS,/arxiv_data1/oa_pdf/9d/ed/pharmpract-14-650.PMC4800013.pdf
Available in:  http://www4.ncsu.edu/unity/lockers/users/f/felder/public/Papers /LS_Validity(On-Course).pdf  (accessed 1 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/9d/ed/pharmpract-14-650.PMC4800013.pdf
Avai lable in: http://www.facultyfocus.com/articles/learning- styles/whats-story-learning-styles/  (accessed 1 Jul 2016),Non-OADS,/arxiv_data1/oa_pdf/9d/ed/pharmpract-14-650.PMC4800013.pdf
Availa ble in: http://www.lline.fi/en/article/research/342013/learning- styles-time-to-move-on#title4  (accessed 1 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/9d/ed/pharmpract-14-650.PMC4800013.pdf
"Available from:  http://www.audit-commission.gov.u k/nationalstudies/health/other /Pages/aspoonfulofsugar.aspx  (accessed March 1,  2015).",OADS,/arxiv_data1/oa_pdf/f1/1c/pharmpract-14-656.PMC4800014.pdf
"Available at: https://www.acpe- accredit.org/pdf/CPE_Standards_Final.pdf  (accessed April 1, 2015).",Non-OADS,/arxiv_data1/oa_pdf/90/ff/pharmpract-14-676.PMC4800015.pdf
"Available at: https://www.acpe- accredit.org/pdf/Standards2016FINAL.pdf  (accessed Jan 14, 2016).",Non-OADS,/arxiv_data1/oa_pdf/90/ff/pharmpract-14-676.PMC4800015.pdf
"http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Researc h/Salt-Selection-in-Drug- Development/ArticleStandard/Article/detail/500407  (accessed May 31, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/f6/pharmpract-14-677.PMC4800016.pdf
"https://www.ismp.org/tools/guide lines/labelFormats/comments/def ault.asp  (accessed March 19, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/f6/pharmpract-14-677.PMC4800016.pdf
"http://www.state.ia.us/ibpe/rules_laws/  (accessed March 30, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/f6/pharmpract-14-677.PMC4800016.pdf
"http://www.pharmacy.ca.gov/laws_regs/  (accessed March  30, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/f6/pharmpract-14-677.PMC4800016.pdf
"http://www.op.nysed.gov/prof/pharm/pharmlaw.htm  (accessed March 30, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/f6/pharmpract-14-677.PMC4800016.pdf
"http://www.rld.state.nm.us/boards/Pharmacy_Rules_and_Laws.aspx  (accessed March 30, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/f6/pharmpract-14-677.PMC4800016.pdf
"https://www.dhp.virginia.gov/pharmacy  /pharmacy_laws_regs.htm  (accessed March 30, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e1/f6/pharmpract-14-677.PMC4800016.pdf
"Pharmacy Practice 2016 Jan-Mar;14(1):708. doi: 10.18549/PharmPr act.2016.01.708  www.pharmacypractice.org (ISSN: 1886-3655)  6to enrollment for members of subgroups and to  implement programs to encourage enrollment; and  3) transparency – to make data by demographic  subgroup more available.34 One program recently  launched to improve transparency is Drug Trial  Snapshots, available at  http://www.fda.gov/Drugs /InformationOnDrugs/ucm 412998.htm .",Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
"Selected resources fo r clinicians, academicians, and r esearchers   Sex-based Biology   Web-based Training Courses: The  science of sex and gender in h uman health (joint project with the NIH Office of Research on  Women’s Health)  Available at https://sexandgendercourse.od.nih.gov/     IOM.",Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at  http://www.nap.edu/catalog/10028/exploring-the-biological-contr ibutions-to-human-heal th-does-sex-matter    IOM.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at  http://iom.nationalacademies.or g/Reports/2010/Womens-Health-Res earch-Progress-Pitfalls-and-Promise.aspx     Curricula Guides   “Beyond women’s health: incorporating sex and gender differenc es into graduate public health  curricula”.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at:  http://www.aspph.org/wp-content/uploads/2014/06/Womens-Health-F INAL.pdf    Women’s health curricula: final r eport on expert panel recomme ndations for interprofessional col laboration across the health  professions.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at: http://www.aacn.nche.edu/education- resources/HRSA-Womens-Health -Curricula-Report.pdf    Women’s health curriculum and to olbox jointly developed by Ame rican Association of Colleges of Pharmacy and FDA OWH.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at http://www.aacp.org/RESOURCES/EDUCATION/WHC/Pages/default.aspx   Women’s Health Resources   Women’s health resources web portal.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at: http://orwh.od.nih.gov     FDA OWH.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at: http://www.fda.gov/ForConsumers/ByAudience/ForWomen/default.htm    U.S. Department of Health and Hum an Services OWH.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
"Available at  http://www.womenshealth.gov/index.php    Clinical Trial Materials   NIH Outreach notebook for the in clusion, recruitment and reten tion of women and minority subjec ts in clinical research.",Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
"Avail able  at http://orwh.od.nih.gov/research/inclusion/pdf/Outreach-Notebook -021315.pdf      NIH outreach toolkit: how to engage, recruit, and retain women  in clinical research.",Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at http://orwh.od.nih.gov/toolkit/       FDA Women in Clinical Trials.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at http://www.fda.gov/ForConsumers/ByAudience/ForWomen/ucm118508.h tm    The Society for Women’s Health Research and FDA OWH.,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
"Available at:   http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/Wome nsHealthResearch/UCM334959.pdf    National Institute on Drug Abuse Treatment Clinical Trials Net work: Successfully including women in clinical trials, a guide for  researchers.",Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at https://www.drugabuse.gov/sites/default/files/womens-brochure_1 025-004_508.pdf    FDA= Food and Drug Administrati on;  IOM:  Institute of Medicine ; NIH= National Institutes of Health; OWH=  Office of Women’s H ealth,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at https://www.drugabuse.gov/sites/ default/files/womens-brochure_1 025-004_508.pdf   (accessed 2015 Dec 6).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at  http://www.cdc.gov/std/health-d isparities/stds-women-042011.pdf  (accessed 2015 Nov 28).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at:  http://www.cbsnews.com/news/sex-matters-drugs-can-affect-sexes- differently/  (accessed 2015 Dec 6).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at:  http://www.healthypeople.gov/2020/about/foundation-health-measu res/Disparities  (accessed 2015 Dec 6).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at  http://www.fda.gov/scienceresear ch/specialtopics/womenshealthre search/ucm472932.htm  (accessed 2015 Oct 24).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Avail able at  http://www.fda.gov/AboutFDA/CentersOffices/OC/OfficeofWomensHea lth/default.htm  (accessed 2015 Oct 24).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available  at  http://orwh.od.nih.gov/research/i nclusion/pdf/Inclusion-Compreh ensiveReport-FY-2009-2010.pdf  (accessed 2015 Oct  24).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Agenda for Research on Women’s Health for the 21st Century Volume 5: A Report of the Task Force on the NIH  Women’s Health Research Agenda for the 21st Century Available a t http://www.britecenter.org/wp- content/uploads/2013/02/Psychologica l-Differences-Between-Men-a nd-Women-Implications-for-a-Research-Agenda- on-Womens-Physical-and-Mental-Health.pdf  (accessed 2015 Oct 24).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at  http://www.fda.gov/downloads/RegulatoryInformation/Legislation/ SignificantAmendmentstotheFDCAct/FDASIA/UCM365 544.pdf  (accessed 2015 Oct 24).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Brigham and Women’s Hospital: 2014 Available at:  http://www.brighamandwomens.org/Departments_and_Services/womens health/ConnorsCenter/Policy/ConnorsReportFI NAL.pdf  (accessed 2015 Nov 28).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available  at  http://www.fda.gov/Drugs/InformationOnDrugs/ucm412998.htm  (accessed 2015 Nov 28).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at  http://blogs.fda.gov/fdavoice/i ndex.php/2015/02/recent-progress -on-demographic-information-and-clinical- trials/?source=govdelivery&utm_ medium=email&utm_source=govdeliv ery (accessed 2015 Oct 24).,OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
"Bethesda (MD): National  Institutes of Health, 2002 Available at: http://orwh.od.nih.gov/research/in clusion/pdf/Outreach-Notebook -021315.pdf    (accessed 2015 Nov 28).",Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Avai lable at: http://orwh.od.nih.gov/research/pdf/ACRWH- Biennial-Report2011-2012-S ection508Complete.pdf  (accessed 2015 Nov 28).,Non-OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Selected Findings From  the 2010 National Healthcare Quality and Disparities Reports Av ailable at  http://archive.ahrq.gov/research /findings/nhqrdr/nhqrdr10/women .pdf (accessed 2015 Nov 28).,OADS,/arxiv_data1/oa_pdf/18/d5/pharmpract-14-708.PMC4800017.pdf
Available at:  http://www.ginasthma.org  (accessed 1 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/37/pharmpract-14-713.PMC4800018.pdf
Available at: http://www.nhlbi.nih.gov/guide lines/asthma/02_sec1_intro.pdf  (accessed 1 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/37/pharmpract-14-713.PMC4800018.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2015.11.015,Non-OADS,/arxiv_data1/oa_pdf/49/a7/main.PMC4800055.pdf
http://dx.doi.org/10.1111/ans.13152 .,Non-OADS,/arxiv_data1/oa_pdf/49/a7/main.PMC4800055.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2015.11.007,OADS,/arxiv_data1/oa_pdf/f3/d5/main.PMC4800056.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2016.01.003,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
"CA Cancer J Clin 64(1), 9 –29 http://dx.doi.org/10.3322/caac.21208.",Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
"Transl Lung Cancer Res 4(1), 36 –54 http://dx.doi.org/10.3978/j.issn.2218-6751.2014.05.01.",Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
"N Engl J Med 372(21), 2018 –2028 http://dx.doi.org/10.1056/NEJMoa1501824.",Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1016/S1470-2045(09)70155-X .,OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
"Int Immunol 27(1), 39 –46.http://dx.doi.org/10.1093/intimm/dxu095 .",OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.2217/imt.14.82 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1517/14728214.2014.964682 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1007/s10549-013-2581-3 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.2147/OTT.S59959 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1097/JTO.0000000000000414 .,OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1093/annonc/mdu445 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1007/s12032-010-9515-2 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
"Tumori 98(6), 751 –755.http://dx.doi.org/10.1700/1217.13499 .",Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1038/labinvest.2013.130 .,OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1016/j.ejca.2014.01.018 .,OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1097/MD.0000000000000515 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.03.02 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1016/- j.ejso.2015.01.020 [Epub Jan 31].,OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
http://dx.doi.org/10.1038/bjc.2014.555 .,Non-OADS,/arxiv_data1/oa_pdf/3b/db/main.PMC4800057.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2015.11.005,OADS,/arxiv_data1/oa_pdf/95/76/main.PMC4800058.pdf
(D) DEK gene was bioinformatically predicted as target of miR-200a using online software ( http://www.microrna.org/ ).,OADS,/arxiv_data1/oa_pdf/95/76/main.PMC4800058.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/d9/main.PMC4800059.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.01.002,OADS,/arxiv_data1/oa_pdf/0d/d9/main.PMC4800059.pdf
"Examples of relevant radiation factors and their concisedescription for publication are givenin the appendix of [41,42] http://dx.doi.org/10.6028/jres.118.021.Setup used for the study Setup, shielding and shielding efficacy Use of restraint and/or anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/0d/d9/main.PMC4800059.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/90/01/main.PMC4800060.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2015.11.016,OADS,/arxiv_data1/oa_pdf/90/01/main.PMC4800060.pdf
"The other seven patients (seven primary tumors) were enrolled in the NACT ISPY-2trial ( http://ispy2.org ), where patients were randomized to receive standard of care regimen or standard of care regimen plus experimental drugs.",Non-OADS,/arxiv_data1/oa_pdf/90/01/main.PMC4800060.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2015.12.005,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1053/joca.1998.0128 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1080/14653240902923153 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
"J Genet Syndr Gene Ther S3, 008. http://dx.doi.org/10.4172/2157-7412.S3-008 .",OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1002/dvdy.10359 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1016/j.ydbio.2010.06.023 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1006/mvre.2001.2376 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/ 10.1111/j.1469-7580.2005.00480.x .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4538-08.2009 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1002/jnr.10523 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1111/j.1755-148X.2011.00929.x .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1371/journal.pbio.1001993 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1006/excr.1995.1371 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1002/(SICI)1097-4547(19960201)43:3 b315:: AID-JNR6 N3.0.CO;2-M .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1074/jbc.M210010200 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1074/jbc.M706074200 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
"Nat Rev Neurosci 10(1), 9–22.http://dx.doi.org/10.1038/nrn2495 .",Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1002/glia.22859 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
Brain Res.http://dx.doi.org/10.1016/j.brainres.2015.06.009 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1226-07.2007 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1083/jcb.200210110 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1242/dev.047951 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1016/j.canlet.2015.05.026 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1016/j.ccr.2011.08.011 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/ 10.1016/S0002-9440(10)61750-6 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1006/excr.1997.3674 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1016/j.ajpath.2011.11.006 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.08.026 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
"Angiogenesis 17(1), 61 –76.http://dx.doi.org/10.1007/s10456-013-9378-1 .",Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-04-0517 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.2147/IJN.S63472 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1093/jnci/djq343 .,OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1196/annals.1322.040 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-10-1134 .,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
http://dx.doi.org/10.1371/journal.pone.0084883 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/98/5c/main.PMC4800061.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2015.11.010,OADS,/arxiv_data1/oa_pdf/b9/58/main.PMC4800062.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/da/main.PMC4800063.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.01.004,OADS,/arxiv_data1/oa_pdf/27/da/main.PMC4800063.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/cc/main.PMC4800064.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2015.11.011,OADS,/arxiv_data1/oa_pdf/d4/cc/main.PMC4800064.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/85/main.PMC4800065.pdf
1936-5233/16 http://dx.doi.org/10.1016/j.tranon.2015.12.001,Non-OADS,/arxiv_data1/oa_pdf/37/85/main.PMC4800065.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/49/bmjdrc-2015-000188.PMC4800068.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010245).,Non-OADS,/arxiv_data1/oa_pdf/3e/5a/bmjopen-2015-010245.PMC4800110.pdf
http://www.diabetes.org/diabetes-basics/statistics/ 2.,Non-OADS,/arxiv_data1/oa_pdf/3e/5a/bmjopen-2015-010245.PMC4800110.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010244).,Non-OADS,/arxiv_data1/oa_pdf/dc/31/bmjopen-2015-010244.PMC4800111.pdf
"John Wiley & Sons, Ltd, 2012. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006586.pub4/abstract.",Non-OADS,/arxiv_data1/oa_pdf/dc/31/bmjopen-2015-010244.PMC4800111.pdf
2007. https://www.rcog.org.uk/globalassets/documents/guidelines/gt48managementpremensturalsyndrome.pdf (accessed 12 Mar 2014).,OADS,/arxiv_data1/oa_pdf/dc/31/bmjopen-2015-010244.PMC4800111.pdf
2015. http://www.studd.co.uk/pms_transdermal.php (accessed 8 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/dc/31/bmjopen-2015-010244.PMC4800111.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010201).,Non-OADS,/arxiv_data1/oa_pdf/0c/b6/bmjopen-2015-010201.PMC4800112.pdf
"One such randomised trial is underway testing the utility ofrapid access testing of BNP in the ambulance trying to shorten the time to therapy and potentially clinical out- comes (NCT01634425, http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/0c/b6/bmjopen-2015-010201.PMC4800112.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010488).,Non-OADS,/arxiv_data1/oa_pdf/fa/81/bmjopen-2015-010488.PMC4800113.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009629).,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-009629.PMC4800114.pdf
"The analysis report of syphilis and gonorrhea epidemic in China, 2012. http://www.ncstdc.org/(accessed 8 Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-009629.PMC4800114.pdf
http://www.gov.cn/gongbao/content/2004/content_62975 (accessed8 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-009629.PMC4800114.pdf
http://www.nhfpc.gov.cn/mohzcfgs/pgz/ 200901/38689 (accessed 8 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-009629.PMC4800114.pdf
http://www.gov.cn/banshi/ 2005-08/02/content_19262.html (accessed 27 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-009629.PMC4800114.pdf
http://www.nhfpc.gov.cn/zwgkzt/s9491/201212/34114 (accessed 8 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/ef/d6/bmjopen-2015-009629.PMC4800114.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010137).,Non-OADS,/arxiv_data1/oa_pdf/7f/a4/bmjopen-2015-010137.PMC4800117.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010763).,Non-OADS,/arxiv_data1/oa_pdf/50/68/bmjopen-2015-010763.PMC4800118.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/50/68/bmjopen-2015-010763.PMC4800118.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010673).,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/bmjopen-2015-010673.PMC4800119.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/bmjopen-2015-010673.PMC4800119.pdf
http://www.escardio.,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/bmjopen-2015-010673.PMC4800119.pdf
http://www.fda.gov/ ForConsumers/ConsumerUpdates/ucm372915.htm (accessed Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/bmjopen-2015-010673.PMC4800119.pdf
https://ec.europa.eu/ jrc/en/publication/eur-scientific-and-technical-research-reports/trans-fatty-acids-europe-where-do-we-stand (accessed Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/bmjopen-2015-010673.PMC4800119.pdf
23. https://matsne.gov.ge/ka/document/view/3071941 (accessed Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/bmjopen-2015-010673.PMC4800119.pdf
http://ec.europa.eu/dgs/health_ food-safety/dyna/enews/enews.cfm?al_id=1650 (accessed Feb2016).,Non-OADS,/arxiv_data1/oa_pdf/e1/0a/bmjopen-2015-010673.PMC4800119.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010150).,Non-OADS,/arxiv_data1/oa_pdf/73/a2/bmjopen-2015-010150.PMC4800120.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009781).,Non-OADS,/arxiv_data1/oa_pdf/02/56/bmjopen-2015-009781.PMC4800122.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4b/e5/bmjopen-2015-009957.PMC4800123.pdf
"WONCA Europe, 2011. http://www.unige.ch/medecine/umpr/Enseignement/stage3ememaster/Definition_wonca_tree.pdf (accessed 18 Mar 2014).",Non-OADS,/arxiv_data1/oa_pdf/4b/e5/bmjopen-2015-009957.PMC4800123.pdf
http://www.kith.no/upload/ 2705/icpc-2-english.pdf (accessed: 22 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/4b/e5/bmjopen-2015-009957.PMC4800123.pdf
"March, 2011. http://handbook.cochrane.org/ 15.",OADS,/arxiv_data1/oa_pdf/4b/e5/bmjopen-2015-009957.PMC4800123.pdf
2014. https://www.framinghamheartstudy.,Non-OADS,/arxiv_data1/oa_pdf/4b/e5/bmjopen-2015-009957.PMC4800123.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010186).,Non-OADS,/arxiv_data1/oa_pdf/dc/40/bmjopen-2015-010186.PMC4800124.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009991).,Non-OADS,/arxiv_data1/oa_pdf/c5/1e/bmjopen-2015-009991.PMC4800125.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/1e/bmjopen-2015-009991.PMC4800125.pdf
"2015, Population Reference Bureau.http://www.prb.org/pdf15/poppov-reprohealth-econ-eastafrica-brief.pdf 9.",Non-OADS,/arxiv_data1/oa_pdf/c5/1e/bmjopen-2015-009991.PMC4800125.pdf
http://www.prb.org/Publications/Datasheets/2012/world-population-data-sheet/fact-sheet-unmet-need.aspx 10.,Non-OADS,/arxiv_data1/oa_pdf/c5/1e/bmjopen-2015-009991.PMC4800125.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010072).,Non-OADS,/arxiv_data1/oa_pdf/d0/a2/bmjopen-2015-010072.PMC4800126.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/a2/bmjopen-2015-010072.PMC4800126.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010250).,Non-OADS,/arxiv_data1/oa_pdf/ed/47/bmjopen-2015-010250.PMC4800129.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008695).,Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmjopen-2015-008695.PMC4800130.pdf
https://www.nice.org.uk/guidance/cg160 4.,Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmjopen-2015-008695.PMC4800130.pdf
http://www.astm.,Non-OADS,/arxiv_data1/oa_pdf/c0/5c/bmjopen-2015-008695.PMC4800130.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010409).,Non-OADS,/arxiv_data1/oa_pdf/33/56/bmjopen-2015-010409.PMC4800131.pdf
This review protocol is prepared according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis Protocols (PRISMA-P) 2015 statement 23and the results will be presen ted following the PRISMA ﬂow diagram ( ﬁgure 1 ).24This protocol has also been published in the PROSPERO International Prospective Register of sys-tematic reviews with registration number CRD42015026881 (http://www.crd.york.ac.uk/PROSPERO).,OADS,/arxiv_data1/oa_pdf/33/56/bmjopen-2015-010409.PMC4800131.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/33/56/bmjopen-2015-010409.PMC4800131.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-009013).,Non-OADS,/arxiv_data1/oa_pdf/0e/8b/bmjopen-2015-009013.PMC4800132.pdf
2011; last updated April 2014. http://www.nicedsu.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/0e/8b/bmjopen-2015-009013.PMC4800132.pdf
2011; last updated April 2014. http://www.nicedsu.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/0e/8b/bmjopen-2015-009013.PMC4800132.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008663).,Non-OADS,/arxiv_data1/oa_pdf/a1/fb/bmjopen-2015-008663.PMC4800133.pdf
"Ethnicity was also self-reported by students, and based on this, categorisedas one of the following: White, Asian, Black, Chinese, Mixed and Other †DfE link http://www.education.gov.uk/schools/performance/.",Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
‡HEFCE POLAR 3 link: http://www.hefce.ac.uk/media/hefce/content/pubs/2013/201328/HEFCE_2013_28.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
§IMD link: https://www.gov.uk/government/publications/english-indices-of-deprivation-2010.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
IMD link: https://www.gov.uk/government/publications/english-indices-of-deprivation-2010.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
"Bristol: HEFCE, 2014. http://www.offa.org.uk/wp-content/uploads/2014/07/OFFA201405-1213monitoring-outcomes.pdf 39.",Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
http://dera.ioe.ac.uk/2644/ 40.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
2014. http://www.ifs.org.uk/uploads/publications/wps/WP201431.pdf 53.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
2014. http://www.medschools.ac.uk/SiteCollectionDocuments/Selecting-for-Excellence-research-Professor-Jen-Cleland-et-al.pdf 83.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/bmjopen-2015-010169.PMC4800134.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-008175).,Non-OADS,/arxiv_data1/oa_pdf/f8/e5/bmjopen-2015-008175.PMC4800135.pdf
http://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/67/81; 2012.,Non-OADS,/arxiv_data1/oa_pdf/f8/e5/bmjopen-2015-008175.PMC4800135.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010263).,Non-OADS,/arxiv_data1/oa_pdf/98/d2/bmjopen-2015-010263.PMC4800138.pdf
http://qualitynet.org/dcs/BlobServer?blobkey=id&blobnocache= true&blobwhere=1228890294248&blobheader=multipart%2Foctet- stream&blobheadername1=Content-Disposition&blobheadervalue1=attachment%3Bfilename%3DRdmsn_Updts_AMIPNCOPDSTK_032114.pdf&blobcol=urldata&blobtable=MungoBlobs 27.,OADS,/arxiv_data1/oa_pdf/98/d2/bmjopen-2015-010263.PMC4800138.pdf
http://www.minorityhealth.hhs.gov/npa/files/Plans/HHS/HHS_Plan_complete.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/d2/bmjopen-2015-010263.PMC4800138.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010599).,Non-OADS,/arxiv_data1/oa_pdf/e3/29/bmjopen-2015-010599.PMC4800139.pdf
to rank drugs for risk of a speci ﬁc drug harm such as drug-induced arrhythmias (http://www.CredibleMeds.,Non-OADS,/arxiv_data1/oa_pdf/e3/29/bmjopen-2015-010599.PMC4800139.pdf
"org, http://www.BrugadaDrugs.org), but these arelacking an overall harm pro ﬁle.",Non-OADS,/arxiv_data1/oa_pdf/e3/29/bmjopen-2015-010599.PMC4800139.pdf
http://www.fda.gov/ downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm075057.pdf & http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm075082.pdf(accessed 12/2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/29/bmjopen-2015-010599.PMC4800139.pdf
http://ec.europa.eu/health/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf (accessed 12/2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/29/bmjopen-2015-010599.PMC4800139.pdf
http://www.accessdata.fda.gov/ scripts/cder/drugsatfda (accessed 07/2015).,OADS,/arxiv_data1/oa_pdf/e3/29/bmjopen-2015-010599.PMC4800139.pdf
http://www.ema.europa.eu/ema/ index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124 (accessed 07/2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/29/bmjopen-2015-010599.PMC4800139.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010720).,Non-OADS,/arxiv_data1/oa_pdf/0a/f6/bmjopen-2015-010720.PMC4800140.pdf
Revised June 2001. http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/principles-medical-ethics.page.,Non-OADS,/arxiv_data1/oa_pdf/0a/f6/bmjopen-2015-010720.PMC4800140.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
Available from: https://www.england.nhs.uk/wp-content/uploads/2014/10/5yfv-web.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
Available from: https://www.nice.org.uk/guidance/ng33/evidence/appendix-n-ph37-80851860866 (accessed 11 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
Available from: http://www.cmft.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/360335/TB_Annual_report__4_0_300914.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
Available from:https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/492431/TB_Annual_Report_v2.6_07012016.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
https://tbsummit.wordpress.com/2013/03/26/nw-regional-tb-regional-audit-cohort-review-handbook/ 17.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
Available from: https://tbsummit.files.wordpress.com/2013/12/nw-tb-cohort-audit-2014-report-final.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
Availablefrom: http://www.ncbi.nlm.nih.gov/books/NBK2672/ 37.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
http://www.ncbi.nlm.nih.gov/books/NBK262946/ doi:10.3310/hsdr01070 46.,Non-OADS,/arxiv_data1/oa_pdf/f4/e2/bmjopen-2015-010536.PMC4800141.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d8/3b/bmjopen-2015-010791.PMC4800142.pdf
"As qualitative articles are poorlyindexed, 23we hand searched nine key tobacco, socio- logical and qualitative research journals, the reference lists of included articles and relevant PhD theses, andundertook key author searching to identify additional articles (see 20for more details and http://www.crd.york.",Non-OADS,/arxiv_data1/oa_pdf/63/0e/bmjopen-2015-010260.PMC4800143.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/63/0e/bmjopen-2015-010260.PMC4800143.pdf
"Enforcing bans on tobacco advertising, promotion andsponsorship 2013. http://www.who.int/tobacco/global_report/2013/en 3.",Non-OADS,/arxiv_data1/oa_pdf/63/0e/bmjopen-2015-010260.PMC4800143.pdf
Secondary Tobacco Free Initiative(TFI) Second-hand tobacco smoke 2015. http://www.who.int/tobacco/research/secondhand_smoke/en/ 4.,Non-OADS,/arxiv_data1/oa_pdf/63/0e/bmjopen-2015-010260.PMC4800143.pdf
A report of the Tobacco Advisory Group of the Royal College of Physicians 2010. https://www.rcplondon.ac.uk/sites/default/files/documents/passive-smoking-and-children.pdf 5.,Non-OADS,/arxiv_data1/oa_pdf/63/0e/bmjopen-2015-010260.PMC4800143.pdf
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014014115 21.,Non-OADS,/arxiv_data1/oa_pdf/63/0e/bmjopen-2015-010260.PMC4800143.pdf
"Secondary Qualitative Research Checklist, 2013. http://media.wix.com/ugd/dded87_29c5b002d99342f788c6ac670e49f274.pdf 27.",Non-OADS,/arxiv_data1/oa_pdf/63/0e/bmjopen-2015-010260.PMC4800143.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009998).,Non-OADS,/arxiv_data1/oa_pdf/9f/34/bmjopen-2015-009998.PMC4800145.pdf
http://hiru.mcmaster.ca/hiru/HIRU_Hedges_MEDLINE_Strategies.aspx 44.,Non-OADS,/arxiv_data1/oa_pdf/9f/34/bmjopen-2015-009998.PMC4800145.pdf
http://www.evidencepartners.com/resources/ 47.,Non-OADS,/arxiv_data1/oa_pdf/9f/34/bmjopen-2015-009998.PMC4800145.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008671).,Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
2013. http://social.nesdb.go.th/SocialStat/ StatReport_Final.aspx?reportid=256&template=1R2C&yeartype=M&subcatid=18 3.,OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
Secondary Exchange rate 2014. http://www2.bot.or.th/statistics/BOTWEBSTAT.aspx?reportID=145&language=TH 16.,OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
2014. http://www2.bot.or.th/statistics/ReportPage.aspx?,Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
http://dmsic.moph.go.th/price.htm 18.,Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
2014. http://www.health.gov.on.ca 27.,Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
2012. http://www.health.gov.bc.ca 28.,Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
http://www.elmmb.nhs.uk 31.,Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
"2014. http://drug.fda.moph.go.th:81/nlem.in.th/medicine/essential/list 10 Sruamsiri R, et al.BMJ Open 2016; 6:e008671.",Non-OADS,/arxiv_data1/oa_pdf/07/b6/bmjopen-2015-008671.PMC4800146.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
World Alzheimer ’s report 2013 Journey of Caring: an analysis of long-term care for dementia.http://www.alz.co.uk/research/WorldAlzheimerReport2013.pdf(accessed 4 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
"London: Stationary Office, 2009. http://www.rcpsych.ac.uk/pdf/Antipsychotic%20Bannerjee%20Report.pdf (accessed 29 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
http://www.ic.nhs.uk/dementiaaudit (accessed 31 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
"Royal Pharmaceutical Society, Dementia Action Alliance, NHS Institute for Innovation and Improvement, 2014. http://www.rpharms.com/support-pdfs/the-right-prescription.pdf (accessed on 31 Jul 2015).",Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
http://www.alzheimers.org.uk/site/scripts/download_info.php?fileID=1133(accessed 29 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
http://eprints.uwe.ac.uk/11735/2/thematic_ analysis_revised_-_final.pdf (accessed 12 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
2015. http://www.telegraph.co.uk/news/health/11790711/Boots-Tesco-and-Superdrug-to-get-access-to-NHS-medical-records.html (accessed 29 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
http://www.nihr.ac.uk/research/research-for-patient-benefit.htm (accessed 9 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/52/e7/bmjopen-2015-010278.PMC4800147.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009942).,Non-OADS,/arxiv_data1/oa_pdf/76/c9/bmjopen-2015-009942.PMC4800148.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/76/c9/bmjopen-2015-009942.PMC4800148.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009278).,Non-OADS,/arxiv_data1/oa_pdf/4f/2e/bmjopen-2015-009278.PMC4800149.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ 8 Brubacher JR, et al.BMJ Open 2016; 6:e009278.",Non-OADS,/arxiv_data1/oa_pdf/4f/2e/bmjopen-2015-009278.PMC4800149.pdf
"Ottawa, ON: Canadian Centre on Substance Abuse, 2009. http://www.ccsa.ca/2009%20CCSA%20Documents/ccsa0115382009_e.pdf 19.",Non-OADS,/arxiv_data1/oa_pdf/4f/2e/bmjopen-2015-009278.PMC4800149.pdf
http://www.nhtsa.gov/staticfiles/nti/pdf/ 809725-DrugsHumanPerformFS.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/4f/2e/bmjopen-2015-009278.PMC4800149.pdf
"http://www.pssg.gov.bc.ca/osmv/data/index.htm Brubacher JR, et al.BMJ Open 2016; 6:e009278.",OADS,/arxiv_data1/oa_pdf/4f/2e/bmjopen-2015-009278.PMC4800149.pdf
Full details are given in appendix B of the surveydocumentation: http://doc.ukdataservice.ac.uk/doc/ 6533/mrdoc/pdf/6533_ndns_rp_yr1 –4_userguide.pdf.,OADS,/arxiv_data1/oa_pdf/2f/13/bmjopen-2015-010159.PMC4800150.pdf
Data ﬁles from 4 years (2008 to 2012) of the NDNS Rolling Programme were obtained under licencefrom the UK Data Archive (http://www.esds.ac.uk).,OADS,/arxiv_data1/oa_pdf/2f/13/bmjopen-2015-010159.PMC4800150.pdf
http://www.nice.org.uk/guidance/CG43 (accessed 18 Feb 2011).,Non-OADS,/arxiv_data1/oa_pdf/2f/13/bmjopen-2015-010159.PMC4800150.pdf
https://www.noo.org.uk/slide_sets 2013.,Non-OADS,/arxiv_data1/oa_pdf/2f/13/bmjopen-2015-010159.PMC4800150.pdf
"Addis Ababa, Ethiopia: EconomicCommission for Africa, 2014, pp 58, 66. http://www.uneca.org/sites/default/files/PublicationFiles/2014_mdg_report.pdf.",Non-OADS,/arxiv_data1/oa_pdf/27/ff/bmjopen-2015-009443.PMC4800153.pdf
All analyses were performed in R V .3.0.3 (http://CRAN.R-project.org) using the ‘metafor ’package.,OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
Euro Surveill 2010;15:pii: 19711. http://www.ncbi.nlm.nih.gov/pubmed/ 21144429 (accessed 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/10789670 (accessed 28 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
http://www.ncbi.nlm.nih.gov/pubmed/24531175 (accessed 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
http://www.ncbi.nlm.nih.gov/pubmed/24916877 (accessed 2 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
http://www.ncbi.nlm.nih.gov/pubmed/25518564 (accessed 23 Nov2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/22169782 (accessed 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
Euro Surveill 2013;18:20626. http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
Euro Surveill 2012;17:pii: 20248. http://www.ncbi.nlm.nih.gov/pubmed/22913977(accessed 20 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/3e/bmjopen-2015-009971.PMC4800154.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 009914).,Non-OADS,/arxiv_data1/oa_pdf/c6/20/bmjopen-2015-009914.PMC4800155.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c6/20/bmjopen-2015-009914.PMC4800155.pdf
http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/index-eng.php (accessed Jul 2015).,OADS,/arxiv_data1/oa_pdf/c6/20/bmjopen-2015-009914.PMC4800155.pdf
"Toronto, ON: Institute for Clinical EvaluativeSciences, 2005. http://www.ices.on.ca/Publications/Atlases-and-Reports/2005/Supply-and-utilization (accessed Jul 2015).",Non-OADS,/arxiv_data1/oa_pdf/c6/20/bmjopen-2015-009914.PMC4800155.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010632).,Non-OADS,/arxiv_data1/oa_pdf/15/60/bmjopen-2015-010632.PMC4800164.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.9c87t.,OADS,/arxiv_data1/oa_pdf/15/60/bmjopen-2015-010632.PMC4800164.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/15/60/bmjopen-2015-010632.PMC4800164.pdf
"Ventolin® Inhaler (CFC-Free) data sheet version 4.0, 18 June 2014. http://www.medsafe.govt.nz/profs/datasheet/v/VentolinCFC-freeinh.pdf (accessed 13 Dec 2015).",OADS,/arxiv_data1/oa_pdf/59/08/bmjresp-2016-000128.PMC4800169.pdf
"To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjresp-2016- 000133) Healthcare providers need to use clinical judgement, knowledge and expertise when deciding whether it is appropriate to apply recommendations for themanagement of patients.",Non-OADS,/arxiv_data1/oa_pdf/b8/00/bmjresp-2016-000133.PMC4800170.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/d1/ehv512.PMC4800173.pdf
"Available from: http://www.who.int/mediacentre/fact- sheets/fs297/en/right 10.Świątkowska B, Szubert Z, Sobala W, Szeszenia-D ąbrowska N. Predictors of lung cancer among former asbestos- exposed workers.",OADS,/arxiv_data1/oa_pdf/2c/3f/ejh-2016-1-2573.PMC4800250.pdf
Available from http://www.ichworld.com/royellis/prob- lems/problem27.htm  7.,Non-OADS,/arxiv_data1/oa_pdf/b4/57/ejh-2016-1-2588.PMC4800253.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF GYNECOLOGIC SURGERY Volume 32, Number 2, 2016Mary Ann Liebert, Inc.DOI: 10.1089/gyn.2015.0106 111",Non-OADS,/arxiv_data1/oa_pdf/e8/43/gyn.2015.0106.PMC4800265.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproductio n in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/5a/a4/adt.2016.704.PMC4800267.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 22, Numbers 5 and 6, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tea.2015.0284 436",Non-OADS,/arxiv_data1/oa_pdf/22/30/ten.tea.2015.0284.PMC4800276.pdf
"TheInteractive Fly database (http://www.sdbonline.org/ ﬂy/aimain/ 1aahome.htm; 47th Edition) 25was used as a source of annotated functional genetic data, and we enlisted genes present in at least one but commonly in several of the subcategories: tumorsuppression, apico-basal cell polarity, tissue polarity, junctionalcomplexes and their regulators, and asymmetric cell division.",OADS,/arxiv_data1/oa_pdf/e7/a9/onc2015196a.PMC4800288.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Par6 in cell proliferation suppression E Marques et al 1398 Oncogene (2016) 1386 –1398 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e7/a9/onc2015196a.PMC4800288.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Steroid-induced CK5+ cells in ER α+ breast cancer CR Goodman et al 1385 © 2016 Macmillan Publishers Limited Oncogene (2016) 1373 –1385",Non-OADS,/arxiv_data1/oa_pdf/51/7c/onc2015193a.PMC4800289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)p75NTR-mediated glioma invasion requires PDLIM1 BY Ahn et al 1422 Oncogene (2016) 1411 –1422 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/96/4a/onc2015199a.PMC4800290.pdf
"A platelet count of 4400 remains the most robust criteria by which to select patients for intermittent therapy, and this is being investigated in the FOCUS-4 study (http://www.focus4trial.org/).",Non-OADS,/arxiv_data1/oa_pdf/78/62/bjc201623a.PMC4800295.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)dNLR is predictive of survival from intermittent therapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.23 615,Non-OADS,/arxiv_data1/oa_pdf/78/62/bjc201623a.PMC4800295.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Long-term everolimus resistance in PNET 658 www.bjcancer.com | DOI:10.1038/bjc.2016.25,Non-OADS,/arxiv_data1/oa_pdf/95/a9/bjc201625a.PMC4800296.pdf
"The full PICNICC model has complexity (with the series of different predictors for type of malignancy, and the use of log-transformed data) which makes it likely to be unwieldy unless made easily applicable, for example on a spreadsheet (for a basic version see: http://goo.gl/3AOa9R) or smart phone ‘app’, into which the clinicians would enter the data and return a calculated probability of MDI.",Non-OADS,/arxiv_data1/oa_pdf/79/13/bjc201628a.PMC4800297.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Predicting risk in paediatric FN: IPD meta-analysis 630 www.bjcancer.com | DOI:10.1038/bjc.2016.28,Non-OADS,/arxiv_data1/oa_pdf/79/13/bjc201628a.PMC4800297.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Hypoxia induced by androgen deprivation promotes EMT 668 www.bjcancer.com | DOI:10.1038/bjc.2016.29,Non-OADS,/arxiv_data1/oa_pdf/4a/91/bjc201629a.PMC4800298.pdf
A summary of the included studies was reported previously (http://jco.ascopubs.org/ content/33/4/349/T1.large.jpg)Primary outcome and definition.,Non-OADS,/arxiv_data1/oa_pdf/17/55/bjc201632a.PMC4800299.pdf
Available at http://guidance.nice.org.uk/CG164/NICEGuidance/pdf/English (lastaccessed 23 September 2013).,Non-OADS,/arxiv_data1/oa_pdf/17/55/bjc201632a.PMC4800299.pdf
Available at http://richtlijnendatabase.nl/en/richtlijn/breast_cancer/screening.html (last accessed 10 February 2016).,Non-OADS,/arxiv_data1/oa_pdf/17/55/bjc201632a.PMC4800299.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER B-cell receptor stimulation in CLL 712 www.bjcancer.com | DOI:10.1038/bjc.2016.35,Non-OADS,/arxiv_data1/oa_pdf/10/6e/bjc201635a.PMC4800300.pdf
"Adapted from Valente and Mai (2014), http://www.fda.gov/default.htm.BRITISH JOURNAL OF CANCER Inhibition of histone deacetylases in cancer therapy 608 www.bjcancer.com | DOI:10.1038/bjc.2016.36",Non-OADS,/arxiv_data1/oa_pdf/23/5a/bjc201636a.PMC4800301.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Inhibition of histone deacetylases in cancer therapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.36 611",Non-OADS,/arxiv_data1/oa_pdf/23/5a/bjc201636a.PMC4800301.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Blood biomarkers of cancer cachexia BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.3 687,Non-OADS,/arxiv_data1/oa_pdf/a9/46/bjc20163a.PMC4800302.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)PK/PD modelling of abemaciclib and vemurafenib BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.40 679",Non-OADS,/arxiv_data1/oa_pdf/04/50/bjc201640a.PMC4800303.pdf
Availableat http://www.proteinatlas.org/ENSG00000189377-CXCL17/tissue.,OADS,/arxiv_data1/oa_pdf/50/a9/bjc20164a.PMC4800305.pdf
"Dr. Lee first established a system of subspecialties in the neu -A Great Teacher of Neurosurgery in Korea:   Hun Jae Lee (1921–1983) Dong Ah Shin1, Joong Uhn Choi2, Keun Su Kim1, and Hyoung Woo Park3 1Department of Neurosurgery, Yonsei University College of Medicine, Seoul; 2Department of Neurosurgery, CHA University College of Medicine, Seongnam; 3Department of Anatomy and Medical History, Yonsei University College of Medicine, Seoul, Korea.Yonsei Med J 2016 May;57(3):539-541 http://dx.doi.org/10.3349/ymj.2016.57.3.539Editorial pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 1, 2016 Corresponding author:  Dr. Keun Su Kim, Professor and Chairman of Neurosur - gery, Director of Spine Hospital, Gangnam Severance Hospital, Yonsei University  College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea.",Non-OADS,/arxiv_data1/oa_pdf/87/c7/ymj-57-539.PMC4800339.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Editorial Series: Frontiers of Medicine in Korea",Non-OADS,/arxiv_data1/oa_pdf/87/c7/ymj-57-539.PMC4800339.pdf
"540 A Great Teacher of Neurosurgery in Korea http://dx.doi.org/10.3349/ymj.2016.57.3.539rological department, which remains a tremendous legacy  from the great pioneer.",Non-OADS,/arxiv_data1/oa_pdf/87/c7/ymj-57-539.PMC4800339.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.539vited Professor of Michigan University.,Non-OADS,/arxiv_data1/oa_pdf/87/c7/ymj-57-539.PMC4800339.pdf
"Key Words:   Food allergy, children, maternal nutrition, epidemiology, epigenetic regulation, immune toleranceYonsei Med J 2016 May;57(3):542-548 http://dx.doi.org/10.3349/ymj.2016.57.3.542Review Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 25, 2016 Corresponding author:  Dr. Hyeyoung Kim, Department of Food and Nutrition,   Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
"543 http://dx.doi.org/10.3349/ymj.2016.57.3.542Sun Eun Lee and Hyeyoung Kim nuts, cow’s milk, and egg) and nutrients (vitamin D and n-3 fat - ty acids) that have been rather widely studied.",Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.542 544Early Nutrition and Food Allergy in Children risk of allergy at 12 months of age.,Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
"545 http://dx.doi.org/10.3349/ymj.2016.57.3.542Sun Eun Lee and Hyeyoung Kim breast-fed.68 This association was significantly modified by in - dividual or joint 3 single nucleotide polymorphism (SNP) in the  IL12RB1 , TLR9 , and TSLP  genes.",Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.542 546Early Nutrition and Food Allergy in Children ACKNOWLEDGEMENTS This work was supported by a grant from the NRF of Korea,  which is funded by the Korean government (NRF-2015  R1A2A2A01004855).",Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
Available at:  https://www.niaid.nih.gov/topics/foodAllergy/Documents/ foodallergy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
547 http://dx.doi.org/10.3349/ymj.2016.57.3.542Sun Eun Lee and Hyeyoung Kim and lactation may decrease the risk of infant allergy.,Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.542 548Early Nutrition and Food Allergy in Children 77.,Non-OADS,/arxiv_data1/oa_pdf/d8/14/ymj-57-542.PMC4800340.pdf
"Key Words:   Small cell lung cancer, apolipoprotein, biomarker, prognosis Yonsei Med J 2016 May;57(3):549-556 http://dx.doi.org/10.3349/ymj.2016.57.3.549Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 14, 2015   Revised:  March 11, 2015 Accepted:  April 9, 2015 Corresponding author:  Dr. Jian Shi, Department of Medical Oncology, Forth  Hospital of Hebei Medical University, Tumor Hospital of Hebei Province, 12 Jiank - ang Rd, Qiaodong, Shijiazhuang, Hebei 050011, China.",Non-OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.549 550Apolipoproteins as Clinical Markers for SCLC ovarian cancer, renal cancer, bladder cancer, etc.9,10 We previ - ously reported on the up-regulation of ApoE in the serum of  SCLC patients, suggesting that apolipoproteins can serve as po - tential biomarkers for SCLC.11 Therefore, in order to analyze the  possibility of utilizing apolipoproteins in SCLC diagnosis, we  sought to systematically characterize the expression of different  apolipoproteins in SCLC tissue samples from patients of vari - ous clinical histories.",Non-OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"551 http://dx.doi.org/10.3349/ymj.2016.57.3.549Jian Shi, et al.",OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.549 552Apolipoproteins as Clinical Markers for SCLC DISCUSSION Altered expression of apolipoproteins in SCLC Small cell lung cancers account for approximately 10 –15% of all  lung cancers.3 Despite a low prevalence, the disease is highly  malignant.",Non-OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"553 http://dx.doi.org/10.3349/ymj.2016.57.3.549Jian Shi, et al.",OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.549 554Apolipoproteins as Clinical Markers for SCLC Mdm2, and Smad proteins.29,30 Mdm2 antagonizes the indirect  inhibition of p53 and SHP on ApoC-III, which is probably the  underlying mechanism for the involvement of ApoC-III in tu - morigenesis and cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"555 http://dx.doi.org/10.3349/ymj.2016.57.3.549Jian Shi, et al.",OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.549 556Apolipoproteins as Clinical Markers for SCLC 21.,Non-OADS,/arxiv_data1/oa_pdf/f9/01/ymj-57-549.PMC4800341.pdf
"Key Words:   Gastric cancer, stress, metastasis, periostin, extracellular matrix, nichYonsei Med J 2016 May;57(3):557-564 http://dx.doi.org/10.3349/ymj.2016.57.3.557Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 28, 2015   Revised:  December 1, 2015 Accepted:  December 10, 2015 Co-corresponding authors:  Dr. Bo Wei, Department of General Surgery, Chinese  PLA General Hospital, 28 Fu Xing Road, Beijing 100853, China.",Non-OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.557 558Periostin Expression in Gastric Cancer ways.,Non-OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
"559 http://dx.doi.org/10.3349/ymj.2016.57.3.557Guo-Xiao Liu, et al.",OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.557 560Periostin Expression in Gastric Cancer nese Academy of Medical Science.,Non-OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
"561 http://dx.doi.org/10.3349/ymj.2016.57.3.557Guo-Xiao Liu, et al.",OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.557 562Periostin Expression in Gastric Cancer microenvironment, or metastatic niche, capable of promoting  cancer development and progression.",Non-OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
"563 http://dx.doi.org/10.3349/ymj.2016.57.3.557Guo-Xiao Liu, et al.",OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.557 564Periostin Expression in Gastric Cancer REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bf/0d/ymj-57-557.PMC4800342.pdf
"Key Words:   Prostate cancer, prostate biopsy, magnetic resonance imagingYonsei Med J 2016 May;57(3):565-571 http://dx.doi.org/10.3349/ymj.2016.57.3.565Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  April 24, 2015   Revised:  July 26, 2015 Accepted:  August 2, 2015 Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.565 566Multiparametric MRI-Targeted Prostate Biopsy veillance (AS) candidates in prostate cancer patients who  need definite therapy.7-9 This results in the undersampling of  significant prostate cancer.,Non-OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
"567 http://dx.doi.org/10.3349/ymj.2016.57.3.565Dong Hoon Lee, et al.",OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.565 568Multiparametric MRI-Targeted Prostate Biopsy patients with lesions of low suspicion, there were fewer clear  TRUS lesions that could be used as a target for MRI-visual-Bx.",Non-OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
"569 http://dx.doi.org/10.3349/ymj.2016.57.3.565Dong Hoon Lee, et al.",OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.565 570Multiparametric MRI-Targeted Prostate Biopsy visual-Bx.,Non-OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
"571 http://dx.doi.org/10.3349/ymj.2016.57.3.565Dong Hoon Lee, et al.",OADS,/arxiv_data1/oa_pdf/8b/52/ymj-57-565.PMC4800343.pdf
"Key Words:   Adolescent cancer patients, symptom interval, patient delayYonsei Med J 2016 May;57(3):572-579 http://dx.doi.org/10.3349/ymj.2016.57.3.572Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 8, 2015   Revised:  August 29, 2015 Accepted:  September 7, 2015 Corresponding author:  Dr. Jung Woo Han, Division of Pediatric Hematology and  Oncology, Department of Pediatrics, Yonsei University College of Medicine, Yonsei  University Health System, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
"573 http://dx.doi.org/10.3349/ymj.2016.57.3.572Song Lee Jin, et al.",OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.572 574Symptom Interval and Patient Delay in Adolescent Cancer and compared using the log-rank test.,OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
"575 http://dx.doi.org/10.3349/ymj.2016.57.3.572Song Lee Jin, et al.",OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.572 576Symptom Interval and Patient Delay in Adolescent Cancer <0.6 groups showed similar hazard ratio (1.079; 95% CI, 0.388 – 2.995; p=0.885).",OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
"577 http://dx.doi.org/10.3349/ymj.2016.57.3.572Song Lee Jin, et al.",OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.572 578Symptom Interval and Patient Delay in Adolescent Cancer care center at the proper time.,Non-OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
Available at:  http://www.nccn.org/professionals/physician_gls/pdf/aya.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
"579 http://dx.doi.org/10.3349/ymj.2016.57.3.572Song Lee Jin, et al.",OADS,/arxiv_data1/oa_pdf/97/be/ymj-57-572.PMC4800344.pdf
"Key Words:   CA125, ovarian cancer, prognostic factor, tumour markerYonsei Med J 2016 May;57(3):580-587 http://dx.doi.org/10.3349/ymj.2016.57.3.580Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 28, 2015   Revised:  August 28, 2015 Accepted:  September 24, 2015 Co-corresponding authors:  Dr. Jae-Hoon Kim, Department of Obstetrics and  Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine,  211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"581 http://dx.doi.org/10.3349/ymj.2016.57.3.580Maria Lee, et al.",OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.580 582CA125 and Advanced Ovarian Cancer date of the minimum value.,Non-OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"583 http://dx.doi.org/10.3349/ymj.2016.57.3.580Maria Lee, et al.",OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.580 584CA125 and Advanced Ovarian Cancer CA125, compared to that at baseline after the first chemother - apy cycle, were sequentially selected for OS; time to CA125  normalization followed by CA125 level after the first chemo - therapy cycle was selected for PFS (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"585 http://dx.doi.org/10.3349/ymj.2016.57.3.580Maria Lee, et al.",OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.580 586CA125 and Advanced Ovarian Cancer spective study with 494 subjects, Riedinger, et al.23 determined  that patients with normal baseline CA125 levels or patients  who showed a >50% decrease to <35 U/mL before the second  chemotherapy cycle had a favourable prognosis.",Non-OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"587 http://dx.doi.org/10.3349/ymj.2016.57.3.580Maria Lee, et al.",OADS,/arxiv_data1/oa_pdf/c0/d6/ymj-57-580.PMC4800345.pdf
"Key Words:   Tolfenamic acid, nasopharyngeal cancer, p38 mitogen-activated protein kinase, SlugYonsei Med J 2016 May;57(3):588-598 http://dx.doi.org/10.3349/ymj.2016.57.3.588Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  August 10, 2015   Revised:  August 22, 2015 Accepted:  August 23, 2015 Co-corresponding authors:  Dr. Chul-Ho Kim, Departments of Otolaryngology &  Molecular Science and Technology, Ajou University School of Medicine, 164 World  cup-ro, Yeongtong-gu, Suwon 16499, Korea.",Non-OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"589 http://dx.doi.org/10.3349/ymj.2016.57.3.588Tatsanachat Jittreetat, et al.",OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.588 590Effects of Tolfenamic Acid in Nasopharynx Cancer value<0.05 was considered statistically significant [ p<0.05 (*),  p<0.01 (**), p<0.001 (***)].",OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"591 http://dx.doi.org/10.3349/ymj.2016.57.3.588Tatsanachat Jittreetat, et al.",OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.588 592Effects of Tolfenamic Acid in Nasopharynx Cancer Fig.,Non-OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"593 http://dx.doi.org/10.3349/ymj.2016.57.3.588Tatsanachat Jittreetat, et al.",OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.588 594Effects of Tolfenamic Acid in Nasopharynx Cancer  Fig.,Non-OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"595 http://dx.doi.org/10.3349/ymj.2016.57.3.588Tatsanachat Jittreetat, et al.",OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.588 596Effects of Tolfenamic Acid in Nasopharynx Cancer of TA in both NPC cell lines (Fig.,Non-OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"597 http://dx.doi.org/10.3349/ymj.2016.57.3.588Tatsanachat Jittreetat, et al.",OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.588 598Effects of Tolfenamic Acid in Nasopharynx Cancer Tetrahydrocurcumin induces G2/M cell cycle arrest and apopto - sis involving p38 MAPK activation in human breast cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/02/47/ymj-57-588.PMC4800346.pdf
"Key Words:   Breast neoplasms, lymphangiogenesis, fibrosis, elasticity imaging techniquesYonsei Med J 2016 May;57(3):599-605 http://dx.doi.org/10.3349/ymj.2016.57.3.599Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  April 23, 2015   Revised:  August 3, 2015 Accepted:  September 1, 2015 Corresponding author:  Dr. Nam Hoon Cho, Department of Pathology, Severance  Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu,  Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.599 600Lymphangiogenesis and Matrix Stiffness breast cancers and to analyze the value of predicting lymph  node metastasis and other clinicopathologic parameters.,Non-OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
"601 http://dx.doi.org/10.3349/ymj.2016.57.3.599Yoon Jin Cha, et al.",OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.599 602Lymphangiogenesis and Matrix Stiffness HER2, and Ki-67 LI status, the tumors were divided into four  subtypes: luminal A (ER-positive and/or PR-positive, HER2- negative, and Ki-67 LI<14%); luminal B (ER-positive and/or  PR-positive, HER2-negative, and Ki-67 LI ≥14% or ER-positive  and/or PR-positive and HER2-positive, irrespective of Ki-67 LI);  HER2-enriched (ER-negative, PR-negative, and HER2-posi - tive); and triple-negative breast cancer (TNBC) (ER-negative,  PR-negative, and HER2-negative).",Non-OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
"603 http://dx.doi.org/10.3349/ymj.2016.57.3.599Yoon Jin Cha, et al.",OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.599 604Lymphangiogenesis and Matrix Stiffness Fibrosis observed in the center and periphery of tumors cor - relates well with elasticity value.,Non-OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
"605 http://dx.doi.org/10.3349/ymj.2016.57.3.599Yoon Jin Cha, et al.",OADS,/arxiv_data1/oa_pdf/2c/7d/ymj-57-599.PMC4800347.pdf
"Key Words:   Paclitaxel-coated balloon, de novo  coronary lesion, main vessel, side-branch ostium, optical coherence tomographyYonsei Med J 2016 May;57(3):606-613 http://dx.doi.org/10.3349/ymj.2016.57.3.606Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 3, 2015   Revised:  September 4, 2015 Accepted:  September 7, 2015 Corresponding author:  Dr. Eun-Seok Shin, Department of Cardiology, Ulsan Uni - versity Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan - do-ro, Dong-gu, Ulsan 44033, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
"607 http://dx.doi.org/10.3349/ymj.2016.57.3.606Ae-Young Her, et al.",OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.606 608Side-Branch Ostial Changes after Main Vessel PCB Treatment Patients with stable or unstable angina pectoris scheduled for  percutaneous coronary intervention (PCI) but unable to re - ceive long-term dual antiplatelet therapy (DAPT) due to high bleeding risk, poor compliance or awaiting non-cardiac surgery  and therefore planned for PCB treatment for their de novo  le- sions, were eligible for enrollment.",Non-OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
"609 http://dx.doi.org/10.3349/ymj.2016.57.3.606Ae-Young Her, et al.",OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.606 610Side-Branch Ostial Changes after Main Vessel PCB Treatment back at a rate of 20 mm/s during continuous flushing of 20 mLs  of contrast media.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
"611 http://dx.doi.org/10.3349/ymj.2016.57.3.606Ae-Young Her, et al.",OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.606 612Side-Branch Ostial Changes after Main Vessel PCB Treatment cedure and 9-months.,Non-OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
"613 http://dx.doi.org/10.3349/ymj.2016.57.3.606Ae-Young Her, et al.",OADS,/arxiv_data1/oa_pdf/7c/b1/ymj-57-606.PMC4800348.pdf
"Key Words:   Angina pectoris, variant, coronary vasospasm, erythrocyte indicesYonsei Med J 2016 May;57(3):614-620 http://dx.doi.org/10.3349/ymj.2016.57.3.614Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  June 8, 2015   Revised:  August 8, 2015 Accepted:  September 7, 2015 Corresponding author:  Dr. Dong Il Shin, Department of Cardiovascular Medicine,  Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Ko - rea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Korea.",Non-OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
"615 http://dx.doi.org/10.3349/ymj.2016.57.3.614Mi-Hyang Jung, et al.",OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.614 616Vasospastic Angina and Red Cell Distribution Width Table 1.,OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
"617 http://dx.doi.org/10.3349/ymj.2016.57.3.614Mi-Hyang Jung, et al.",OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.614 618Vasospastic Angina and Red Cell Distribution Width tributed among the groups ( p=0.028) (Table 4).,OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
"619 http://dx.doi.org/10.3349/ymj.2016.57.3.614Mi-Hyang Jung, et al.",OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.614 620Vasospastic Angina and Red Cell Distribution Width with the prevalence of VSA and the high-risk angiographic sub - type of coronary spasm, consequently emphasizing the clini - cal value of a proactive clinical investigation of VSA in Korean  patients with an elevated RDW.",Non-OADS,/arxiv_data1/oa_pdf/19/44/ymj-57-614.PMC4800349.pdf
"Key Words:   Patent foramen ovale, device closure, ischemic strokes, transient ischemic attackYonsei Med J 2016 May;57(3):621-625 http://dx.doi.org/10.3349/ymj.2016.57.3.621Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 6, 2015   Revised:  August 11, 2015 Accepted:  September 7, 2015 Corresponding author:  Dr. Woong Chol Kang, Cardiology, Department of Internal  Medicine, Gachon University, Gil Medical Center, 21 Namdong-daero 774beon-gil,  Namdong-gu, Incheon 21565, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5c/85/ymj-57-621.PMC4800350.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/85/ymj-57-621.PMC4800350.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.621 622The Efficacy of PFO Closure in Ischemic Stroke MATERIALS AND METHODS Study population This study is a prospective observational study from the Gil  Medical Center PFO registry.,Non-OADS,/arxiv_data1/oa_pdf/5c/85/ymj-57-621.PMC4800350.pdf
"623 http://dx.doi.org/10.3349/ymj.2016.57.3.621Jeonggeun Moon, et al.",OADS,/arxiv_data1/oa_pdf/5c/85/ymj-57-621.PMC4800350.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.621 624The Efficacy of PFO Closure in Ischemic Stroke ble 3).,Non-OADS,/arxiv_data1/oa_pdf/5c/85/ymj-57-621.PMC4800350.pdf
"625 http://dx.doi.org/10.3349/ymj.2016.57.3.621Jeonggeun Moon, et al.",OADS,/arxiv_data1/oa_pdf/5c/85/ymj-57-621.PMC4800350.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):626-634 http://dx.doi.org/10.3349/ymj.2016.57.3.626",Non-OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.626by 24 hours, 30% by 48 hours, and 40% at 1 week.2 To ensure prompt treatment, cooperation among multidis - ciplinary departments is crucial.",Non-OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
628Critical Pathway for Acute Aortic Disease http://dx.doi.org/10.3349/ymj.2016.57.3.626Data collection Patient data were collected retrospectively from medical re - cords.,OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.626ed.,Non-OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
630Critical Pathway for Acute Aortic Disease http://dx.doi.org/10.3349/ymj.2016.57.3.626groups.,Non-OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.626tervention declined from 11 (11.7%) in the pre-period to 4 (3.8%)  in the post-period ( p=0.037).,OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
"632Critical Pathway for Acute Aortic Disease http://dx.doi.org/10.3349/ymj.2016.57.3.626ratio (95% confidence interval)=0.416 (0.150, 1.156); p=0.093].",OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.626gency intervention was the improvement of the notification  system of the consulted department.,Non-OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
634Critical Pathway for Acute Aortic Disease http://dx.doi.org/10.3349/ymj.2016.57.3.62623.,Non-OADS,/arxiv_data1/oa_pdf/64/7d/ymj-57-626.PMC4800351.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):635-640 http://dx.doi.org/10.3349/ymj.2016.57.3.635",Non-OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
"636Warfarin Dosing Algorithms in Stroke Patients http://dx.doi.org/10.3349/ymj.2016.57.3.635and patient compliance level have shown to have large influ - ence on warfarin dosing,7 frequent monitoring of its effect, as  measured by the international normalized ratio (INR), is war - ranted.",Non-OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
PCR and direct sequencing were performed using primers  designed in Primer3 software (http://bioinfo.ut.ee/prim - er3-0.4.0/).,OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.635SNPs, because VKORC1  1173 genotype is suggested to be in  complete linkage disequilibrium with VKORC1 -1639 and  2255.13,25 Nine algorithms were selected from the literature that met  our inclusion criteria.",Non-OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
"Predicted  dose was calculated using published equations, except Gage’s  calculated by input on the website http://www.warfarindos - ing.org.",OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
638Warfarin Dosing Algorithms in Stroke Patients http://dx.doi.org/10.3349/ymj.2016.57.3.635the difference in the stable warfarin dose between patients with  homozygous for  CYP2C9*1  (3.8±1.4 mg/day) and heterozy - gous for CYP2C9*3 (2.6±0.5 mg/day) was not significant.,OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.635challenging, because warfarin has narrow therapeutic index.",Non-OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
"640Warfarin Dosing Algorithms in Stroke Patients http://dx.doi.org/10.3349/ymj.2016.57.3.6354% of the study population was younger than 40 years of age;  therefore, additional models for stroke patients with younger  age are needed, as age is important factor of prediction.",Non-OADS,/arxiv_data1/oa_pdf/60/44/ymj-57-635.PMC4800352.pdf
"Key Words:   Tigecycline, Klebsiella pneumoniae , ramRYonsei Med J 2016 May;57(3):641-646 http://dx.doi.org/10.3349/ymj.2016.57.3.641Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  April 23, 2015   Revised:  July 2, 2015 Accepted:  September 7, 2015 Corresponding author:  Dr. Seok Hoon Jeong, Department of Laboratory Medi - cine, Research Institute of Bacterial Resistance, Yonsei University College of Medi - cine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.641 642Tigecycline Nonsusceptibility in Korea thermore, there is a serious concern about the spread of tige - cycline resistant bacteria.",Non-OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
"643 http://dx.doi.org/10.3349/ymj.2016.57.3.641Chulsoo Ahn, et al.",OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
to identify markers for cephalosporin and carbapenem resis - tance among the samples.10 Multilocus sequence typing Multilocus sequence typing (MLST) was performed according  to the published protocol (http://www.pasteur.fr/recherche/ genopole/PF8/mlst/Kpneumoniae.html).,OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
"Simulta - neously, we performed the eBURST analysis on the webserver  http://eburst.mlst.net/ to identify the clonal complex.",OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.641 644Tigecycline Nonsusceptibility in Korea Table 3.,Non-OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
"645 http://dx.doi.org/10.3349/ymj.2016.57.3.641Chulsoo Ahn, et al.",OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
"We thank the team of the cura - tors at the Institut Pasteur, MLST system (Paris, France) for im - porting novel alleles, profiles, and/or isolates at http://www.pas - teur.fr/mlst.",Non-OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.641 646Tigecycline Nonsusceptibility in Korea REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/65/98/ymj-57-641.PMC4800353.pdf
"Key Words:   Helicobacter pylori , NF-κB, AP-1, oncogenes, hyperproliferationYonsei Med J 2016 May;57(3):647-651 http://dx.doi.org/10.3349/ymj.2016.57.3.647Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  January 14, 2015   Revised:  July 28, 2015 Accepted:  September 3, 2015 Corresponding author:  Dr. Hyeyoung Kim, Department of Food and Nutrition,  Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/ymj-57-647.PMC4800354.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/ymj-57-647.PMC4800354.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.647 648NF-κB and AP-1 Mediate Cell Proliferation are activated by ROS,15 ROS may trigger the activation of these  transcription factors in H. pylori -infected gastric epithelial  cells.",Non-OADS,/arxiv_data1/oa_pdf/e7/67/ymj-57-647.PMC4800354.pdf
"649 http://dx.doi.org/10.3349/ymj.2016.57.3.647Eunyoung Byun, et al.",OADS,/arxiv_data1/oa_pdf/e7/67/ymj-57-647.PMC4800354.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.647 650NF-κB and AP-1 Mediate Cell Proliferation Fig.,OADS,/arxiv_data1/oa_pdf/e7/67/ymj-57-647.PMC4800354.pdf
"651 http://dx.doi.org/10.3349/ymj.2016.57.3.647Eunyoung Byun, et al.",OADS,/arxiv_data1/oa_pdf/e7/67/ymj-57-647.PMC4800354.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):652-657 http://dx.doi.org/10.3349/ymj.2016.57.3.652",Non-OADS,/arxiv_data1/oa_pdf/7c/81/ymj-57-652.PMC4800355.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.652cytopathic viruses.9-11 Immune-mediated tissue injury, so- called immunopathology, is mediated by diverse mechanisms  in different viral infections.12 The inflammatory process is me - diated by cytokines, including interleukin (IL)-1 β, IL-6, and tu - mor necrosis factor- α (TNF-α), and it is suppressed by IL-10.12  Additionally, helper 1 T (Th1) cells and helper 17 T (Th17) cells  contribute to tissue injury by secreting cytokines; e.g., Th1  cells secrete interferon (IFN)- γ and TNF- α, and Th17 cells se - crete IL-17 and IL-21.13 Moreover, cytotoxic T cells and natural  killer (NK) cells directly lyse host cells through perforin/gran - zyme, and Fas ligand-mediated mechanisms.14 Chemokines  are also involved in immune-mediated tissue injury by recruit - ing immune cells to the site of a viral infection.15,16 However, in  AHA and AHB, the exact mechanisms of immune-mediated  liver injury remain to be elucidated.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/ymj-57-652.PMC4800355.pdf
"654Cytokines in Acute Hepatitis A and B http://dx.doi.org/10.3349/ymj.2016.57.3.652Correlation between the serum levels of CXCR3  chemokines and liver injury Next, we analyzed which chemokines were associated with the degree of liver injury, assessing liver injury in terms of se - rum ALT levels.",OADS,/arxiv_data1/oa_pdf/7c/81/ymj-57-652.PMC4800355.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.652tions.17 Fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/81/ymj-57-652.PMC4800355.pdf
656Cytokines in Acute Hepatitis A and B http://dx.doi.org/10.3349/ymj.2016.57.3.652with peak ALT levels (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7c/81/ymj-57-652.PMC4800355.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.652what decides the outcome?,Non-OADS,/arxiv_data1/oa_pdf/7c/81/ymj-57-652.PMC4800355.pdf
"Key Words:   Waist, height, body mass index, metabolic syndrome, obesityYonsei Med J 2016 May;57(3):658-663 http://dx.doi.org/10.3349/ymj.2016.57.3.658Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  March 4, 2015   Revised:  August 12, 2015 Accepted:  August 12, 2015 Co-corresponding authors:  Dr. Eun-Gyong Yoo, Department of Pediatrics, College  of Medicine, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam 13496, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ce/b3/ymj-57-658.PMC4800356.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/b3/ymj-57-658.PMC4800356.pdf
"659 http://dx.doi.org/10.3349/ymj.2016.57.3.658In Hyuk Chung, et al.",OADS,/arxiv_data1/oa_pdf/ce/b3/ymj-57-658.PMC4800356.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.658 660Waist-to-Height Ratio and Cardiometabolic Risk Decreased HDL-C was defined as an HDL-C level of <40 mg/ dL for all boys and girls of <16 years of age and of <50 mg/dL in  girls of ≥16 years of age.14 The presence of two or more CMRFs  among hypertension, hyperglycemia, hypertriglyceridemia,  and decreased HDL-C was classified as multiple CMRFs.",Non-OADS,/arxiv_data1/oa_pdf/ce/b3/ymj-57-658.PMC4800356.pdf
"661 http://dx.doi.org/10.3349/ymj.2016.57.3.658In Hyuk Chung, et al.",OADS,/arxiv_data1/oa_pdf/ce/b3/ymj-57-658.PMC4800356.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.658 662Waist-to-Height Ratio and Cardiometabolic Risk central obesity, the prevalence of multiple CMRFs was signifi - cantly higher in the WHtR≥0.5 group compared to the WHtR  <0.5 group (12.6% vs. 8.4%, p=0.021) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ce/b3/ymj-57-658.PMC4800356.pdf
"663 http://dx.doi.org/10.3349/ymj.2016.57.3.658In Hyuk Chung, et al.",OADS,/arxiv_data1/oa_pdf/ce/b3/ymj-57-658.PMC4800356.pdf
"Key Words:   Curcumin, diabetic nephropathy, oxidative stress, lipid metabolismYonsei Med J 2016 May;57(3):664-673 http://dx.doi.org/10.3349/ymj.2016.57.3.664Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  February 12, 2015   Revised:  July 22, 2015 Accepted:  August 22, 2015 Corresponding author:  Dr. Choon Hee Chung, Department of Internal Medicine,  Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Korea.",Non-OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"665 http://dx.doi.org/10.3349/ymj.2016.57.3.664Bo Hwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.664 666The Effects of Curcumin in Diabetic Nephropathy studies.,Non-OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"667 http://dx.doi.org/10.3349/ymj.2016.57.3.664Bo Hwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.664 668The Effects of Curcumin in Diabetic Nephropathy DISCUSSION In the present study, we found that anti-oxidant enzymes were  suppressed and lipid-related molecules were excessively ex - pressed in the kidneys of type 2 diabetic OLETF rats.",Non-OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"669 http://dx.doi.org/10.3349/ymj.2016.57.3.664Bo Hwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.664 670The Effects of Curcumin in Diabetic Nephropathy a previous study, SREBP-1, which activates fatty acid synthesis,  and SREBP-2, which activates cholesterol biosynthesis, were  increased in the DN; however, curcumin significantly reduced  SREBP-1 and SREBP-2 in the present study.",Non-OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"671 http://dx.doi.org/10.3349/ymj.2016.57.3.664Bo Hwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.664 672The Effects of Curcumin in Diabetic Nephropathy id accumulation in the kidneys of diabetic rats.33 In conclusion, curcumin decreased TC, TG, and FFA in se - rum and decreased lipid accumulation in the kidneys through  AMPK signaling.",Non-OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"673 http://dx.doi.org/10.3349/ymj.2016.57.3.664Bo Hwan Kim, et al.",OADS,/arxiv_data1/oa_pdf/73/78/ymj-57-664.PMC4800357.pdf
"Key Words:  Diabetes mellitus, obesity, visceral fatYonsei Med J 2016 May;57(3):674-680 http://dx.doi.org/10.3349/ymj.2016.57.3.674Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  September 22, 2015   Revised:  December 21, 2015 Accepted:  January 4, 2016 Corresponding author:  Dr. Dae Jung Kim, Department of Endocrinology and Me - tabolism, Ajou University School of Medicine, 164 World cup-ro, Yeongtong-gu,  Suwon 16499, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
"675 http://dx.doi.org/10.3349/ymj.2016.57.3.674Suk Hwa Jung, et al.",OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.674 676Visceral Fat Mass and Diabetes and Prediabetes 1800 Auto Analyzer; Siemens Medical Solutions, Malvern, PA,  USA).",Non-OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
"13.2.0 (MedCalc  Software, Ostend, Belgium; http://www.medcalc.org; 2014).",Non-OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
"677 http://dx.doi.org/10.3349/ymj.2016.57.3.674Suk Hwa Jung, et al.",OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.674 678Visceral Fat Mass and Diabetes and Prediabetes tive distribution of fat within the body.,Non-OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
"679 http://dx.doi.org/10.3349/ymj.2016.57.3.674Suk Hwa Jung, et al.",OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.674 680Visceral Fat Mass and Diabetes and Prediabetes tolerance: a prospective study among Japanese Americans.,Non-OADS,/arxiv_data1/oa_pdf/6e/02/ymj-57-674.PMC4800358.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):681-689 http://dx.doi.org/10.3349/ymj.2016.57.3.681",Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
"682Soy Protein Improve Type 2 Diabetes or MS http://dx.doi.org/10.3349/ymj.2016.57.3.681factors for CVD, such as body weight, lipids, and glucose me - tabolism, although results are controversial.",Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.681Table 1.,Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
684Soy Protein Improve Type 2 Diabetes or MS http://dx.doi.org/10.3349/ymj.2016.57.3.681Table 1.,Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.681publications, lack of interest in the presently investigated rela - tionship, and no soy protein supplementation were excluded.",Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
686Soy Protein Improve Type 2 Diabetes or MS http://dx.doi.org/10.3349/ymj.2016.57.3.681Table 2.,Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.6812).,Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
688Soy Protein Improve Type 2 Diabetes or MS http://dx.doi.org/10.3349/ymj.2016.57.3.681ger supplementation duration (≥6 mo) reduced blood glucose  levels significantly.,Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.681on renal function and proteinuria in patients with type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/83/44/ymj-57-681.PMC4800359.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):690-697 http://dx.doi.org/10.3349/ymj.2016.57.3.690",Non-OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.690100-fold higher sensitivity than standard assays, can detect CRP  at extremely low concentrations with its lower detection limit  of 0.1–0.2 mg/L.9,10 CRP measured using high-sensitivity assays  is referred to as high-sensitivity CRP (hs-CRP).",Non-OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
692hs-CRP and Small Airway Obstruction http://dx.doi.org/10.3349/ymj.2016.57.3.690linear interpolation of the log dose-response curve.,OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.690There was also no significant difference in asthma severity be - tween the positive hs-CRP group and the negative hs-CRP gr- oup (Table 1).,OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
"694hs-CRP and Small Airway Obstruction http://dx.doi.org/10.3349/ymj.2016.57.3.690FEF 25–75, and significant positive correlations with R5 and X5.",Non-OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.690increase in circulating pro-inflammatory cytokines, such as  interleukin (IL)-6 and tumor necrosis factor (TNF)- α, a conse - quent increase in acute-phase reactants such as CRP , and the  presence of immune cells, such as neutrophils and natural kill - er cells in asthmatic patients.27 Accordingly, several studies re - port associations between hs-CRP , a sensitive marker of sys - temic inflammation, and asthma.",Non-OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
696hs-CRP and Small Airway Obstruction http://dx.doi.org/10.3349/ymj.2016.57.3.690hs-CRP can reflect small airway inflammation.,Non-OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.690Change in C-reactive protein levels and FEV1 decline: a longitudi - nal population-based study.,OADS,/arxiv_data1/oa_pdf/64/25/ymj-57-690.PMC4800360.pdf
"Key Words:  Allergic disease, school children, ISAAC, air pollution, trafficYonsei Med J 2016 May;57(3):698-713 http://dx.doi.org/10.3349/ymj.2016.57.3.698Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  October 24, 2014   Revised:  August 27, 2015 Accepted:  September 4, 2015 Corresponding author:  Dr. Young Wook Lim, Institute for Environmental Research,  Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722,  Korea.",Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"699 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.698 700Air Pollution on Allergic Diseases in Elementary School Children tigation focused on traffic volume during a specific time peri - od, and traffic volume was measured over 15-minute intervals.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"701 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.698 702Air Pollution on Allergic Diseases in Elementary School Children view Board of Severance Hospital, Yonsei University Health  System (4-2013-0450).",Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"703 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.698 704Air Pollution on Allergic Diseases in Elementary School Children traffic-related zones.,Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"705 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.698 706Air Pollution on Allergic Diseases in Elementary School Children sure (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"707 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.698 708Air Pollution on Allergic Diseases in Elementary School Children schools (OR=1.17, 95% CIs 1.02 –1.35) and in complex source  schools (OR=1.34, 95% CIs 1.16 –1.55) compared with children  from the S1 school (Fig.",Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"709 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.698 710Air Pollution on Allergic Diseases in Elementary School Children comparable to the concentration level in the downtown area  in Reche, et al.32 Importantly, the BC concentration measured  indoors is higher than the background concentration level  suggested by Reche, et al.,32 with a concentration of 1.01 –5.24  μg/m3 in classrooms on lower floors (2nd floor) and of 1.03 – 4.76 μg/m3 in classrooms on higher floors (4th floor).",Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"711 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.698 712Air Pollution on Allergic Diseases in Elementary School Children (NEXUS): study design and methods.,Non-OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"713 http://dx.doi.org/10.3349/ymj.2016.57.3.698Ho Hyun Kim, et al.",OADS,/arxiv_data1/oa_pdf/5f/9f/ymj-57-698.PMC4800361.pdf
"Key Words:   Allergy, change, correlation, pollen, skin positivity rate, SeoulYonsei Med J 2016 May;57(3):714-720 http://dx.doi.org/10.3349/ymj.2016.57.3.714Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  July 20, 2015   Revised:  September 2, 2015 Accepted:  September 20, 2015 Co-corresponding authors:  Dr. Chein-Soo Hong, Severance Health Check-up, 10  Tongil-ro, Jung-gu, Seoul 04257, Korea.",Non-OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
"Tel: 82-31-560-2254, Fax: 82-31-552-9493, E-mail: jaewonoh@hanyang.ac.kr •The authors have no financial conflicts of intere st. © Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
"715 http://dx.doi.org/10.3349/ymj.2016.57.3.714Hye Jung Park, et al.",OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.714 716Changes in Pollen Counts and Skin Positivity Rates between the changes in pollen count and the skin positivity  rate, as measured by the SPT, from January 2009 through De - cember 2013.",OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
"717 http://dx.doi.org/10.3349/ymj.2016.57.3.714Hye Jung Park, et al.",OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.714 718Changes in Pollen Counts and Skin Positivity Rates DISCUSSION During the pollination season, anemophilous plants produce  small, lightweight pollen grains that may be disseminated by  air currents over a large geographical area, sometimes exceed - ing 100 km.",Non-OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
"719 http://dx.doi.org/10.3349/ymj.2016.57.3.714Hye Jung Park, et al.",OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.714 720Changes in Pollen Counts and Skin Positivity Rates et al.,OADS,/arxiv_data1/oa_pdf/35/05/ymj-57-714.PMC4800362.pdf
"Key Words:   Alexithymia, COMT Val158Met polymorphism, endophenotype, obsessive-compulsive disorder, Toronto alexithymia scale Yonsei Med J 2016 May;57(3):721-727 http://dx.doi.org/10.3349/ymj.2016.57.3.721Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  April 1, 2015   Revised:  August 6, 2015 Accepted:  August 12, 2015 Corresponding author:  Dr.",Non-OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.721 722Alexithymia and COMT  in OCD functional emotion regulation and recognition.7 Although the  cause of alexithymia remains unclear, there are several lines of  evidence suggesting the involvement of genetic influences.",Non-OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
"723 http://dx.doi.org/10.3349/ymj.2016.57.3.721Min Jung Koh, et al.",OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.721 724Alexithymia and COMT  in OCD Table 2.,Non-OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
"725 http://dx.doi.org/10.3349/ymj.2016.57.3.721Min Jung Koh, et al.",OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.721 726Alexithymia and COMT  in OCD thymia and that each dimension might have different underly - ing neural correlates.38 Moreover, the TAS-20 is known to assess  the cognitive component, which refers to the processing of  emotions at the cognitive level and comprises a limited ability  to identify, verbalize, and analyze one’s feelings;35 as such, it is  not a good representation of the emotional component.39 The present study had several limitations.",Non-OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
"727 http://dx.doi.org/10.3349/ymj.2016.57.3.721Min Jung Koh, et al.",OADS,/arxiv_data1/oa_pdf/c0/79/ymj-57-721.PMC4800363.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):728-734 http://dx.doi.org/10.3349/ymj.2016.57.3.728",Non-OADS,/arxiv_data1/oa_pdf/d2/14/ymj-57-728.PMC4800364.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.728tional Sample Project (NSP) large data sets.,OADS,/arxiv_data1/oa_pdf/d2/14/ymj-57-728.PMC4800364.pdf
730Applicability of TRISS Coefficients in Korea http://dx.doi.org/10.3349/ymj.2016.57.3.728with actual patient survival status.,Non-OADS,/arxiv_data1/oa_pdf/d2/14/ymj-57-728.PMC4800364.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.728to our trauma center.,Non-OADS,/arxiv_data1/oa_pdf/d2/14/ymj-57-728.PMC4800364.pdf
"732Applicability of TRISS Coefficients in Korea http://dx.doi.org/10.3349/ymj.2016.57.3.728When certain TRISS predictor variables were modified  (mTRISS) in an aim to identify a model superior to the exist - ing TRISS model, we discovered that converting “coded age”  into “continuous age” alone (b= α+βage×continuous value of age+  βRR×RR+βSBP×SBP+βGCS×GCS+βISS×ISS) produced a model with  a higher AUC value (0.913) and greater explanatory power (-2  log likelihood=437.652 vs. 455.739, R2=0.408 vs. 0.380, respec - tively) than the existing TRISS model.",OADS,/arxiv_data1/oa_pdf/d2/14/ymj-57-728.PMC4800364.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.728been firmly established, resulting in many patients being shuf - fled from one hospital to another until they are finally admitted.",Non-OADS,/arxiv_data1/oa_pdf/d2/14/ymj-57-728.PMC4800364.pdf
734Applicability of TRISS Coefficients in Korea http://dx.doi.org/10.3349/ymj.2016.57.3.728REFERENCES 1.,OADS,/arxiv_data1/oa_pdf/d2/14/ymj-57-728.PMC4800364.pdf
"Key Words:   HIF-2α, VEGF , cartilage degeneration, KL gradeYonsei Med J 2016 May;57(3):735-740 http://dx.doi.org/10.3349/ymj.2016.57.3.735Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  February 2, 2015   Revised:  March 26, 2015 Accepted:  July 6, 2015 Corresponding author:  Dr. Zhou Jian-lin, Department of Orthopedics, Renmin  Hospital of Wuhan University, Wuhan, Hubei Province 430060, China.",Non-OADS,/arxiv_data1/oa_pdf/c7/b8/ymj-57-735.PMC4800365.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/b8/ymj-57-735.PMC4800365.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.735 736HIF-2α and VEGF Were Correlated with OA Severity the Department of Orthopedics and diagnosed with knee OA  according to the American College of Rheumatology classifica - tion criteria were enrolled in the study.,Non-OADS,/arxiv_data1/oa_pdf/c7/b8/ymj-57-735.PMC4800365.pdf
"737 http://dx.doi.org/10.3349/ymj.2016.57.3.735Zhou Jian-lin, et al.",OADS,/arxiv_data1/oa_pdf/c7/b8/ymj-57-735.PMC4800365.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.735 738HIF-2α and VEGF Were Correlated with OA Severity were classified into four groups in relation to OA grading: 5 pa - tients were categorized as grade 0, 16 as grade 2, 13 as grade 3  and 16 as grade 4.",OADS,/arxiv_data1/oa_pdf/c7/b8/ymj-57-735.PMC4800365.pdf
"739 http://dx.doi.org/10.3349/ymj.2016.57.3.735Zhou Jian-lin, et al.",OADS,/arxiv_data1/oa_pdf/c7/b8/ymj-57-735.PMC4800365.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.735 740HIF-2α and VEGF Were Correlated with OA Severity 14.,Non-OADS,/arxiv_data1/oa_pdf/c7/b8/ymj-57-735.PMC4800365.pdf
"Key Words:   Hallux valgus, hallux valgus angle, intermetatarsal angle, measurement, reliabilityYonsei Med J 2016 May;57(3):741-747 http://dx.doi.org/10.3349/ymj.2016.57.3.741Original Article  pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 28, 2015   Revised:  July 14, 2015 Accepted:  August 28, 2015 Corresponding author:  Dr. Ji-Yong Ahn, Department of Orthopaedic Surgery, Ui - jeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea,  271 Cheonbo-ro, Uijeongbu 11765, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.741 742Measurements of the Hallux Valgus Deformity tomatic hallux valgus patients with subluxated joint, bigger  HVA would be related with clinical symptoms (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
"743 http://dx.doi.org/10.3349/ymj.2016.57.3.741Jeong-Ho Seo, et al.",OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.741 744Measurements of the Hallux Valgus Deformity reliability of pre- and postoperative HVA/IMA determined us - ing the new point-connecting method was higher than that de - termined using the conventional midline method.,Non-OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
"745 http://dx.doi.org/10.3349/ymj.2016.57.3.741Jeong-Ho Seo, et al.",OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.741 746Measurements of the Hallux Valgus Deformity surement reliability.,Non-OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
"747 http://dx.doi.org/10.3349/ymj.2016.57.3.741Jeong-Ho Seo, et al.",OADS,/arxiv_data1/oa_pdf/8b/30/ymj-57-741.PMC4800366.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):748-753 http://dx.doi.org/10.3349/ymj.2016.57.3.748",Non-OADS,/arxiv_data1/oa_pdf/66/b0/ymj-57-748.PMC4800367.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.748ganglion (DRG) neurons innervating intervertebral discs after  disc injury or during inflammation and degeneration.,Non-OADS,/arxiv_data1/oa_pdf/66/b0/ymj-57-748.PMC4800367.pdf
750Anti-NaV1.7 Antibody for Disc Injury http://dx.doi.org/10.3349/ymj.2016.57.3.748between right and left sides ( p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/66/b0/ymj-57-748.PMC4800367.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.748NaV1.7 antibody group and non-puncture group ( p>0.05).,Non-OADS,/arxiv_data1/oa_pdf/66/b0/ymj-57-748.PMC4800367.pdf
"752Anti-NaV1.7 Antibody for Disc Injury http://dx.doi.org/10.3349/ymj.2016.57.3.748was involved in injury-induced neuronal hyperexcitability in  a burn-injury model, and blocking NaV1.7 attenuated the hy - perexcitability.32 It was suggested that NaV1.7 inhibition may  be an effective tool for pain control in patients.",Non-OADS,/arxiv_data1/oa_pdf/66/b0/ymj-57-748.PMC4800367.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.748dorsal root ganglia neurons in inflammatory pain.,Non-OADS,/arxiv_data1/oa_pdf/66/b0/ymj-57-748.PMC4800367.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):754-760 http://dx.doi.org/10.3349/ymj.2016.57.3.754",Non-OADS,/arxiv_data1/oa_pdf/af/b4/ymj-57-754.PMC4800368.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.754early ER positive breast cancer in postmenopausal women.,Non-OADS,/arxiv_data1/oa_pdf/af/b4/ymj-57-754.PMC4800368.pdf
756Steroid Sulfatase in Endometrial Cancer Patients  http://dx.doi.org/10.3349/ymj.2016.57.3.754Interpretation of steroid sulfatase immunostaining  Immunohistochemical staining of STS was evaluated semi - quantitatively based on staining intensity and percentage of  positive cells.,OADS,/arxiv_data1/oa_pdf/af/b4/ymj-57-754.PMC4800368.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.754more than stage IB who were received adjuvant treatment;  three patients were grade 1, 5 patients were grade 2 and 8 pa - tients were grade 3.",Non-OADS,/arxiv_data1/oa_pdf/af/b4/ymj-57-754.PMC4800368.pdf
758Steroid Sulfatase in Endometrial Cancer Patients  http://dx.doi.org/10.3349/ymj.2016.57.3.754tality in group B.,Non-OADS,/arxiv_data1/oa_pdf/af/b4/ymj-57-754.PMC4800368.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.754cancer xenograft, the cancer cell growth was inhibited by 48%  and 67%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/af/b4/ymj-57-754.PMC4800368.pdf
760Steroid Sulfatase in Endometrial Cancer Patients  http://dx.doi.org/10.3349/ymj.2016.57.3.754dometrial carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/af/b4/ymj-57-754.PMC4800368.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):761-768 http://dx.doi.org/10.3349/ymj.2016.57.3.761",Non-OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
"762STAT3 and ERK Signaling Pathways Related with OSM http://dx.doi.org/10.3349/ymj.2016.57.3.761Oncostatin M (OSM), a cytokine in the IL-6 family, is a mul - tifunctional cytokine that affects the growth and differentia - tion of many different cell types.",Non-OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.761Invasion assay  A Matrigel invasion assay was performed as described previ - ously.4 The invasive ability of HTR8/SVneo cells was examined  using a cell invasion assay kit with a polycarbonate mem - brane (pore size: 8 µm; CHEMICON, Billerica, MA, USA) on  ECMatrixTM.",OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
"764STAT3 and ERK Signaling Pathways Related with OSM http://dx.doi.org/10.3349/ymj.2016.57.3.761RESULTS Effect of STAT3 inhibitor (stattic) and STAT3 siRNA on  OSM-mediated changes in MMP-2 and MMP-9  expression in HTR8/SVneo cells To investigate the role of the STAT3 pathway in the OSM-in - duced upregulation of MMP-2 and MMP-9, HTR8/SVneo  cells were pretreated with stattic (0.5, 1, or 2.5 µM) and then  stimulated with OSM (20 ng/mL, 48 h).",OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.761without transfection ( p<0.05 for both).,OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
766STAT3 and ERK Signaling Pathways Related with OSM http://dx.doi.org/10.3349/ymj.2016.57.3.761 Control OSM Stattic 0.5 uM Stattic 1 uM Stattic 2.5 uM OSM+stattic 0.5 uM OSM+stattic 1 uM OSM+stattic 2.5 uM Control OSM Stattic 0.5 Stattic 1 Stattic 2.5 OSM+stattic 0.5 OSM+stattic 1 OSM+stattic 2.5Control OSM Stattic U0126 Stattic+U0126 OSM+stattic OSM+U0126 OSM+stattic+U0126MMP-2 MMP-9 40× 40× <Scale> 40×: 100 µm 200×: 20 µm200× 200×MMP-2 & MMP-9 (24 h) Fig.,OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.761trophoblasts during early pregnancy.1 We previously reported  that OSM induced the expression of both enzymes in the  HTR8/SVneo cells.4 Using specific pharmacologic inhibitors  and siRNAs, we were able to demonstrate that major path - ways of the IL-6 family, including ERK and STAT3 pathways,  mediate the induction of these proteases via OSM.",OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
768STAT3 and ERK Signaling Pathways Related with OSM http://dx.doi.org/10.3349/ymj.2016.57.3.7612.,OADS,/arxiv_data1/oa_pdf/b3/d2/ymj-57-761.PMC4800369.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):769-775 http://dx.doi.org/10.3349/ymj.2016.57.3.769",Non-OADS,/arxiv_data1/oa_pdf/87/0e/ymj-57-769.PMC4800370.pdf
770Incentive Spirometer Exercise in CP http://dx.doi.org/10.3349/ymj.2016.57.3.769regarding the effectiveness of respiratory training on pulmo - nary function in children with CP .,Non-OADS,/arxiv_data1/oa_pdf/87/0e/ymj-57-769.PMC4800370.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.769through a mouthpiece.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/ymj-57-769.PMC4800370.pdf
772Incentive Spirometer Exercise in CP http://dx.doi.org/10.3349/ymj.2016.57.3.769various chairs in consideration of each child’s size.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/ymj-57-769.PMC4800370.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.769assessed as outcome measures in this study.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/ymj-57-769.PMC4800370.pdf
774Incentive Spirometer Exercise in CP http://dx.doi.org/10.3349/ymj.2016.57.3.769duction in children with CP .,Non-OADS,/arxiv_data1/oa_pdf/87/0e/ymj-57-769.PMC4800370.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.76934.,Non-OADS,/arxiv_data1/oa_pdf/87/0e/ymj-57-769.PMC4800370.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):776-783 http://dx.doi.org/10.3349/ymj.2016.57.3.776",Non-OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.776calculated odds ratio (OR) of 1.6 [95% confidence interval (CI):  1.1–2.4].,OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
778Risk Factor and Acoustic Neuroma http://dx.doi.org/10.3349/ymj.2016.57.3.776Meta-analysis results Noise exposure and acoustic neuroma The included studies in the meta-analysis for the risk associat - ed with noise exposure comprised eight studies.,OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.776rent smokers, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
780Risk Factor and Acoustic Neuroma http://dx.doi.org/10.3349/ymj.2016.57.3.776meta-analysis result.,OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.776mosomal changes necessary for neoplastic transformation.11 Smoking and acoustic neuroma  The OR of acoustic neuroma for the ever (versus never) smok - ing was 0.53 (95% CI: 0.30–0.94), while subgroup analysis in - dicated ORs of 0.95 (95% CI: 0.81–1.10) and 0.49 (95% CI: 0.41– 0.59) for ex-smokers and current smokers, respectively.",OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
"782Risk Factor and Acoustic Neuroma http://dx.doi.org/10.3349/ymj.2016.57.3.776ly, our meta-analysis contains 11 case-control studies.",OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.776MA.,OADS,/arxiv_data1/oa_pdf/e7/95/ymj-57-776.PMC4800371.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):784-789 http://dx.doi.org/10.3349/ymj.2016.57.3.784",Non-OADS,/arxiv_data1/oa_pdf/a5/49/ymj-57-784.PMC4800372.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.784Depressive disorders have been an important issue in a re- alm of mental health globally.11-14 Since depressive disorder is  a complex disease, due to both genetic and environmental fac - tors,15 it would be useful to investigate any association between  SOB and the epidemiological and clinical characteristics of  depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/a5/49/ymj-57-784.PMC4800372.pdf
786Season of Birth and Clinical Characteristics in MDD http://dx.doi.org/10.3349/ymj.2016.57.3.784births.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/ymj-57-784.PMC4800372.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.784that MDD patients with spring/summer birth are associated  with less illness burden than those with autumn/winter birth.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/ymj-57-784.PMC4800372.pdf
"788Season of Birth and Clinical Characteristics in MDD http://dx.doi.org/10.3349/ymj.2016.57.3.784Second, the familywise error rate due to multiple comparisons  may have been significant, since we did not use Bonferroni’s  correction.",Non-OADS,/arxiv_data1/oa_pdf/a5/49/ymj-57-784.PMC4800372.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.784version of WHO Quality of Life Scale Abbreviated Version (WHO - QOL-BREF).,OADS,/arxiv_data1/oa_pdf/a5/49/ymj-57-784.PMC4800372.pdf
"Key Words:   AAV-DJ, large scale production, liver-specific expressionYonsei Med J 2016 May;57(3):790-794 http://dx.doi.org/10.3349/ymj.2016.57.3.790Technical Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  May 28, 2015   Revised:  June 15, 2015 Accepted:  June 19, 2015 Corresponding author:  Dr. Young-Ah Moon, Department of Molecular Medicine,  Inha University School of Medicine, 100 Inha-ro, Nam-gu, Incheon 22212, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5c/61/ymj-57-790.PMC4800373.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/61/ymj-57-790.PMC4800373.pdf
"791 http://dx.doi.org/10.3349/ymj.2016.57.3.790Jingjing Liu and Young-Ah Moon cific gene expression.18 The use of AAV-DJ in animals has not  been reported, likely for the reason that there are no established  large-scale preparation/purification methods or protocols.",Non-OADS,/arxiv_data1/oa_pdf/5c/61/ymj-57-790.PMC4800373.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.790 792Purification of AAV-DJ  5000× g for 15 min.,OADS,/arxiv_data1/oa_pdf/5c/61/ymj-57-790.PMC4800373.pdf
"793 http://dx.doi.org/10.3349/ymj.2016.57.3.790Jingjing Liu and Young-Ah Moon lutions, quantitative PCR was performed with SYBR Green mix  (Thermo Fisher) as described previously.20 The viral titer was  determined by comparing C T values of the viral solutions to the  standards.",OADS,/arxiv_data1/oa_pdf/5c/61/ymj-57-790.PMC4800373.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.790 794Purification of AAV-DJ  5.,OADS,/arxiv_data1/oa_pdf/5c/61/ymj-57-790.PMC4800373.pdf
"Key Words:   Thymus hyperplasia; graves disease; receptors thyrotropin; immunoglobulins, thyroid-stimulatingYonsei Med J 2016 May;57(3):795-798 http://dx.doi.org/10.3349/ymj.2016.57.3.795Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  December 18, 2014   Revised:  March 21, 2015 Accepted:  June 19, 2015 Corresponding author:  Dr. Young Joo Park, Department of Internal Medicine,  Seoul National University College of Medicine, Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 03080, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/ymj-57-795.PMC4800374.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/ymj-57-795.PMC4800374.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.795 796Thymic Hyperplasia in Graves’ Disease mined (Table 1, visit #1).",Non-OADS,/arxiv_data1/oa_pdf/ec/e8/ymj-57-795.PMC4800374.pdf
"797 http://dx.doi.org/10.3349/ymj.2016.57.3.795Young Shin Song, et al.",OADS,/arxiv_data1/oa_pdf/ec/e8/ymj-57-795.PMC4800374.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.795 798Thymic Hyperplasia in Graves’ Disease been reported that TSH-R in the orbit and fibroblasts results  in Graves’ ophthalmopathy and dermopathy.5 Murakami, et al.6  identified the presence of TSH-R in non-neoplastic thymic tis - sues obtained from non-thyroidal disease patients.",OADS,/arxiv_data1/oa_pdf/ec/e8/ymj-57-795.PMC4800374.pdf
"Key Words:   Clubbing fingers, platypnea-orthodeoxia syndrome, secundum atrial septal defect, Amplatzer Septal OccluderYonsei Med J 2016 May;57(3):799-802 http://dx.doi.org/10.3349/ymj.2016.57.3.799Case Report pISSN: 0513-5796 · eISSN: 1976-2437 Received:  April 7, 2015   Revised:  May 29, 2015 Accepted:  June 16, 2015 Corresponding author:  Dr. Meng-Luen Lee, Department of Pediatrics, Division of  Pediatric Cardiology, Changhua Christian Children’s Hospital, No.",Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ymj-57-799.PMC4800375.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ymj-57-799.PMC4800375.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.799 800Platypnea-Orthodeoxia Syndrome shunt.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ymj-57-799.PMC4800375.pdf
801 http://dx.doi.org/10.3349/ymj.2016.57.3.799Meng-Luen Lee and Ing-Sh Chiu secundum ASD with a right-to-left shunt.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ymj-57-799.PMC4800375.pdf
http://dx.doi.org/10.3349/ymj.2016.57.3.799 802Platypnea-Orthodeoxia Syndrome 2.,Non-OADS,/arxiv_data1/oa_pdf/d0/7d/ymj-57-799.PMC4800375.pdf
"© Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.Yonsei Med J 2016 May;57(3):803-805 http://dx.doi.org/10.3349/ymj.2016.57.3.803Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/04/80/ymj-57-803.PMC4800376.pdf
"http://dx.doi.org/10.3349/ymj.2016.57.3.803 804Levosulpiride-Associated Hemichorea Brain SPECT showing hyperperfusion in the basal ganglia dur - ing the initial study revealed hypoperfusion upon follow-up.7  Increased cerebral blood flow has been suggested to be a com - pensation for the rapid normalization of blood glucose level.7  Dopamine transporter imaging showed dopaminergic deficits  in the basal ganglia with Huntington’s disease and chorea- acanthocytosis.8,9 It might be difficult to draw conclusions, as  these previous studies observed cases due to various causes;  nevertheless, we can infer that striatal dysfunction might be a  common pathophysiologic mechanism for the development of  chorea.",Non-OADS,/arxiv_data1/oa_pdf/04/80/ymj-57-803.PMC4800376.pdf
"805 http://dx.doi.org/10.3349/ymj.2016.57.3.803Hyun Chang Lee, et al.",OADS,/arxiv_data1/oa_pdf/04/80/ymj-57-803.PMC4800376.pdf
")Yonsei Med J 2016 May;57(3):806-806 http://dx.doi.org/10.3349/ymj.2016.57.3.806Erratum pISSN: 0513-5796 · eISSN: 1976-2437 © Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.We would like to add the grant information  as written below.",Non-OADS,/arxiv_data1/oa_pdf/c5/93/ymj-57-806.PMC4800377.pdf
")Yonsei Med J 2016 May;57(3):807-807 http://dx.doi.org/10.3349/ymj.2016.57.3.807Erratum pISSN: 0513-5796 · eISSN: 1976-2437 © Copyright: Yonsei University College of Medicine 2016 This is an Open Access article distributed under the terms of the Creative Com - mons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.We would like to add the grant information  as written below.",Non-OADS,/arxiv_data1/oa_pdf/9e/bf/ymj-57-807.PMC4800378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/32/omw011.PMC4800453.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/49/ofw045.PMC4800455.pdf
Available at: http://ota.fas.org/ reports/9503.pdf .,Non-OADS,/arxiv_data1/oa_pdf/09/49/ofw045.PMC4800455.pdf
Available at: http://www.cdc.gov/ nchs/ahcd/ahcd_questionnaires.htm .,OADS,/arxiv_data1/oa_pdf/09/49/ofw045.PMC4800455.pdf
Available at: http://www2.sas.com/proceedings/forum2007/ 183-2007.pdf .,Non-OADS,/arxiv_data1/oa_pdf/09/49/ofw045.PMC4800455.pdf
Available at: http://www.sciencedaily.com/releases/2009/01/090116111137.,Non-OADS,/arxiv_data1/oa_pdf/09/49/ofw045.PMC4800455.pdf
Available at: http://www.npcnow.org/publication/ pharmaceutical-bene ﬁts-under-state-medical-a ssistance-programs-2003 .A c - cessed 16 April 2015.,Non-OADS,/arxiv_data1/oa_pdf/09/49/ofw045.PMC4800455.pdf
Demographic data for 2005 were extracted from http://worldgazetteer.com/home.php 18 and for 2012 from the  World Population Prospects: The 2010 revision of the United Nations for the year (2012).,OADS,/arxiv_data1/oa_pdf/15/0c/10.1177_0269216315598671.PMC4800456.pdf
"Geneva: WHO, http://apps.who.int/ gb/ebwha/pdf_files/WHA67/A67_31-en.pdf (accessed 4  April–27 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/15/0c/10.1177_0269216315598671.PMC4800456.pdf
"IP/A/ENVI/ST/2007-22; PE404.899, http://www.europarl.europa.eu/activities/committees/studies/down- load.do?file=21421 (accessed March 2010).",Non-OADS,/arxiv_data1/oa_pdf/15/0c/10.1177_0269216315598671.PMC4800456.pdf
14. http://www.lifebeforedeath.com/qualityofdeath/index.shtml (accessed March 2011).,Non-OADS,/arxiv_data1/oa_pdf/15/0c/10.1177_0269216315598671.PMC4800456.pdf
18. http://worldgazetteer.com/home.php  19.,Non-OADS,/arxiv_data1/oa_pdf/15/0c/10.1177_0269216315598671.PMC4800456.pdf
World Population Prospects: The  2010 revision of the United Nations for the year 2012. http://www.un.org/en/development/desa/population/publi-cations/trends/population-prospects_2010_revision.shtml  20.,Non-OADS,/arxiv_data1/oa_pdf/15/0c/10.1177_0269216315598671.PMC4800456.pdf
"Hospitals  2014 Snapshot, https://www.capc.org/topics/metrics-and-measurement-palliative-care/ (accessed 15 March 2015).",Non-OADS,/arxiv_data1/oa_pdf/15/0c/10.1177_0269216315598671.PMC4800456.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/e8/ofw035.PMC4800457.pdf
Available at: http://www.apf.pt/sites/default/ ﬁles/media/2015/unaids_ 2008globalreport_en_1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bc/e8/ofw035.PMC4800457.pdf
Available at: http://arv.ashm.org.au/clinical-guidance .,Non-OADS,/arxiv_data1/oa_pdf/bc/e8/ofw035.PMC4800457.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/b8/ofw036.PMC4800458.pdf
Supplementary material for this article is available on the Journal of  Biomolecular Screening Web site at http://jbx.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/07/2d/10.1177_1087057115618347.PMC4800460.pdf
"In brief, paired-end sequencing reads were assembled de novo using CLC Bio Genomics Workbench version 8.0.3 (QIAGEN) and the SPAdes genome assembler(http://bioinf.spbau.ru/spades ) and then mapped to the previ- ously sequenced MGAS10750 serotype M4 reference genome (NC_008024.1).",OADS,/arxiv_data1/oa_pdf/21/fb/ofw042.PMC4800461.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/fb/ofw042.PMC4800461.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/ad/ofw040.PMC4800462.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/80/rjw038.PMC4800463.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/66/ofw034.PMC4800464.pdf
Rhesus macaques reach puberty at 3 to 4 years of age with 1 year of rhe-sus life being approximately equivalent to 4 years of human life (http://genomics.senescence.info/species/entry.php?,Non-OADS,/arxiv_data1/oa_pdf/03/66/ofw034.PMC4800464.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/33/ofw044.PMC4800465.pdf
"R Foundation for Statistical Computing, Vienna, Austria, 2008 ; Available at:http://www.R-project.org .",Non-OADS,/arxiv_data1/oa_pdf/ba/33/ofw044.PMC4800465.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/c1/ofw041.PMC4800466.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/5f/ofw038.PMC4800467.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/lupus-2015- 000136).,Non-OADS,/arxiv_data1/oa_pdf/df/f9/lupus-2015-000136.PMC4800735.pdf
doi:10.1136/ openhrt-2016-000401 Accepted 21 January 2016 ▸http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ad/ab/openhrt-2016-000401.PMC4800756.pdf
2015. http://www.ons.gov.uk/ons/rel/vsob1/mortality-statistics –deaths-registered-in-england-and-wales – series-dr-/2012/index.html 3.,Non-OADS,/arxiv_data1/oa_pdf/ad/ab/openhrt-2016-000401.PMC4800756.pdf
2012. http://www.bcis.org.uk/resources/BCIS_Audit_2012_for_web_V2_14-10-20131.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/1f/8f/openhrt-2015-000389.PMC4800760.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/97/91/openhrt-2015-000339.PMC4800761.pdf
"[http://dx.doi.org/10.1016/j.spinee.2009.05.006 ] [PMID: 19540168 ] [3] C.  Myeroff,  and  M.  Archdeacon,  ""Autogenous  bone  graft:  donor  sites  and  techniques"",  J.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.2106/JBJS.J.01513 ] [PMID: 22159859 ] [4] E. Ortiz-Cruz, M.C.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1126/science.284.5411.143 ] [PMID: 10102814 ] [6] J. Goshima, V.M.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1016/j.bone.2007.06.022 ] [PMID: 17690025 ] [8] I. Torigoe, S. Sotome, A. Tsuchiya, T. Yoshii, M. Takahashi, S. Kawabata, and K. Shinomiya, ""Novel cell seeding system into a porous scaffold using a modified low-pressure method to enhance cell seeding efficiency and bone formation"", Cell Transplant.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.3727/000000007783465109 ] [PMID: 18019362 ] [9] I. Torigoe, S. Sotome, A. Tsuchiya, T. Yoshii, H. Maehara, Y. Sugata, S. Ichinose, K. Shinomiya, and A. Okawa, ""Bone regeneration with autologous plasma, bone marrow stromal cells, and porous β-tricalcium phosphate in nonhuman primates"", Tissue Eng.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1089/ten.tea.2008.0317 ] [PMID: 19191499 ] [10] M. Mastrogiacomo, A. Corsi, E. Francioso, M. Di Comite, F. Monetti, S. Scaglione, A. Favia, A. Crovace, P. Bianco, and R. Cancedda, ""Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate"", Tissue Eng.",Non-OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1089/ten.2006.12.1261 ] [PMID: 16771639 ] [11] P. Giannoni, M. Mastrogiacomo, M. Alini, S.G. Pearce, A. Corsi, F. Santolini, A. Muraglia, P. Bianco, and R. Cancedda, ""Regeneration of large bone defects in sheep using bone marrow stromal cells"", J. Tissue Eng.",Non-OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1002/term.90 ] [PMID: 18537203 ] [12] G. Liu, L. Zhao, W. Zhang, L. Cui, W. Liu, and Y. Cao, ""Repair of goat tibial defects with bone marrow stromal cells and β-tricalcium phosphate"", J.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
[http://dx.doi.org/10.1007/s10856-007-3348-3 ] [PMID: 18158615 ] [13] M.B.,Non-OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1002/jbm.a.32239 ] [PMID: 19065569 ] [14] X. Liu, X. Li, Y.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1111/j.1525-1594.2010.01042.x ] [PMID: 20946293 ] [16] U.  Ripamonti,  B.",Non-OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1016/S0934-8832(11)80115-0 ] [PMID: 8309427 ] [17] U. Ripamonti, ""Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models"", Biomaterials , vol.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1016/0142-9612(96)80752-6 ] [PMID: 8962945 ] [18] Z. Yang, H. Yuan, W. Tong, P. Zou, W. Chen, and X. Zhang, ""Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals"", Biomaterials , vol.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1016/0142-9612(96)00044-0 ] [PMID: 8922598 ] [19] S. Fujibayashi, M. Neo, H.M. Kim, T. Kokubo, and T. Nakamura, ""Osteoinduction of porous bioactive titanium metal"", Biomaterials , vol.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1016/S0142-9612(03)00551-9 ] [PMID: 14585692 ] [20] D. Le Nihouannen, G. Daculsi, A. Saffarzadeh, O. Gauthier, S. Delplace, P. Pilet, and P. Layrolle, ""Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles"", Bone , vol.",Non-OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1016/j.bone.2005.02.017 ] [PMID: 15869915 ] [21] P. Habibovic, T.M.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1002/jbm.a.30712 ] [PMID: 16557498 ] [22] N.  Akiyama,  M.  Takemoto,  S.  Fujibayashi,  M.  Neo,  M.  Hirano,  and  T.  Nakamura,  ""Difference  between  dogs  and  rats  with  regard  to osteoclast-like cells in calcium-deficient hydroxyapatite-induced osteoinduction"", J. Biomed.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1002/jbm.a.32995 ] [PMID: 21171160 ] [23] T. Yamada, M. Yuasa, T. Masaoka, T. Taniyama, H. Maehara, I. Torigoe, T. Yoshii, K. Shinomiya, A. Okawa, and S. Sotome, ""After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate"", Bone , vol.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1016/j.bone.2013.08.028 ] [PMID: 24029132 ] Received: March 3, 2015 Revised: September 30, 2015 Accepted: October 14, 2015 © Masaoka et al.",OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/6f/TOBEJ-10-2.PMC4800777.pdf
"[http://dx.doi.org/10.1345/aph.1A178] [PMID: 11895065] [3] Woodward DF, Wang JW, Poloso NJ.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
[http://dx.doi.org/10.1124/pr.112.007088] [PMID: 23893067] [4] Kashiwagi K. Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community.,Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.2174/1874364101004010007] [PMID: 20556196] [5] Woodward DF, Krauss AH, Chen J, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
[http://dx.doi.org/10.1016/S0039-6257(01)00224-7] [PMID: 11434936] [6] Smid SD.,OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.2147/OPTH.S6337] [PMID: 20054414] [7] DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1016/S0039-6257(01)00212-0] [PMID: 11434938] [8] DuBiner HB, Mroz M, Shapiro AM, Dirks MS. A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1016/S0149-2918(01)80150-8] [PMID: 11813932] [9] Noecker RJ, Earl ML, Mundorf T, Peace J, Williams RD.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1007/BF02850259] [PMID: 12836812] [10] Dirks MS, Noecker RJ, Earl M, Roh S, Silverstein SM, Williams RD.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1007/BF02850159] [PMID: 16912020] [11] Li T, Lindsley K, Rouse B, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
[http://dx.doi.org/10.1016/j.ophtha.2015.09.005.],OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
[http://dx.doi.org/10.2147/OPTH.S87613] [PMID: 26300624],Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
[http://dx.doi.org/10.1371/journal.pone.0140601] [PMID: 26484767] [14] Kashiwagi  K.  Efficacy  and  safety  of  switching  to  travoprost/timolol  fixed-combination  therapy  from  latanoprost  monotherapy.,Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1007/s10384-012-0139-2] [PMID: 22581454] [15] Mandić Z, Novak-Laus K, Bojić L, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.2147/OPTH.S10694] [PMID: 20505839] [17] Denis  P,  Lafuma  A,  Khoshnood  B,  Mimaud  V,  Berdeaux  G.  A  meta-analysis  of  topical  prostaglandin  analogues  intra-ocular  pressure lowering in glaucoma therapy.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1185/030079907X178720] [PMID: 17355741] [18] Noecker RJ, Awadallah NS, Kahook MY.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1358/dot.2007.43.2.1032058] [PMID: 17353945] [19] Ishikawa S, Nakamura Y, Nakamura Y, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.2147/OPTH.S3997] [PMID: 19668419] [20] Cheng  JW,  Li  Y,  Wei  RL.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1159/000225963] [PMID: 19546601] [21] Zhang S, Wang H, Lu Q, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1016/j.brainres.2009.09.029] [PMID: 19765568] [22] Hodge WG, Lachaine J, Steffensen I, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1136/bjo.2007.123737] [PMID: 18156371] [23] Miyata K, Amano S, Sawa M, Nishida T. A novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeability.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1001/archopht.121.11.1537] [PMID: 14609908] [24] Aptel F, Cucherat M, Denis P. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e3181666557] [PMID: 19092464] [25] Kawaguchi I, Higashide T, Ohkubo S, Kawaguchi C, Sugiyama K. Comparison of efficacy of four prostaglandin analogues by bilateral treatment in healthy subjects.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1007/s10384-012-0155-2] [PMID: 22669351] [26] Pfennigsdorf S, Ramez O, von Kistowski G, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.2147/OPTH.S31330] [PMID: 22654501] [27] Sato S, Hirooka K, Baba T, et al.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1089/jop.2011.0020] [PMID: 21790301] [28] Nixon DR. A randomized, prospective study of bimatoprost 0.01% or travoprost/timolol in patients previously treated with latanoprost and timolol to reduce intraocular pressure.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1089/jop.2013.0108] [PMID: 24070367] [29] Day DG, Hollander DA.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1185/030079908X301848] [PMID: 18402717] [30] Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1097/IJG.0b013e31815072fe] [PMID: 18414111] [31] van der Valk R, Webers CA, Lumley T, Hendrikse F, Prins MH, Schouten JS.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
[http://dx.doi.org/10.1016/j.jclinepi.2008.04.012] [PMID: 19716679],OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1016/S0002-9394(03)00098-9] [PMID: 12719078] [33] Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J. Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1136/bjo.2007.135111] [PMID: 19019922] [34] Kurtz S, Mann O.",OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.2147/OPTH.S36628] [PMID: 23055677] [36] Eisenberg DL, Toris CB, Camras CB.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1016/S0039-6257(02)00327-2] [PMID: 12204706] [37] Manni G, Centofanti M, Parravano M, Oddone F, Bucci MG. A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1007/s00417-004-0866-2] [PMID: 15241611] [38] Aihara M, Shirato S, Sakata R. Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"[http://dx.doi.org/10.1007/s10384-011-0075-6] [PMID: 21953485] Received: November 17, 2015 Revised: December 17, 2015 Accepted: December 17, 2015 © Imasawa et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/d2/TOOPHTJ-10-94.PMC4800778.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/rmdopen-2015-000219).,Non-OADS,/arxiv_data1/oa_pdf/25/80/rmdopen-2015-000219.PMC4800803.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ rmdopen-2015-000203).,Non-OADS,/arxiv_data1/oa_pdf/cc/a8/rmdopen-2015-000203.PMC4800804.pdf
To view please visit the journal (http://dx.doi.org/10.1136/rmdopen-2015- 000205).,Non-OADS,/arxiv_data1/oa_pdf/4a/cb/rmdopen-2015-000205.PMC4800805.pdf
http://clinicaltrials.gov/show/NCT00444691 NLM Identifier: NCT00444691.,Non-OADS,/arxiv_data1/oa_pdf/4a/cb/rmdopen-2015-000205.PMC4800805.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/rmdopen-2015-000159).,Non-OADS,/arxiv_data1/oa_pdf/98/1e/rmdopen-2015-000159.PMC4800807.pdf
"Rituximab is given either in patients with SScoverlap syndrome with RA, or as part of a randomised placebo-controlled clinical trial (RITIS), registered at http://www.clinicaltrialsregister.eu/ EudraCT Number:2008-007180-16.",Non-OADS,/arxiv_data1/oa_pdf/98/1e/rmdopen-2015-000159.PMC4800807.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2015-000184).,Non-OADS,/arxiv_data1/oa_pdf/14/95/rmdopen-2015-000184.PMC4800834.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/14/95/rmdopen-2015-000184.PMC4800834.pdf
2011. http://www.svenskreumatologi.se/sites/default/files/49/Guidelines_for_the_Pharmaceutical_Management_of_Rheumatoid_Arthritis.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/14/95/rmdopen-2015-000184.PMC4800834.pdf
No: ChiCTR‑OOC‑14005629; http://www.chictr.org.cn/showproj.aspx?proj=9875.,Non-OADS,/arxiv_data1/oa_pdf/53/d9/CMJ-129-410.PMC4800841.pdf
Available from:  http://www.zacb.com.,Non-OADS,/arxiv_data1/oa_pdf/39/13/CMJ-129-417.PMC4800842.pdf
Two bioinformatic predictive softwares TargetScan and  PicTar (http://www.targetscan.org/; http://pictar.mdc‑berlin.,OADS,/arxiv_data1/oa_pdf/71/aa/CMJ-129-424.PMC4800843.pdf
"Several studies have revealed that induction  of autophagy plays a significant role in the resistance and Table 2: Examples of clinical trials involving chloroquine or hydroxychloroquine for the treatment of gastrointestinal  cancer Condition HCQ combined therapy Phase Clinical trial ID Liver cancer TACE I/II NCT02013778 Advanced solid tumors V orinostat I NCT01023737 Colorectal cancer V orinostat II NCT02316340 Advanced solid tumors, melanoma,  prostate or kidney cancerMK2206 (Akt inhibitor) I NCT01480154 Pancreatic cancer Proton or Photon beam radiation therapy and capecitabine II NCT01494155 Pancreatic cancer Gemcitabine/abraxane I/II NCT01506973 Advanced or metastatic cancer Sirolimus/vorinostat I NCT01266057 Pancreatic cancer Gemcitabine hydrochloride and paclitaxel albumin‑stabilized  nanoparticle formulationII NCT01978184 Colorectal cancer Fluorouracil, leucovorin calcium, oxaliplatin, and bevacizumab I/II NCT01206530 Colorectal cancer Bevacizumab and combination chemotherapy II NCT01006369 Metastatic solid tumors Temsirolimus I NCT00909831 Refractory or relapsed solid tumors Sorafenib I NCT01634893 The content of Table 2 was from http://www.cancer.gov/clinicaltrials.",Non-OADS,/arxiv_data1/oa_pdf/c5/20/CMJ-129-456.PMC4800847.pdf
doi:  http://dx.doi.org/10.1016/j.ccr.2006.06.001.,OADS,/arxiv_data1/oa_pdf/c5/20/CMJ-129-456.PMC4800847.pdf
doi: http://dx.doi.org/10.1016/j.canlet.2012.03.002.,OADS,/arxiv_data1/oa_pdf/c5/20/CMJ-129-456.PMC4800847.pdf
Available from: https://fri.wisc.edu/ files/Briefs_File/parasites.pdf   3.,Non-OADS,/arxiv_data1/oa_pdf/5c/1d/SaudiMedJ-37-288.PMC4800893.pdf
[Accessed 2012 May 14] Available from: http://www.scr.org.sa/reports/SCR 2005.pdf   4.,OADS,/arxiv_data1/oa_pdf/77/58/SaudiMedJ-37-329.PMC4800902.pdf
Available from:  http://www.who.int/mediacentre/news/statements/2016/1st-emergency-committee-zika/en/,Non-OADS,/arxiv_data1/oa_pdf/d8/2d/SaudiMedJ-37-332.PMC4800905.pdf
Available from URL: http://www.fiqhacademy.org.sa/   38.,Non-OADS,/arxiv_data1/oa_pdf/9e/10/SaudiMedJ-37-121.PMC4800908.pdf
Sample references are available from:   http://www.nlm.nih.gov/bsd/uniform_requirements.html,Non-OADS,/arxiv_data1/oa_pdf/13/c3/SaudiMedJ-37-127.PMC4800909.pdf
Available from: http://www.cdc.gov/growthchart10.,OADS,/arxiv_data1/oa_pdf/c8/e8/SaudiMedJ-37-161.PMC4800915.pdf
Available from: http://www.phac-aspc.gc.ca/cd-mc/sleepapnea- apneesommeil/ff-rr-2009-eng.php   5.,Non-OADS,/arxiv_data1/oa_pdf/df/89/SaudiMedJ-37-183.PMC4800918.pdf
Available from: http://dent.ksu.edu.sa/en   2.,Non-OADS,/arxiv_data1/oa_pdf/3e/da/SaudiMedJ-37-208.PMC4800922.pdf
Available from: http://dental.pacific.edu/Documents/ microsites/accreditation/Predoc%20Standards%2002%2012.,Non-OADS,/arxiv_data1/oa_pdf/3e/da/SaudiMedJ-37-208.PMC4800922.pdf
"The consequence of the mutation unraveled in this  study was assessed using ExPASy translation tool  (http://web.expasy.org/translate/ ) and PolyPhen-2,  which predicts the functional effects of human  nonsynonymous SNPs ( http://genetics.bwh.harvard.",OADS,/arxiv_data1/oa_pdf/6a/35/SaudiMedJ-37-215.PMC4800924.pdf
Available from:  http://www.who.int/mediacentre/news/releases/2015/eliminate-rabies/en/ -------------------------------------------------------------------------------------------------------,Non-OADS,/arxiv_data1/oa_pdf/6e/d6/SaudiMedJ-37-220.PMC4800927.pdf
Available from:  http://www.who.int/mediacentre/news/releases/2015/report-malaria-elimination/en/WHO News Release,Non-OADS,/arxiv_data1/oa_pdf/36/fd/SaudiMedJ-37-221.PMC4800928.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/8c/87/IJA-60-157.PMC4800930.pdf
Available  from: http://www.hindawi.com/journals/isrn/2013/812964/.,Non-OADS,/arxiv_data1/oa_pdf/5d/0c/IJA-60-163.PMC4800931.pdf
"Medical College & Teaching Hospital, Nizamabad Organising Secretary:  Dr. Chintala Kishan Contact:  +91 98480 71377 & 99490 46637 E-mail: isacontelangana2016@gmail.com, chintala_kishan@yahoo.in Website: www.isatelangana.org Name of the conference: ISACON MP - 2016   30th Annual State Conference of ISA MP State Chapter Date:  10th September 2016 Venue:  Hotel Jabali Palace, Jabalpur Organising Secretary:  Dr. Ashish Sethi Contact:  +91 98261 68747 E-mail: ashsethi64@yahoo.com Website: http://www.isampchapter.com Name of the conference: 4th World Congress of Ophthalmic Anaesthesia  (WCOA), 2016 Organized by:  Sankara Nethralaya and British Ophthalmic Anaesthesia Society Date:  3rd & 4th September, 2016 Venue:  ITC Grand Chola, Chennai Organising Secretary:  Dr. Jaichandran V V Contact:  +91 98840 96860 E-mail: wcoa2016@gmail.com Website: www.sankaranethralaya.org/wcoa2016Announcement",Non-OADS,/arxiv_data1/oa_pdf/b2/d9/IJA-60-187.PMC4800935.pdf
Available from:  http://www.capca.ca/wp‑content/uploads.,Non-OADS,/arxiv_data1/oa_pdf/15/66/IJA-60-218.PMC4800943.pdf
Available from:  http://www.capca.ca/wp‑content/uploads.,Non-OADS,/arxiv_data1/oa_pdf/4e/27/IJA-60-219.PMC4800944.pdf
Available from: http://www.censusindia.gov.,OADS,/arxiv_data1/oa_pdf/92/f0/IJA-60-225.PMC4800947.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/9d/71/IJA-60-226.PMC4800948.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/9d/71/IJA-60-226.PMC4800948.pdf
Available from: http://www.scholarlyoa.com/2012/11/20/ journal -indexing -what -it-is-and-what -its-not/.,Non-OADS,/arxiv_data1/oa_pdf/1c/a6/IJOrtho-50-115.PMC4800951.pdf
Available from: https://www.en.wikipedia.org/ wiki/Citation_index.,Non-OADS,/arxiv_data1/oa_pdf/1c/a6/IJOrtho-50-115.PMC4800951.pdf
Index Medicu s. Available from: https://www.en.wikipedia.org/ wiki/Index_Medicus.,Non-OADS,/arxiv_data1/oa_pdf/1c/a6/IJOrtho-50-115.PMC4800951.pdf
Available from: https://www.en.wikipedia.org/wiki/ Embase.,Non-OADS,/arxiv_data1/oa_pdf/1c/a6/IJOrtho-50-115.PMC4800951.pdf
Available from: https://www.en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/1c/a6/IJOrtho-50-115.PMC4800951.pdf
Available from: http://www.mciindia.org/circulars/ Circular03.09.2015 -TEQ-Promotion -Publication.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/a6/IJOrtho-50-115.PMC4800951.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/23/ofw039.PMC4800993.pdf
Available at: http://www.wpro.who.int/mvp/ documents/docs/Pknowlesi_ ﬁnal_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/de/23/ofw039.PMC4800993.pdf
Available at: http://www.moh.gov.my/english.php/pages/view/118 .,Non-OADS,/arxiv_data1/oa_pdf/de/23/ofw039.PMC4800993.pdf
"3, 119~126, September , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.3.119  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 1 May 2015, Received in revised form 12 May 2015, Accepted 22 May 2015   † Corresponding Author : Se-Pill Park, Faculty of Biotechnology, College of Applied Life Sciences, Jeju National University, 102 Jejudaehak -ro, Jeju,  Jeju Special Self -Governing Province, 63243, Korea.",Non-OADS,/arxiv_data1/oa_pdf/13/3c/DR-19-119.PMC4801015.pdf
"3, 145~152, September , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.3.145  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 30 June 2015, Received in revised form 9 July 2015, Accepted 23 July 2015   † Corresponding Author : Yong -Pil Cheon , Division of Developmental Biology and Physiology, School of Biosciences and Chemistry, Sunghsin  Women’s University, Mia -Unjeong -Green Campus, 147 Mi a-dong, Kangbuk -gu, Seoul 142 -742, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/dc/ae/DR-19-145.PMC4801041.pdf
"For image analysis the freeware  ImageJ (National Institutes of Health software) v1.33 and  the Color Histogram plug -in, both downloaded from the  NIH website (http://rsb.info.nih.gov/ij) were used .",OADS,/arxiv_data1/oa_pdf/dc/ae/DR-19-145.PMC4801041.pdf
"3, 135~144, September , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.3.135  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 17 June 2015, Received in revised form 25 June 2015, Accepted 7 July 2015   † Corresponding Author : Hee Jeong Kong , Biotechnology Research Division, National Fisheries Research and Development Institute (NFRDI), 216  Haean -ro, Gijang -up, Gijang -gun, Busan 46083 , Republic of Korea .",Non-OADS,/arxiv_data1/oa_pdf/70/16/DR-19-135.PMC4801042.pdf
The  nucleotide sequence was analyzed and compared using  the  BLASTX search program ( http://www.ncbilnlm.ni h.gov/   BLAST/).,OADS,/arxiv_data1/oa_pdf/70/16/DR-19-135.PMC4801042.pdf
Multiple sequence alignment and phylogenetic  analysis   The relevant sequences were compared using the BLASTX   search program (http://www.ncbi.nlm.nih.gov/BLAST/) and   retrieved from GenBank for multiple sequence alignments  using CLUSTALW (http://www.genome.jp/tools -bin/clustalw).,OADS,/arxiv_data1/oa_pdf/70/16/DR-19-135.PMC4801042.pdf
"A search  using the BLASTX program ( http://www.ncbi.nlm.ni h.gov/   blast/Blast.cgi) and pairwise alignment revealed that the  deduced amino acids of EST clones RU -1-2a_I02, RU -1- 3a_F01, RU -2-1a_I11 and RU -2-3a_F17 showed the high  homology with heat shock protein 70kDa 4 -like (HSP4),  heat shock cognate 70 (HSC70), he at shock protein 70kDa  12A-like (HSP12 A) and glucose regulated protein 78 (GRP78)  of other species, respectively .",OADS,/arxiv_data1/oa_pdf/70/16/DR-19-135.PMC4801042.pdf
"3, 163~166, September , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.3.163  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 6 July 2015, Received in revised form 16 July 2015, Accepted 3 August  2015   † Corresponding author : Jong-Man Yoon , Dept .",Non-OADS,/arxiv_data1/oa_pdf/d0/52/DR-19-163.PMC4801043.pdf
"3, 153~161, September , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.3.153  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 4 May 2015, Received in revised form 15 May 2015, Accepted 30 May 2015   † Corresponding author : In-Seok Park, Division of Marine Bioscience, College of Ocean Science and Technology, Korea Maritime and Ocean University,  Busan  606-791, Korea.",Non-OADS,/arxiv_data1/oa_pdf/40/2b/DR-19-153.PMC4801044.pdf
"3, 127~134, September , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.3.127  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 4 May 2015, Received in revised form 15 May 2015, Accepted 30 May 2015   * Corresponding author  : In Bon Goo, Inland Aquaculture Research Center, National Fisheries Research & Development Institute, Jinhae 645 -758, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c8/1e/DR-19-127.PMC4801045.pdf
"2, 79~84, June, 2015  http://dx.doi.org/10.12717/DR.2015.19.2.079  ISSN 1226-6752 (Print)  ISSN 2287-7967 (Online)    Manuscript received 5 April 2015, Received in revised form 12 April 2015, Accepted 20 May 2015   † Corresponding Author : Seongsoo Hwang, Animal Biotechnology Division, NIAS, RDA, Wanju 565-851, Korea.",Non-OADS,/arxiv_data1/oa_pdf/dc/ae/DR-19-79.PMC4801046.pdf
"2, 85~96, June, 2015  http://dx.doi.org/10.12717/DR.2015.19.2.085  ISSN 1226-6752 (Print)  ISSN 2287-7967 (Online)    Manuscript received 20 April 2015, Received in revised form 11 May 2015, Accepted 22 May 2015   † Corresponding Author : In-Seok Park, Division of Marine Bioscience, College of Ocean Science and Technology, Korea Maritime and Ocean University,  Busan 606-791, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d7/fd/DR-19-85.PMC4801047.pdf
"2, 97~109, June, 2015  http://dx.doi.org/10.12717/DR.2015.19.2.097  ISSN 1226-6752 (Print)  ISSN 2287-7967 (Online)    Manuscript received 11 May 2015, Received in revised form 28 May 2015, Accepted 9 June 2015   † Corresponding Author : In-Seok Park, Division of Marine Bioscience, College of Ocean Science and Technology, Korea Maritime and Ocean University,  Busan 606-791, Korea.",Non-OADS,/arxiv_data1/oa_pdf/72/15/DR-19-97.PMC4801048.pdf
"2, 111~118, June , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.2.111  ISSN 1226 -6752 (Print)   ISSN  2287 -7967 (Online)     Manuscript received 22 May 2015, Received in revised form 5 June 2015, Accepted 12 June 2015   † Corresponding Author : Na-Kyoung Kim , College of Law, Sungshin University, Seoul, 136 -742, Korea .",Non-OADS,/arxiv_data1/oa_pdf/91/98/DR-19-111.PMC4801049.pdf
"2, 69~77, June , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.2.069  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 3 April  2015, Received in revised form 20 April  2015, Accepted 20 May 2015   † Corresponding Author : Ki-Ho Lee, Dept .",Non-OADS,/arxiv_data1/oa_pdf/ac/f9/DR-19-69.PMC4801050.pdf
"2, 61~67, June , 201 5  http://dx.doi.org/10.12717/DR.201 5.19.2.061  ISSN 1226 -6752 (Print)   ISSN 2287 -7967 (Online)     Manuscript received 1 April  2015, Received in revised form 9 April  2015, Accepted 4 May 2015   † Corresponding Author :  Leeyup Chung, Dept .",Non-OADS,/arxiv_data1/oa_pdf/41/88/DR-19-61.PMC4801051.pdf
"Brain research, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/41/88/DR-19-61.PMC4801051.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cf/18/ccid-9-063.PMC4801055.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/cf/18/ccid-9-063.PMC4801055.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and Investigational Dermatology 2016:9 63–70Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  63OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S9878 7a placebo-controlled, double-blind clinical   trial to evaluate the efficacy of Imedeen®   Time Perfection® for improving the appearance   of photodamaged skin Thomas J stephens1 Monya l sigler1 James h herndon Jr2 lisa Dispensa3 anne le Moigne3 1Thomas J. stephens and associates,   Inc., richardson, TX, 2Dermatology  Center of Dallas, Dallas, TX, 3Pfizer  Consumer healthcare, Madison, nJ,   Usa Correspondence:  Thomas J stephens   Thomas J. stephens and associates, Inc.,  3310 Keller springs road, suite 130,  Carrollton, TX 75006, Usa   T el +1 972 392 1529 ext 203   Fax +1 972 392 2347   email tstephens@stephens-associates.",Non-OADS,/arxiv_data1/oa_pdf/cf/18/ccid-9-063.PMC4801055.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/cf/18/ccid-9-063.PMC4801055.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/18/ccid-9-063.PMC4801055.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/3b/iew009.PMC4801057.pdf
"Bioinformatic Analysis All 563 mature bmo-miRNA sequences used were downloaded fromthe searchable database (miRBase 21, http://www.mirbase.org/).",OADS,/arxiv_data1/oa_pdf/24/3b/iew009.PMC4801057.pdf
"Thesequence of BmFMBP-1 (1481 bp, protein ID: NP_001036969.1) and the 3 0-UTR (825 bp) were obtained from NCBI (http://www.ncbi.nlm.nih.gov/nuccore/NM_001043504.1) by a BLAST search.",OADS,/arxiv_data1/oa_pdf/24/3b/iew009.PMC4801057.pdf
The online bioinformatics prediction software RNAhybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/) and RNA22 (http://cbcsrv.watson.ibm.com/rna22.html) were employed for prediction of basepairing between BmFMBP-1 3 0UTR and the seed regions (a conserved nucleotide sequence positions 2–8 in the 5’end of the miRNA) of thebmo-miRNAs.,OADS,/arxiv_data1/oa_pdf/24/3b/iew009.PMC4801057.pdf
"Construction of Recombinant Vectors The primary sequence of bmo-miR-2758 (pri-bmo-miR-2758) that100-bp extended at upstream and downstream of the precursorsequence was obtained from the miRBase database and SilkwormGenome Database (SilkDB, http://www.silkdb.org/silkdb/).",OADS,/arxiv_data1/oa_pdf/24/3b/iew009.PMC4801057.pdf
Available at: http://edwardboches.com/five-things-that-work-in-social-media.,Non-OADS,/arxiv_data1/oa_pdf/93/6f/gox-4-e599.PMC4801087.pdf
http://links.lww.com/PrSgO/a161.,Non-OADS,/arxiv_data1/oa_pdf/5e/da/gox-4-e597.PMC4801090.pdf
"Fleiss’ κ was  used to assess interrater reliability using ReCal3  (available online at http://dfreelon.org/utils/recal- front/recal3/; accessed February–May, 2015).",OADS,/arxiv_data1/oa_pdf/9c/0e/gox-4-e598.PMC4801100.pdf
"1A and see  Fig., Supplementary Digital Content 1, which displays a flowchart overview of the case report, http://links.lww.com/PRSGO/A162).",Non-OADS,/arxiv_data1/oa_pdf/d5/e2/gox-4-e594.PMC4801102.pdf
"Six months  after conclusion of lipofilling, complete remission  of skin radiation sequelae was observed and the skin was soft and elastic again (see Fig., Supplementary  Digital Content 1, which displays a flowchart overview  of the case report, http://links.lww.com/PRSGO/A162) and with a minimum subcutaneous thickness of 2 cm at whole left breast topography (confirmed by  ultrasonographyc and magnetic resonance imaging controls; see video, Supplementary Digital Content 3, which shows a complete remission of skin radiation  sequelae.",Non-OADS,/arxiv_data1/oa_pdf/d5/e2/gox-4-e594.PMC4801102.pdf
http://links.lww.com/PRSGO/A164).,Non-OADS,/arxiv_data1/oa_pdf/d5/e2/gox-4-e594.PMC4801102.pdf
"• Fat Grafting to the Breast Fig., Supplementary Digital Content 1, which displays  a flowchart overview of the case report, http://links.lww.com/PRSGO/A162).",Non-OADS,/arxiv_data1/oa_pdf/d5/e2/gox-4-e594.PMC4801102.pdf
http://links.lww.,Non-OADS,/arxiv_data1/oa_pdf/d5/e2/gox-4-e594.PMC4801102.pdf
http://links.lww.com/pRsGo/a164.,Non-OADS,/arxiv_data1/oa_pdf/d5/e2/gox-4-e594.PMC4801102.pdf
"Developmental Cognitive  Neuroscience  16  (2015)  63–70 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Cannabis use in  early  adolescence:  Evidence  of  amygdala hypersensitivity  to signals of  threat Philip A.  Spechlera,∗,  Catherine  A.  Orrb,  Bader  Chaarania,  Kees-Jan  Kana,  Scott  Mackeya, Aaron Mortona,  Mitchell  P.  Snowea,  Kelsey  E.  Hudsona,  Robert  R.  Althoffa, Stephen T.  Higginsa,  Anna  Cattrellc,d,  Herta  Flore,  Frauke  Neesf,  Tobias  Banaschewskie, Arun L.W.",Non-OADS,/arxiv_data1/oa_pdf/ee/23/main.PMC4801124.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/23/main.PMC4801124.pdf
http://dx.doi.org/10.1016/j.dcn.2015.08.007 1878-9293/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/23/main.PMC4801124.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/ee/23/main.PMC4801124.pdf
The smoothness  of  the  data  was  estimated  using  3dFWHMx  (details  at http://afni.nimh.nih.gov/pub/dist/doc/program  help/ ).,OADS,/arxiv_data1/oa_pdf/ee/23/main.PMC4801124.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.dcn.2015.08.007 .",OADS,/arxiv_data1/oa_pdf/ee/23/main.PMC4801124.pdf
"Anxiety  25  (6),  496–505,  http://dx.doi.org/10.1002/ da.20347 .",Non-OADS,/arxiv_data1/oa_pdf/ee/23/main.PMC4801124.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/24/opth-10-477.PMC4801125.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 477–483Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  477Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S9889 2Treatment costs of cystoid macular edema among  patients following cataract surgery Jordana K schmier1 David W Covert2 Carolyn K hulme-lowe1 anmol Mullins3 emmanuel M Mahlis4 1health sciences, exponent inc.,   alexandria, V a, 2health economics,   3global Market access, 4Us Pharma  Medical affairs, alcon inc., Fort Worth,   TX, UsaPurpose:  The current costs of treating cystoid macular edema (CME), a complication that can  follow cataract surgery, are largely unknown.",Non-OADS,/arxiv_data1/oa_pdf/fc/24/opth-10-477.PMC4801125.pdf
"Keywords:  claims analysis, costs and cost analysis, cystoid macular edema, diabetic retinopathy Introduction Cataract is a leading cause of visual impairment in the US, with almost one-third of  adults aged 65 years and older having been diagnosed with the condition.1 It is the most  common cause of low vision among adults older than 40 years.2 More than 20 million  Americans have cataracts in one or both eyes,2 and prevalence increases with age.3  Among Medicare beneficiaries, ∼20% had a claim for cataract diagnosis between 1981  and 1988; cataracts were responsible for more than half of all allowable charges for  eye care in the 1980s.4 This continued to be the main source of Medicare ophthalmic  charges in the 1990s.5 Despite the expense of the surgery, cataract surgery has con - sistently been demonstrated to be cost-effective, with recent analyses reiterating this  finding given trends in disease and treatment strategies.6,7Correspondence: Jordana K schmier exponent inc., 1800 Diagonal road,  suite 500, alexandria, Va 22314, Usa Tel +1 571 227 7241 Fax +1 571 227 7299 email jschmier@exponent.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Schmier et al Running head recto: Treatment costs of cystoid macular edema DOI: http://dx.doi.org/10.2147/OPTH.S98892",Non-OADS,/arxiv_data1/oa_pdf/fc/24/opth-10-477.PMC4801125.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fc/24/opth-10-477.PMC4801125.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/24/opth-10-477.PMC4801125.pdf
